<?xml version="1.0"?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2014//EN" "http://www.ncbi.nlm.nih.gov/corehtml/query/DTD/pubmed_140101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25130540</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1873-2518</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>14</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Vaccine</Title>
                <ISOAbbreviation>Vaccine</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Complete protection against lethal challenge of novel H7N9 virus with heterologous inactivated H7 vaccine in mice.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">S0264-410X(14)01069-X</ELocationID>
            <ELocationID EIdType="doi">10.1016/j.vaccine.2014.07.087</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">A prototype H7 influenza vaccine constructed based on the H7N7 outbreak in 2003 was tested for the protective efficacy against the novel H7N9 virus in a lethal murine challenge model. Serum samples from vaccinated mice showed significant neutralizing activity against the H7N9 virus and the mice were completely protected with no significant weight loss. The results have direct implications on how to overcome potential vaccine shortage and identify donors for immune sera for passive immunization.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 Elsevier Ltd. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Lynn</LastName>
                    <ForeName>Tang Lay Hoon</ForeName>
                    <Initials>TL</Initials>
                    <Affiliation>Medical Countermeasures (Biological) Laboratory, DMERI, DSO National Laboratories, 27 Medical Drive, 117510, Republic of Singapore.</Affiliation>
                </Author>
                <Author>
                    <LastName>Lim</LastName>
                    <ForeName>Jie Hui</ForeName>
                    <Initials>JH</Initials>
                    <Affiliation>Medical Countermeasures (Biological) Laboratory, DMERI, DSO National Laboratories, 27 Medical Drive, 117510, Republic of Singapore.</Affiliation>
                </Author>
                <Author>
                    <LastName>Kuah</LastName>
                    <ForeName>Li Fang</ForeName>
                    <Initials>LF</Initials>
                    <Affiliation>Medical Countermeasures (Biological) Laboratory, DMERI, DSO National Laboratories, 27 Medical Drive, 117510, Republic of Singapore.</Affiliation>
                </Author>
                <Author>
                    <LastName>Lau</LastName>
                    <ForeName>Yuk Fai</ForeName>
                    <Initials>YF</Initials>
                    <Affiliation>Medical Countermeasures (Biological) Laboratory, DMERI, DSO National Laboratories, 27 Medical Drive, 117510, Republic of Singapore; Program in Emerging Infectious Diseases, Duke-NUS Graduate Medical School, 8 College Road, 169857, Republic of Singapore. Electronic address: lyukfai@dso.org.sg.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>14</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Vaccine</MedlineTA>
            <NlmUniqueID>8406899</NlmUniqueID>
            <ISSNLinking>0264-410X</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">H7N9</Keyword>
            <Keyword MajorTopicYN="N">Influenza</Keyword>
            <Keyword MajorTopicYN="N">Vaccine</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2013</Year>
                <Month>10</Month>
                <Day>22</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>4</Month>
                <Day>29</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>31</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">S0264-410X(14)01069-X</ArticleId>
            <ArticleId IdType="doi">10.1016/j.vaccine.2014.07.087</ArticleId>
            <ArticleId IdType="pubmed">25130540</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25130539</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1873-2518</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>14</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Vaccine</Title>
                <ISOAbbreviation>Vaccine</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Parenteral administration of GnRH constructs and adjuvants: Immune responses and effects on reproductive tissues of male mice.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">S0264-410X(14)01027-5</ELocationID>
            <ELocationID EIdType="doi">10.1016/j.vaccine.2014.07.075</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Two gonadotrophin releasing hormone (GnRH) constructs prepared by either chemical conjugation to keyhole limpet hemocyanin (GnRH-KLH) or as an expressed recombinant fusion protein (Multimer) were evaluated with or without adjuvants (immunostimulating complexes, ISCOMs, or cytosine-phosphate-guanosine oligodeoxynucleotides, CpG ODNs). After subcutaneous administration to Balb/c male mice at Weeks 0, 2 and 4, these preparations were assessed for induction of immune responses and effects on reproductive organs. GnRH-KLH plus ISCOMs formulation induced strong IgG immune responses from Week 4 through Week 12 resulting in consistent reproductive organ atrophy by Week 12 after subcutaneous administration. GnRH-KLH plus CpG ODNs generated immune responses but no atrophy of reproductive tissues by Week 12. Multimer plus ISCOMs induced poor immune responses and no effects on reproductive tissues by Week 12. In the absence of additional adjuvant, none of the GnRH constructs induced reproductive organ atrophy. GnRH-KLH induced stronger immune responses when formulated with ISCOMs or CpG ODN compared to Multimer. GnRH-KLH with ISCOMs could be an effective colloidal alternative for emulsion GnRH vaccine formulations.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 Elsevier Ltd. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Sharma</LastName>
                    <ForeName>Sameer</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Commonwealth Scientific and Industrial Research Organisation (CSIRO), Biosecurity Flagship, GPO Box 1700, Canberra, ACT, Australia; Invasive Animals Cooperative Research Centre (IACRC), University of Canberra, Canberra, ACT, Australia.</Affiliation>
                </Author>
                <Author>
                    <LastName>McDonald</LastName>
                    <ForeName>Ian</ForeName>
                    <Initials>I</Initials>
                    <Affiliation>Commonwealth Scientific and Industrial Research Organisation (CSIRO), Biosecurity Flagship, GPO Box 1700, Canberra, ACT, Australia; Invasive Animals Cooperative Research Centre (IACRC), University of Canberra, Canberra, ACT, Australia; School of Agriculture and Food Science, University of Queensland, Brisbane, Queensland, Australia.</Affiliation>
                </Author>
                <Author>
                    <LastName>Miller</LastName>
                    <ForeName>Lowell</ForeName>
                    <Initials>L</Initials>
                    <Affiliation>National Wildlife Research Center, USDA, Fort Collins, CO, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Hinds</LastName>
                    <ForeName>Lyn A</ForeName>
                    <Initials>LA</Initials>
                    <Affiliation>Commonwealth Scientific and Industrial Research Organisation (CSIRO), Biosecurity Flagship, GPO Box 1700, Canberra, ACT, Australia; Invasive Animals Cooperative Research Centre (IACRC), University of Canberra, Canberra, ACT, Australia. Electronic address: Lyn.Hinds@csiro.au.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>14</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Vaccine</MedlineTA>
            <NlmUniqueID>8406899</NlmUniqueID>
            <ISSNLinking>0264-410X</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Cytosine-phosphate-guanosine oligodeoxynucleotides</Keyword>
            <Keyword MajorTopicYN="N">Endogenous peptide</Keyword>
            <Keyword MajorTopicYN="N">Epididymis</Keyword>
            <Keyword MajorTopicYN="N">Immunostimulating complexes</Keyword>
            <Keyword MajorTopicYN="N">Testis</Keyword>
            <Keyword MajorTopicYN="N">Vaccine</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>14</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>8</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>21</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">S0264-410X(14)01027-5</ArticleId>
            <ArticleId IdType="doi">10.1016/j.vaccine.2014.07.075</ArticleId>
            <ArticleId IdType="pubmed">25130539</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25130500</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1097-4687</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>18</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of morphology</Title>
                <ISOAbbreviation>J. Morphol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>A Comparison of mucosal surface area and villous histology in small intestines of the Brazilian free-tailed bat (Tadarida brasiliensis) and the mouse (Mus musculus).</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.1002/jmor.20324</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Studies on birds have led to the hypothesis that increased intestinal absorption between enterocytes (paracellular) evolved as a compensation for smaller intestinal size in fliers, which was perhaps selected to minimize the mass of digesta carried. This hypothesis predicts that bats will also exhibit relatively reduced intestinal size and high paracellular absorption, compared with nonflying mammals. Published studies on three bat species indicate relatively high paracellular absorption. One mechanism for increasing paracellular absorption per cm(2) small intestine (SI) is increased number of tight junctions (TJs) across which paracellular absorption occurs. To our knowledge, we provide the first comparative analysis of enterocyte size and number in flying and nonflying mammals. Intestines of insectivorous bats Tadarida brasiliensis were compared with Mus musculus using hematoxylin and eosin staining method. Bats had shorter and narrower SIs than mice, and after correction for body size difference by normalizing to mass(3/4) , the bats had 40% less nominal surface area than the mouse, as predicted. Villous enhancement of surface area was 90% greater in the bat than in the mouse, mainly because of longer villi and a greater density of villi in bat intestines. Bat and mouse were similar in enterocyte diameter. Bats exceeded mice by 54.4% in villous area per cm length SI and by 95% in number of enterocytes per cm(2) of the nominal surface area of the SI. Therefore, an increased density of TJs per cm(2) SI may be a mechanistic explanation that helps to understand the high paracellular absorption observed in bats compared to nonflying mammals. J. Morphol., 2014. ?? 2014 Wiley Periodicals, Inc.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 Wiley Periodicals, Inc.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Zhang</LastName>
                    <ForeName>Zhi-Qiang</ForeName>
                    <Initials>ZQ</Initials>
                    <Affiliation>Instituto Multidisciplinario de Investigaciones Biol??gicas de San Luis, Consejo Nacional de Investigaciones Cient??ficas y T??cnicas, 5700, San Luis, Argentina.</Affiliation>
                </Author>
                <Author>
                    <LastName>Brun</LastName>
                    <ForeName>Antonio</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author>
                    <LastName>Price</LastName>
                    <ForeName>Edwin R</ForeName>
                    <Initials>ER</Initials>
                </Author>
                <Author>
                    <LastName>Cruz-Neto</LastName>
                    <ForeName>Ariovaldo P</ForeName>
                    <Initials>AP</Initials>
                </Author>
                <Author>
                    <LastName>Karasov</LastName>
                    <ForeName>William H</ForeName>
                    <Initials>WH</Initials>
                </Author>
                <Author>
                    <LastName>Caviedes-Vidal</LastName>
                    <ForeName>Enrique</ForeName>
                    <Initials>E</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>J Morphol</MedlineTA>
            <NlmUniqueID>0406125</NlmUniqueID>
            <ISSNLinking>0022-2887</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Bats</Keyword>
            <Keyword MajorTopicYN="N">enterocytes</Keyword>
            <Keyword MajorTopicYN="N">intestinal surface area enlargement factor</Keyword>
            <Keyword MajorTopicYN="N">paracellular absorption</Keyword>
            <Keyword MajorTopicYN="N">rodents</Keyword>
            <Keyword MajorTopicYN="N">small intestine</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>2</Month>
                <Day>16</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>11</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>20</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jmor.20324</ArticleId>
            <ArticleId IdType="pubmed">25130500</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25130467</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>20</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1090-2104</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>14</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Biochemical and biophysical research communications</Title>
                <ISOAbbreviation>Biochem. Biophys. Res. Commun.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Chemical rescue of ??F508-CFTR in C127 epithelial cells reverses aberrant extracellular pH acidification to wild-type alkalization as monitored by microphysiometry.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">S0006-291X(14)01451-X</ELocationID>
            <ELocationID EIdType="doi">10.1016/j.bbrc.2014.08.036</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Cystic fibrosis (CF) is caused by mutations in the gene for CFTR, a cAMP-activated anion channel expressed in apical membranes of wet epithelia. Since CFTR is permeable to HCO3(-), and may regulate bicarbonate exchangers, it is not surprising evidence of changes in extracellular pH (pHo) have been found in CF. Previously we have shown that tracking pHo can be used to differentiate cells expressing wild-type CFTR from controls in mouse mammary epithelial (C127) and fibroblast (NIH/3T3) cell lines. In this study we characterized forskolin-stimulated extracellular acidification rates in epithelia where chemical correction of mutant ??F508-CFTR converted an aberrant response in acidification (10%+ increase) to wild-type (25%+ decrease). Thus treatment with corrector (10% glycerol) and the resulting increased expression of ??F508-CFTR at the surface was detected by microphysiometry as a significant reversal from acidification to alkalization of pHo. These results suggest that CFTR activation as well as correction can be detected by carefully monitoring pHo and support findings in the field that extracellular pH acidification may impact the function of airway surface liquid in CF.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014. Published by Elsevier Inc.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Luckie</LastName>
                    <ForeName>Douglas B</ForeName>
                    <Initials>DB</Initials>
                    <Affiliation>Cystic Fibrosis Research Laboratory, Department of Physiology and Lyman Briggs College, Michigan State University, 2100 Biomedical Sciences Bldg., East Lansing, MI 48824, United States. Electronic address: luckie@msu.edu.</Affiliation>
                </Author>
                <Author>
                    <LastName>Van Alst</LastName>
                    <ForeName>Andrew J</ForeName>
                    <Initials>AJ</Initials>
                    <Affiliation>Cystic Fibrosis Research Laboratory, Department of Physiology and Lyman Briggs College, Michigan State University, 2100 Biomedical Sciences Bldg., East Lansing, MI 48824, United States.</Affiliation>
                </Author>
                <Author>
                    <LastName>Massey</LastName>
                    <ForeName>Marija K</ForeName>
                    <Initials>MK</Initials>
                    <Affiliation>Cystic Fibrosis Research Laboratory, Department of Physiology and Lyman Briggs College, Michigan State University, 2100 Biomedical Sciences Bldg., East Lansing, MI 48824, United States.</Affiliation>
                </Author>
                <Author>
                    <LastName>Flood</LastName>
                    <ForeName>Robert D</ForeName>
                    <Initials>RD</Initials>
                    <Affiliation>Cystic Fibrosis Research Laboratory, Department of Physiology and Lyman Briggs College, Michigan State University, 2100 Biomedical Sciences Bldg., East Lansing, MI 48824, United States.</Affiliation>
                </Author>
                <Author>
                    <LastName>Shah</LastName>
                    <ForeName>Aashish A</ForeName>
                    <Initials>AA</Initials>
                    <Affiliation>Cystic Fibrosis Research Laboratory, Department of Physiology and Lyman Briggs College, Michigan State University, 2100 Biomedical Sciences Bldg., East Lansing, MI 48824, United States.</Affiliation>
                </Author>
                <Author>
                    <LastName>Malhotra</LastName>
                    <ForeName>Vishal</ForeName>
                    <Initials>V</Initials>
                    <Affiliation>Cystic Fibrosis Research Laboratory, Department of Physiology and Lyman Briggs College, Michigan State University, 2100 Biomedical Sciences Bldg., East Lansing, MI 48824, United States.</Affiliation>
                </Author>
                <Author>
                    <LastName>Kozel</LastName>
                    <ForeName>Bradley J</ForeName>
                    <Initials>BJ</Initials>
                    <Affiliation>Cystic Fibrosis Research Laboratory, Department of Physiology and Lyman Briggs College, Michigan State University, 2100 Biomedical Sciences Bldg., East Lansing, MI 48824, United States.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>14</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Biochem Biophys Res Commun</MedlineTA>
            <NlmUniqueID>0372516</NlmUniqueID>
            <ISSNLinking>0006-291X</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Bicarbonate</Keyword>
            <Keyword MajorTopicYN="N">CFTR</Keyword>
            <Keyword MajorTopicYN="N">Corrector</Keyword>
            <Keyword MajorTopicYN="N">Cystic fibrosis</Keyword>
            <Keyword MajorTopicYN="N">Glycerol</Keyword>
            <Keyword MajorTopicYN="N">pH</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>25</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>4</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">25130467</ArticleId>
            <ArticleId IdType="pii">S0006-291X(14)01451-X</ArticleId>
            <ArticleId IdType="doi">10.1016/j.bbrc.2014.08.036</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25130466</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>23</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1090-2104</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>14</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Biochemical and biophysical research communications</Title>
                <ISOAbbreviation>Biochem. Biophys. Res. Commun.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>LOX-1 - dependent mitochondrial DNA damage and NLRP3 activation during systemic inflammation in mice.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">S0006-291X(14)01449-1</ELocationID>
            <ELocationID EIdType="doi">10.1016/j.bbrc.2014.08.034</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Lectin-like oxidized low-density lipoprotein scavenger receptor-1 (LOX-1) is known to be involved in many pathophysiological events, such as inflammation.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">To clarify the role of LOX-1 deletion in mtDNA damage and NLRP3 inflammasome activation, we studied wild-type (WT) and LOX-1 knockout (KO) mice given thioglycollate, an inflammatory stimulus.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">We observed intense inflammatory response (CD45 and CD68 expression) and mtDNA damage in spleen and kidneys of WT mice given thioglycollate. The abrogation of LOX-1 (use of LOX-1 knockout mice) reduced the inflammatory response as well as mtDNA damage (P&lt;0.05 vs. WT mice). We also observed that mice with LOX-1 deletion had markedly reduced expression of caspase-1 (P10 and P20 subunits) as well as cleaved IL-1?? and IL-18. These mice also had much less mtDNA damage and only limited NLRP3 inflammasome expression.</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">These in vivo observations indicate that LOX-1 plays a key role in mtDNA damage which then leads to NLRP3 inflammasome activation during inflammation.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014. Published by Elsevier Inc.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Ding</LastName>
                    <ForeName>Zufeng</ForeName>
                    <Initials>Z</Initials>
                    <Affiliation>Central Arkansas Veterans Healthcare System and the Department of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA; Key Laboratory for Biomechanics and Mechanobiology of Ministry of Education, School of Biological Science and Medical Engineering, Beihang University, Beijing 100191, PR China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Liu</LastName>
                    <ForeName>Shijie</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Central Arkansas Veterans Healthcare System and the Department of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA. Electronic address: SLiu2@uams.edu.</Affiliation>
                </Author>
                <Author>
                    <LastName>Wang</LastName>
                    <ForeName>Xianwei</ForeName>
                    <Initials>X</Initials>
                    <Affiliation>Central Arkansas Veterans Healthcare System and the Department of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Theus</LastName>
                    <ForeName>Sue</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Central Arkansas Veterans Healthcare System and the Department of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA; Key Laboratory for Biomechanics and Mechanobiology of Ministry of Education, School of Biological Science and Medical Engineering, Beihang University, Beijing 100191, PR China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Fan</LastName>
                    <ForeName>Yubo</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Key Laboratory for Biomechanics and Mechanobiology of Ministry of Education, School of Biological Science and Medical Engineering, Beihang University, Beijing 100191, PR China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Deng</LastName>
                    <ForeName>Xiaoyan</ForeName>
                    <Initials>X</Initials>
                    <Affiliation>Key Laboratory for Biomechanics and Mechanobiology of Ministry of Education, School of Biological Science and Medical Engineering, Beihang University, Beijing 100191, PR China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Mehta</LastName>
                    <ForeName>Jawahar L</ForeName>
                    <Initials>JL</Initials>
                    <Affiliation>Central Arkansas Veterans Healthcare System and the Department of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA. Electronic address: MehtaJL@UAMS.edu.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>14</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Biochem Biophys Res Commun</MedlineTA>
            <NlmUniqueID>0372516</NlmUniqueID>
            <ISSNLinking>0006-291X</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">LOX-1</Keyword>
            <Keyword MajorTopicYN="N">Mitochondrial DNA damage</Keyword>
            <Keyword MajorTopicYN="N">NLRP3 inflammasome</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>5</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>8</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">25130466</ArticleId>
            <ArticleId IdType="pii">S0006-291X(14)01449-1</ArticleId>
            <ArticleId IdType="doi">10.1016/j.bbrc.2014.08.034</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25130458</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1601-183X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>6</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Genes, brain, and behavior</Title>
                <ISOAbbreviation>Genes Brain Behav.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Sex-specific behavioral traits in the Brd2 mouse model of Juvenile Myoclonic Epilepsy.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.1111/gbb.12160</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Idiopathic generalized epilepsy represents about 30-35% of all epilepsies in humans. The bromodomain BRD2 gene has been repeatedly associated with the subsyndrome of juvenile myoclonic epilepsy. Our previous work determined that mice haploinsufficient in Brd2 (Brd2+/- ) have increased susceptibility to provoked seizures, develop spontaneous seizures and have significantly decreased GABA markers in the direct basal ganglia pathway as well as in the neocortex and superior colliculus. Here we tested male and female Brd2+/-and wild type littermate mice in a battery of behavioral tests (open field, tube dominance test, elevated plus maze, Morris water maze and Barnes maze) to identify whether Brd2 haploinsufficiency is associated with the human behavioral patterns, so-called juvenile myoclonic epilepsy personality. Brd2+/-females but not males consistently displayed decreased anxiety. Further, we found a highly significant dominance trait (aggression) in the Brd2+/-mice compared to the wild type, more pronounced in females. Brd2+/-mice of either sex did not differ from wild type mice in spatial learning and memory tests. Compared to wild type littermates, we found decreased numbers GABA neurons in the basolateral amygdala, which is consistent with the increase in aggressive behavior. Our results indicate that Brd2+/-haploinsufficient mice show no cognitive impairment but have behavioral traits similar to those found in patients with juvenile myoclonic epilepsy (recklessness, aggression). This suggests that either the BRD2 gene is directly responsible for influencing many traits of juvenile myoclonic epilepsy or it controls upstream regulators of individual phenotypes.</AbstractText>
                <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Chachua</LastName>
                    <ForeName>Tamar</ForeName>
                    <Initials>T</Initials>
                    <Affiliation>Department of Cell Biology &amp; Anatomy, New York Medical College, 40 Sunshine Cottage Rd, Valhalla, NY, 10595, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Goletiani</LastName>
                    <ForeName>Cezar</ForeName>
                    <Initials>C</Initials>
                </Author>
                <Author>
                    <LastName>Maglakelidze</LastName>
                    <ForeName>Giorgi</ForeName>
                    <Initials>G</Initials>
                </Author>
                <Author>
                    <LastName>Sidyelyeva</LastName>
                    <ForeName>Galyna</ForeName>
                    <Initials>G</Initials>
                </Author>
                <Author>
                    <LastName>Daniel</LastName>
                    <ForeName>Margaret</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author>
                    <LastName>Morris</LastName>
                    <ForeName>Emily</ForeName>
                    <Initials>E</Initials>
                </Author>
                <Author>
                    <LastName>Miller</LastName>
                    <ForeName>James</ForeName>
                    <Initials>J</Initials>
                </Author>
                <Author>
                    <LastName>Shang</LastName>
                    <ForeName>Enyuan</ForeName>
                    <Initials>E</Initials>
                </Author>
                <Author>
                    <LastName>Wolgemuth</LastName>
                    <ForeName>Debra J</ForeName>
                    <Initials>DJ</Initials>
                </Author>
                <Author>
                    <LastName>Greenberg</LastName>
                    <ForeName>David A</ForeName>
                    <Initials>DA</Initials>
                </Author>
                <Author>
                    <LastName>Vel????kov??</LastName>
                    <ForeName>Jana</ForeName>
                    <Initials>J</Initials>
                </Author>
                <Author>
                    <LastName>Vel????ek</LastName>
                    <ForeName>Libor</ForeName>
                    <Initials>L</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>6</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Genes Brain Behav</MedlineTA>
            <NlmUniqueID>101129617</NlmUniqueID>
            <ISSNLinking>1601-183X</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Barnes maze</Keyword>
            <Keyword MajorTopicYN="N">Brd2 haploinsufficiency</Keyword>
            <Keyword MajorTopicYN="N">Morris Water Maze</Keyword>
            <Keyword MajorTopicYN="N">aggression</Keyword>
            <Keyword MajorTopicYN="N">anxiety</Keyword>
            <Keyword MajorTopicYN="N">cognition</Keyword>
            <Keyword MajorTopicYN="N">idiopathic generalized epilepsy</Keyword>
            <Keyword MajorTopicYN="N">open field</Keyword>
            <Keyword MajorTopicYN="N">personality</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>5</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>31</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>4</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1111/gbb.12160</ArticleId>
            <ArticleId IdType="pubmed">25130458</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25130446</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1879-291X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>14</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Ultrasound in medicine &amp; biology</Title>
                <ISOAbbreviation>Ultrasound Med Biol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Monitoring and Staging Abdominal Aortic Aneurysm Disease With Pulse Wave Imaging.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">S0301-5629(14)00253-1</ELocationID>
            <ELocationID EIdType="doi">10.1016/j.ultrasmedbio.2014.04.013</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">The abdominal aortic aneurysm (AAA) is a silent and often deadly vascular disease caused by the localized weakening of the arterial wall. Previous work has indicated that local changes in wall stiffness can be detected with pulse wave imaging (PWI), which is a non-invasive technique for tracking the propagation of pulse waves along the aorta at high spatial and temporal resolutions. The aim of this study was to assess the capability of PWI to monitor and stage AAA progression in a murine model of the disease. ApoE/TIMP-1 knockout mice (N??=??18) were given angiotensin II for 30??days via subcutaneously implanted osmotic pumps. The suprarenal sections of the abdominal aortas were imaged every 2-3??d after implantation using a 30-MHz VisualSonics Vevo 770 with 15-??m lateral resolution. Pulse wave propagation was monitored at an effective frame rate of 8??kHz by using retrospective electrocardiogram gating and by performing 1-D cross-correlation on the radiofrequency signals to obtain the displacements induced by the waves. In normal aortas, the pulse waves propagated at constant velocities (2.8??????0.9??m/s, r(2)??=??0.89??????0.11), indicating that the composition of these vessels was relatively homogeneous. In the mice that developed AAAs (N??=??10), the wave speeds in the aneurysm sac were 45% lower (1.6??????0.6??m/s) and were more variable (r(2)??= 0.66??????0.23). Moreover, the wave-induced wall displacements were at least 80% lower within the sacs compared with the surrounding vessel. Finally, in mice that developed fissures (N??=??5) or ruptures (N??=??3) at the sites of their AAA, higher displacements directed out of the lumen and with no discernible wave pattern (r(2)??&lt;??0.20) were observed throughout the cardiac cycle. These findings indicate that PWI can be used to distinguish normal murine aortas from aneurysmal, fissured and ruptured ones. Hence, PWI could potentially be used to monitor and stage human aneurysms by providing information complementary to standard B-mode ultrasound.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 World Federation for Ultrasound in Medicine &amp; Biology. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Nandlall</LastName>
                    <ForeName>Sacha D</ForeName>
                    <Initials>SD</Initials>
                    <Affiliation>Department of Biomedical Engineering, Columbia University, New York, New York, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Goldkang</LastName>
                    <ForeName>Monica P</ForeName>
                    <Initials>MP</Initials>
                    <Affiliation>Department of Medicine, Columbia University, New York, New York, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Kalashian</LastName>
                    <ForeName>Aubrey</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Department of Biomedical Engineering, Columbia University, New York, New York, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Dangra</LastName>
                    <ForeName>Nida A</ForeName>
                    <Initials>NA</Initials>
                    <Affiliation>Department of Biomedical Engineering, Columbia University, New York, New York, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>D'Armiento</LastName>
                    <ForeName>Jeanine M</ForeName>
                    <Initials>JM</Initials>
                    <Affiliation>Department of Medicine, Columbia University, New York, New York, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Konofagou</LastName>
                    <ForeName>Elisa E</ForeName>
                    <Initials>EE</Initials>
                    <Affiliation>Departments of Biomedical Engineering and Radiology, Columbia University, New York, New York, USA. Electronic address: ek2191@columbia.edu.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <GrantList>
                <Grant>
                    <GrantID>R01 HL098830</GrantID>
                    <Acronym>HL</Acronym>
                    <Agency>NHLBI NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>14</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Ultrasound Med Biol</MedlineTA>
            <NlmUniqueID>0410553</NlmUniqueID>
            <ISSNLinking>0301-5629</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Abdominal aortic aneurysm</Keyword>
            <Keyword MajorTopicYN="N">Fissure</Keyword>
            <Keyword MajorTopicYN="N">High-frequency imaging</Keyword>
            <Keyword MajorTopicYN="N">Mice</Keyword>
            <Keyword MajorTopicYN="N">Motion estimation</Keyword>
            <Keyword MajorTopicYN="N">Normalized cross-correlation</Keyword>
            <Keyword MajorTopicYN="N">Pulse wave velocity</Keyword>
            <Keyword MajorTopicYN="N">Regional pulse wave</Keyword>
            <Keyword MajorTopicYN="N">Rupture</Keyword>
            <Keyword MajorTopicYN="N">Speckle tracking</Keyword>
            <Keyword MajorTopicYN="N">Ultrasound imaging</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2013</Year>
                <Month>10</Month>
                <Day>16</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>3</Month>
                <Day>31</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>4</Month>
                <Day>21</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">S0301-5629(14)00253-1</ArticleId>
            <ArticleId IdType="doi">10.1016/j.ultrasmedbio.2014.04.013</ArticleId>
            <ArticleId IdType="pubmed">25130446</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25130440</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1878-5875</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>12</Day>
                    </PubDate>
                </JournalIssue>
                <Title>The international journal of biochemistry &amp; cell biology</Title>
                <ISOAbbreviation>Int. J. Biochem. Cell Biol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Mouse monocyte chemoattractant protein 1 (MCP1) functions as a monomer.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">S1357-2725(14)00253-2</ELocationID>
            <ELocationID EIdType="doi">10.1016/j.biocel.2014.08.002</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Monocyte chemoattractant protein 1 (MCP1) is an important chemoattractant for microglia. Rodent MCP1 carries a heavily glycosylated C-terminus, which has been predicted to increase local MCP1 concentration, promote MCP1 dimerization/oligomerization, and facilitate receptor engagement. Previous studies have shown that MCP1 mutant lacking the glycosylated C-terminus cannot dimerize/oligomerize, but has higher chemotactic potency than the wild-type (full-length) MCP1, suggesting that rodent MCP1 may function as a monomer. Although many groups support this hypothesis, there is no direct evidence on whether rodent MCP1 dimer is functional. In this paper, using forced recombinant dimeric MCP1 proteins we show that the mouse MCP1 dimer is unable to activate Rac1, promote protrusion of lamellipodia, or induce microglial migration, although it can bind to CCR2 and mediate its internalization. These results support the idea that signaling events mediated by MCP1 require the presence of the monomeric form of this chemokine.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014. Published by Elsevier Ltd.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Yao</LastName>
                    <ForeName>Yao</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Department of Pharmacology, Stony Brook University, Stony Brook, NY 11794-8651, USA. Electronic address: styliani-anna.tsirka@stonybrook.edu.</Affiliation>
                </Author>
                <Author>
                    <LastName>Tsirka</LastName>
                    <ForeName>Stella E</ForeName>
                    <Initials>SE</Initials>
                    <Affiliation>Laboratory of Neurobiology and Genetics, The Rockefeller University, New York, NY, 10065, USA.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>12</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Int J Biochem Cell Biol</MedlineTA>
            <NlmUniqueID>9508482</NlmUniqueID>
            <ISSNLinking>1357-2725</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Chemokine</Keyword>
            <Keyword MajorTopicYN="N">Dimerization</Keyword>
            <Keyword MajorTopicYN="N">Migration</Keyword>
            <Keyword MajorTopicYN="N">Mouse</Keyword>
            <Keyword MajorTopicYN="N">Recombinant</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>28</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>13</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>4</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">25130440</ArticleId>
            <ArticleId IdType="pii">S1357-2725(14)00253-2</ArticleId>
            <ArticleId IdType="doi">10.1016/j.biocel.2014.08.002</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25130431</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1096-0961</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>11</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Blood cells, molecules &amp; diseases</Title>
                <ISOAbbreviation>Blood Cells Mol. Dis.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>The effects of Gremlin1 on human umbilical cord blood hematopoietic progenitors.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">S1079-9796(14)00091-6</ELocationID>
            <ELocationID EIdType="doi">10.1016/j.bcmd.2014.07.012</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Bone morphogenetic proteins (BMPs) support malignant hematopoiesis in CML. Conversely, the multi-functional BMP antagonist Gremlin1 supports self-renewing cancer stem cells of other malignancies. Inhibition of BMP signaling in CML, or of Gremlin1 in solid tumors, may therefore have therapeutic potential. However, since BMPs regulate hematopoietic stem cell (HSC) decisions in the stem cell niche, it is necessary to determine how Gremlin1 influences normal HSC. We examined the effects of Gremlin1 on long-term culture-initiating cells (LTC-IC) and transplantable hematopoietic stem cells (SCID-repopulating cells: SRC) in human umbilical cord blood. Gremlin1 inhibited BMP signaling, downregulated BMP-6 and cyclin E2 expression and upregulated hairy and enhancer of split-1 (HES-1; a Notch transcriptional target) and Hedgehog interacting protein-1 (HHIP-1; an inhibitor of Hedgehog signaling). The functional effects of Gremlin1 on SRC, i.e. skewing of their myelopoietic:lymphopoietic potential towards B lymphopoiesis without affecting long-term engraftment potential, were entirely consistent with changes in gene expression induced by Gremlin1. Since both BMPs and Gremlin1 are secreted by osteoblasts in vivo, our studies provide potential insights into the molecular regulation of hematopoiesis in the stem cell niche. These results also suggest that Gremlin1 (and possibly its mimetics that may be developed for therapeutic use) may not adversely affect normal human hematopoietic stem cell survival, though they may reduce their myelopoietic potential.</AbstractText>
                <CopyrightInformation>Published by Elsevier Inc.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Shekels</LastName>
                    <ForeName>Laurie L</ForeName>
                    <Initials>LL</Initials>
                    <Affiliation>Hematology/Oncology Section, Minneapolis VA Health Care System, Minneapolis, MN, USA; Hematology/Oncology/Transplantation Division, Department of Medicine, University of Minnesota, Minneapolis, MN, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Colvin Wanshura</LastName>
                    <ForeName>Leah E</ForeName>
                    <Initials>LE</Initials>
                    <Affiliation>Hematology/Oncology Section, Minneapolis VA Health Care System, Minneapolis, MN, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Xie</LastName>
                    <ForeName>Yonghong</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Hematology/Oncology Section, Minneapolis VA Health Care System, Minneapolis, MN, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Nelson</LastName>
                    <ForeName>Matthew S</ForeName>
                    <Initials>MS</Initials>
                    <Affiliation>Hematology/Oncology Section, Minneapolis VA Health Care System, Minneapolis, MN, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Stephenson</LastName>
                    <ForeName>Elliot J</ForeName>
                    <Initials>EJ</Initials>
                    <Affiliation>Hematology/Oncology Section, Minneapolis VA Health Care System, Minneapolis, MN, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Khan</LastName>
                    <ForeName>Shaukat A</ForeName>
                    <Initials>SA</Initials>
                    <Affiliation>Hematology/Oncology Section, Minneapolis VA Health Care System, Minneapolis, MN, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Gupta</LastName>
                    <ForeName>Pankaj</ForeName>
                    <Initials>P</Initials>
                    <Affiliation>Hematology/Oncology Section, Minneapolis VA Health Care System, Minneapolis, MN, USA; Hematology/Oncology/Transplantation Division, Department of Medicine, University of Minnesota, Minneapolis, MN, USA. Electronic address: pankaj.gupta@va.gov.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>11</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Blood Cells Mol Dis</MedlineTA>
            <NlmUniqueID>9509932</NlmUniqueID>
            <ISSNLinking>1079-9796</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Bone morphogenetic proteins</Keyword>
            <Keyword MajorTopicYN="N">Gremlin 1 protein, human</Keyword>
            <Keyword MajorTopicYN="N">Hematopoietic stem cell transplantation</Keyword>
            <Keyword MajorTopicYN="N">Hematopoietic stem cells</Keyword>
            <Keyword MajorTopicYN="N">Mice, SCID</Keyword>
            <Keyword MajorTopicYN="N">Transcription factors</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>12</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">S1079-9796(14)00091-6</ArticleId>
            <ArticleId IdType="doi">10.1016/j.bcmd.2014.07.012</ArticleId>
            <ArticleId IdType="pubmed">25130431</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25130427</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1527-3350</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>8</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Hepatology (Baltimore, Md.)</Title>
                <ISOAbbreviation>Hepatology</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Genetic ablation of solute carrier family 7a3a leads to hepatic steatosis in zebrafish during fasting.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.1002/hep.27356</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disorder caused by abnormal lipid metabolisms such as reduced hepatic fatty acid oxidation, but intracellular control of fatty acid oxidation under physiological and pathological conditions remains largely undefined. Here, we demonstrate that deprivation of Slc7(3) leads to hepatic steatosis in fasted zebrafish due to defects in arginine-dependent nitric oxide (NO) synthesis. Fast-induced hepatic steatosis in slc7(3) -null mutants can be rescued by treatments with NO donor, cGMP analog, AMPK activator or PPAR?? agonist. In contrast, inhibitors of NO synthases, AMPK or soluble guanylate cyclase and liver-specifically expressed dominant negatives of PGC-1?? and PPAR?? are sufficient to induce hepatic steatosis in fasted wild-type larvae. Moreover, knockdown of Slc7a3 in mice or SLC7A3 in human liver cells impaired AMPK-PPAR?? signaling and resulted in lipid accumulation under fasting or glucose starvation, respectively. Conclusion: These findings have revealed a NO-AMPK-PPAR?? signaling pathway that is crucial for the control of hepatic fatty acid oxidation in vertebrates. (Hepatology 2014;).</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 American Association for the Study of Liver Diseases.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Gu</LastName>
                    <ForeName>Qilin</ForeName>
                    <Initials>Q</Initials>
                    <Affiliation>State Key Laboratory of Freshwater Ecology and Biotechnology, Institute of Hydrobiology, Chinese Academy of Sciences, Wuhan, 430072, China; University of Chinese Academy of Sciences, Beijing, 100049, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Yang</LastName>
                    <ForeName>Xiaojie</ForeName>
                    <Initials>X</Initials>
                </Author>
                <Author>
                    <LastName>Lin</LastName>
                    <ForeName>Li</ForeName>
                    <Initials>L</Initials>
                </Author>
                <Author>
                    <LastName>Li</LastName>
                    <ForeName>Shaoyang</ForeName>
                    <Initials>S</Initials>
                </Author>
                <Author>
                    <LastName>Li</LastName>
                    <ForeName>Qing</ForeName>
                    <Initials>Q</Initials>
                </Author>
                <Author>
                    <LastName>Zhong</LastName>
                    <ForeName>Shan</ForeName>
                    <Initials>S</Initials>
                </Author>
                <Author>
                    <LastName>Peng</LastName>
                    <ForeName>Jinrong</ForeName>
                    <Initials>J</Initials>
                </Author>
                <Author>
                    <LastName>Cui</LastName>
                    <ForeName>Zongbin</ForeName>
                    <Initials>Z</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>8</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Hepatology</MedlineTA>
            <NlmUniqueID>8302946</NlmUniqueID>
            <ISSNLinking>0270-9139</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">AMP-activated protein kinase (AMPK)</Keyword>
            <Keyword MajorTopicYN="N">Nitric oxide (NO)</Keyword>
            <Keyword MajorTopicYN="N">Nonalcoholic fatty liver disease (NAFLD)</Keyword>
            <Keyword MajorTopicYN="N">peroxisome proliferator-activated receptor ?? (PPAR??)</Keyword>
            <Keyword MajorTopicYN="N">peroxisome proliferator-activated receptor-?? coactivator 1?? (PGC-1??)</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>3</Month>
                <Day>9</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>11</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>30</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1002/hep.27356</ArticleId>
            <ArticleId IdType="pubmed">25130427</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25130400</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1932-7420</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>12</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Cell metabolism</Title>
                <ISOAbbreviation>Cell Metab.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>FGF21 Acts Centrally to Induce Sympathetic Nerve Activity, Energy Expenditure, and Weight Loss.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">S1550-4131(14)00320-9</ELocationID>
            <ELocationID EIdType="doi">10.1016/j.cmet.2014.07.012</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">The mechanism by which pharmacologic administration of the hormone FGF21 increases energy expenditure to cause weight loss in obese animals is unknown. Here we report that FGF21 acts centrally to exert its effects on energy expenditure and body weight in obese mice. Using tissue-specific knockout mice, we show that ??Klotho, the obligate coreceptor for FGF21, is required in the nervous system for these effects. FGF21 stimulates sympathetic nerve activity to brown adipose tissue through a mechanism that depends on the neuropeptide corticotropin-releasing factor. Our findings provide an unexpected mechanistic explanation for the strong pharmacologic effects of FGF21 on energy expenditure and weight loss in obese animals.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 Elsevier Inc. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Owen</LastName>
                    <ForeName>Bryn M</ForeName>
                    <Initials>BM</Initials>
                    <Affiliation>Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Ding</LastName>
                    <ForeName>Xunshan</ForeName>
                    <Initials>X</Initials>
                    <Affiliation>Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA; Department of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Morgan</LastName>
                    <ForeName>Donald A</ForeName>
                    <Initials>DA</Initials>
                    <Affiliation>Department of Pharmacology, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Coate</LastName>
                    <ForeName>Katie Colbert</ForeName>
                    <Initials>KC</Initials>
                    <Affiliation>Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA; Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Bookout</LastName>
                    <ForeName>Angie L</ForeName>
                    <Initials>AL</Initials>
                    <Affiliation>Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Rahmouni</LastName>
                    <ForeName>Kamal</ForeName>
                    <Initials>K</Initials>
                    <Affiliation>Department of Pharmacology, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Kliewer</LastName>
                    <ForeName>Steven A</ForeName>
                    <Initials>SA</Initials>
                    <Affiliation>Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA; Department of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA. Electronic address: steven.kliewer@utsouthwestern.edu.</Affiliation>
                </Author>
                <Author>
                    <LastName>Mangelsdorf</LastName>
                    <ForeName>David J</ForeName>
                    <Initials>DJ</Initials>
                    <Affiliation>Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA; Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA. Electronic address: davo.mango@utsouthwestern.edu.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <GrantList>
                <Grant>
                    <GrantID>R01 DK067158</GrantID>
                    <Acronym>DK</Acronym>
                    <Agency>NIDDK NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>T32 GM007062</GrantID>
                    <Acronym>GM</Acronym>
                    <Agency>NIGMS NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>12</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Cell Metab</MedlineTA>
            <NlmUniqueID>101233170</NlmUniqueID>
            <ISSNLinking>1550-4131</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>2</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>2</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">S1550-4131(14)00320-9</ArticleId>
            <ArticleId IdType="doi">10.1016/j.cmet.2014.07.012</ArticleId>
            <ArticleId IdType="pubmed">25130400</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25130399</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1932-7420</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>12</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Cell metabolism</Title>
                <ISOAbbreviation>Cell Metab.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Mitochondrial Complex I Activity Suppresses Inflammation and Enhances Bone Resorption by Shifting Macrophage-Osteoclast Polarization.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">S1550-4131(14)00319-2</ELocationID>
            <ELocationID EIdType="doi">10.1016/j.cmet.2014.07.011</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Mitochondrial complex I (CI) deficiency is associated with multiple neurological and metabolic disorders. However, its effect on innate immunity and bone remodeling is unclear. Using deletion of the essential CI subunit Ndufs4 as a model for mitochondrial dysfunction, we report that mitochondria suppress macrophage activation and inflammation??while promoting osteoclast differentiation and bone resorption via both cell-autonomous and systemic regulation. Global Ndufs4 deletion causes systemic inflammation and osteopetrosis. Hematopoietic Ndufs4 deletion causes an intrinsic lineage shift from osteoclast to macrophage. Liver Ndufs4 deletion causes a metabolic shift from fatty acid oxidation to glycolysis, accumulating fatty acids and lactate (FA/LAC) in the circulation. FA/LAC further activates Ndufs4(-/-) macrophages via reactive oxygen species induction and diminishes osteoclast lineage commitment in Ndufs4(-/-) progenitors; both inflammation and osteopetrosis in Ndufs4(-/-) mice are attenuated by TLR4/2 deletion. Together, these findings reveal mitochondrial CI as a critical rheostat of innate immunity and skeletal homeostasis.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 Elsevier Inc. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Jin</LastName>
                    <ForeName>Zixue</ForeName>
                    <Initials>Z</Initials>
                    <Affiliation>Department of Pharmacology, The University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Wei</LastName>
                    <ForeName>Wei</ForeName>
                    <Initials>W</Initials>
                    <Affiliation>Department of Pharmacology, The University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Yang</LastName>
                    <ForeName>Marie</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Department of Pharmacology, The University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Du</LastName>
                    <ForeName>Yang</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Department of Pharmacology, The University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Wan</LastName>
                    <ForeName>Yihong</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Department of Pharmacology, The University of Texas Southwestern Medical Center, Dallas, TX 75390, USA. Electronic address: yihong.wan@utsouthwestern.edu.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <GrantList>
                <Grant>
                    <GrantID>R01 DK089113</GrantID>
                    <Acronym>DK</Acronym>
                    <Agency>NIDDK NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>12</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Cell Metab</MedlineTA>
            <NlmUniqueID>101233170</NlmUniqueID>
            <ISSNLinking>1550-4131</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>3</Month>
                <Day>4</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>27</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>10</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">S1550-4131(14)00319-2</ArticleId>
            <ArticleId IdType="doi">10.1016/j.cmet.2014.07.011</ArticleId>
            <ArticleId IdType="pubmed">25130399</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25130376</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1098-1136</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>18</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Glia</Title>
                <ISOAbbreviation>Glia</ISOAbbreviation>
            </Journal>
            <ArticleTitle>TGF??1 increases microglia-mediated engulfment of apoptotic cells via upregulation of the milk fat globule-EGF factor 8.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.1002/glia.22740</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Milk fat globule-epidermal growth factor-factor 8 (Mfge8) has been described as an essential molecule during microglia-mediated clearance of apoptotic cells via binding to phosphatidylserine residues and subsequent phagocytosis. Impaired uptake of apoptotic cells by microglia results in prolonged inflammatory responses and damage of healthy cells. Although the mechanisms of Mfge8-mediated engulfment of apoptotic cells are well understood, endogenous or exogenous factors that regulate Mfge8 expression remain elusive. Here, we describe that TGF??1 increases the expression of Mfge8 and enhances the engulfment of apoptotic cells by primary mouse microglia in a Mfge8-dependent manner. Further, apoptotic cells are capable of increasing microglial TGF?? expression and release and shift the microglia phenotype toward alternative activation. Moreover, we provide evidence that Mfge8 expression is differentially regulated in microglia after classical and alternative activation and that Mfge8 is not able to exert direct antiinflammatory effects on LPS-treated primary microglia. Together, these results underline the importance of TGF??1 as a regulatory factor for microglia and suggest that increased TGF??1 expression in models of neurodegeneration might be involved in clearance of apoptotic cells via regulation of Mfge8 expression. GLIA 2014.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 Wiley Periodicals, Inc.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Spittau</LastName>
                    <ForeName>Bj??rn</ForeName>
                    <Initials>B</Initials>
                    <Affiliation>Department of Molecular Embryology, Institute for Anatomy and Cell Biology, Albert-Ludwigs-University, Freiburg, Germany.</Affiliation>
                </Author>
                <Author>
                    <LastName>Rilka</LastName>
                    <ForeName>Jennifer</ForeName>
                    <Initials>J</Initials>
                </Author>
                <Author>
                    <LastName>Steinfath</LastName>
                    <ForeName>Elsa</ForeName>
                    <Initials>E</Initials>
                </Author>
                <Author>
                    <LastName>Z??ller</LastName>
                    <ForeName>Tanja</ForeName>
                    <Initials>T</Initials>
                </Author>
                <Author>
                    <LastName>Krieglstein</LastName>
                    <ForeName>Kerstin</ForeName>
                    <Initials>K</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Glia</MedlineTA>
            <NlmUniqueID>8806785</NlmUniqueID>
            <ISSNLinking>0894-1491</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Mfge8</Keyword>
            <Keyword MajorTopicYN="N">TGF??1</Keyword>
            <Keyword MajorTopicYN="N">apoptotic cells</Keyword>
            <Keyword MajorTopicYN="N">microglia</Keyword>
            <Keyword MajorTopicYN="N">phagocytosis</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2013</Year>
                <Month>9</Month>
                <Day>24</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>22</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>29</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1002/glia.22740</ArticleId>
            <ArticleId IdType="pubmed">25130376</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25130372</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1398-9995</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>13</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Allergy</Title>
                <ISOAbbreviation>Allergy</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Extracellular DNA traps in bronchoalveolar fluid from a murine eosinophilic pulmonary response.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.1111/all.12507</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Asthma is associated with a loss of the structural integrity of airway epithelium and dysfunction of the physical barrier, which protects airways from external harmful factors. Granulocyte activation causes the formation of extracellular traps, releasing web-like structures of DNA and proteins, being important to kill pathogens extracellularly. We investigated whether eosinophils infiltrating airways in an experimental model of asthma would induce eosinophil extracellular traps (EETs) in bronchoalveolar lavage fluid and lung tissue. We showed that an ovalbumin (OVA) asthma protocol presented a significant increase in eosinophil counts with increased extracellular DNA in bronchoalveolar lavage fluid as well as in lung tissue, confirming the presence of DNA traps colocalized with eosinophil peroxidase. EETs formation was reversed by DNase treatment. With these approaches, we demonstrated for the first time that OVA-challenged mice release extracellular DNA traps, which could aggravate pulmonary dysfunction. This article is protected by copyright. All rights reserved.</AbstractText>
                <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Cunha</LastName>
                    <ForeName>A A</ForeName>
                    <Initials>AA</Initials>
                    <Affiliation>Laboratory of Pediatric Respirology.</Affiliation>
                </Author>
                <Author>
                    <LastName>Porto</LastName>
                    <ForeName>B N</ForeName>
                    <Initials>BN</Initials>
                </Author>
                <Author>
                    <LastName>Nu??ez</LastName>
                    <ForeName>N K</ForeName>
                    <Initials>NK</Initials>
                </Author>
                <Author>
                    <LastName>Souza</LastName>
                    <ForeName>R G</ForeName>
                    <Initials>RG</Initials>
                </Author>
                <Author>
                    <LastName>Vargas</LastName>
                    <ForeName>M H M</ForeName>
                    <Initials>MH</Initials>
                </Author>
                <Author>
                    <LastName>Silveira</LastName>
                    <ForeName>J S</ForeName>
                    <Initials>JS</Initials>
                </Author>
                <Author>
                    <LastName>Souza</LastName>
                    <ForeName>T T R</ForeName>
                    <Initials>TT</Initials>
                </Author>
                <Author>
                    <LastName>Jaeger</LastName>
                    <ForeName>N</ForeName>
                    <Initials>N</Initials>
                </Author>
                <Author>
                    <LastName>Pitrez</LastName>
                    <ForeName>P M</ForeName>
                    <Initials>PM</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>13</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Allergy</MedlineTA>
            <NlmUniqueID>7804028</NlmUniqueID>
            <ISSNLinking>0105-4538</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Asthma</Keyword>
            <Keyword MajorTopicYN="N">Eosinophils</Keyword>
            <Keyword MajorTopicYN="N">extracellular DNA traps</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>4</Month>
                <Day>27</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>8</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1111/all.12507</ArticleId>
            <ArticleId IdType="pubmed">25130372</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25130322</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1558-5646</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>1</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Evolution; international journal of organic evolution</Title>
                <ISOAbbreviation>Evolution</ISOAbbreviation>
            </Journal>
            <ArticleTitle>SHAPE-SHIFT: SEMICIRCULAR CANAL MORPHOLOGY RESPONDS TO SELECTIVE BREEDING FOR INCREASED LOCOMOTOR ACTIVITY.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.1111/evo.12501</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Variation in semicircular canal morphology correlates with locomotor agility among species of mammals. An experimental evolutionary mouse model was used to test the hypotheses that semicircular canal morphology (1) evolves in response to selective breeding for increased locomotor activity, (2) exhibits phenotypic plasticity in response to early-onset chronic exercise, and (3) is unique in individuals possessing the mini-muscle phenotype. We examined responses in canal morphology to prolonged wheel access and selection in laboratory mice from four replicate lines bred for high voluntary wheel running (HR) and four non-selected control (C) lines. Linear measurements and a suite of 3D landmarks were obtained from 3D reconstructions of ??CT-scanned mouse crania. Body mass was smaller in HR than C mice and was a significant predictor of both radius of curvature and 3D canal shape. Controlling for body mass, radius of curvature did not differ statistically between HR and C mice, but semicircular canal shape did. Neither chronic wheel access nor mini-muscle affected radius of curvature or canal shape These findings suggest that semi-circular canal morphology is responsive to evolutionary changes in locomotor behavior, but the pattern of response is potentially different in small versus large-bodied species. This article is protected by copyright. All rights reserved.</AbstractText>
                <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Schutz</LastName>
                    <ForeName>Heidi</ForeName>
                    <Initials>H</Initials>
                    <Affiliation>Biology Department, Pacific Lutheran University, Tacoma, WA, 98477; Department of Biology, University of California, Riverside, CA, 92521, USA. schutzha@plu.edu.</Affiliation>
                </Author>
                <Author>
                    <LastName>Jamniczky</LastName>
                    <ForeName>Heather A</ForeName>
                    <Initials>HA</Initials>
                </Author>
                <Author>
                    <LastName>Hallgr??msson</LastName>
                    <ForeName>Benedikt</ForeName>
                    <Initials>B</Initials>
                </Author>
                <Author>
                    <LastName>Garland</LastName>
                    <ForeName>Theodore</ForeName>
                    <Initials>T</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>1</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Evolution</MedlineTA>
            <NlmUniqueID>0373224</NlmUniqueID>
            <ISSNLinking>0014-3820</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">3D morphometrics</Keyword>
            <Keyword MajorTopicYN="N">Experimental evolution</Keyword>
            <Keyword MajorTopicYN="N">voluntary exercise</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>1</Month>
                <Day>13</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>6</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1111/evo.12501</ArticleId>
            <ArticleId IdType="pubmed">25130322</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25130304</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1523-4681</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Jul</Month>
                        <Day>31</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research</Title>
                <ISOAbbreviation>J. Bone Miner. Res.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>SDF-1/CXCR4 Axis in Tie2-lineage Cells Including Endothelial Progenitor Cells Contributes to Bone Fracture Healing.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.1002/jbmr.2318</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">CXC chemokine receptor 4 (CXCR4) is a specific receptor for stromal-derived-factor 1 (SDF-1). SDF-1/CXCR-4 interaction is reported to play an important role in vascular development. On the other hand, the therapeutic potential of endothelial progenitor cells (EPCs) in fracture healing has been demonstrated with mechanistic insight of vasculogenesis/angiogenesis and osteogenesis enhancement at sites of fracture. The purpose of this study is to investigate the influence of the SDF-1/CXCR4 pathway in Tie2-lineage cells (including EPCs) in bone formation. We created CXCR4 gene conditional knockout mice using the Cre/loxP system and set two groups of mice: Tie2-Cre(ER) CXCR4 knockout mice (CXCR4(-/-) ) and wild type mice (WT). We report here, in vitro, EPCs derived from of CXCR4(-/-) mouse bone marrow demonstrated severe reduction of migration activity and EPC colony-forming activity when compared with those derived from WT mouse bone marrow. In vivo, radiological and morphological examinations showed fracture healing delayed in the CXCR4(-/-) group and the relative callus area at week 2 and 3 was significantly smaller in CXCR4(-/-) group mice. Quantitative analysis of capillary density at peri-fracture sites also showed a significant decrease in CXCR4(-/-) group. Especially, CXCR4(-/-) group mice demonstrated significant early reduction of blood flow recovery at fracture sites compared with the WT group in Laser Doppler Perfusion Imaging analysis. Real time RT-PCR analysis showed that the gene expressions of angiogenic markers (CD31, VE-cadherin, vascular endothelial growth factor, VEGF) and osteogenic markers (osteocalcin, collagen1A1, bone morphogenetic protein2, BMP2) were lower in the CXCR4(-/-) group. In the gain-of-function study, the fracture in the SDF-1 intraperitoneally injected WT group healed significantly faster from fracture with enough callus formation comparing them with SDF-1 injected CXCR4(-/-) group. We demonstrated that an EPC SDF-1/CXCR4 axis plays an important role in bone fracture healing using Tie2-Cre(ER) CXCR4 conditional knockout mice. ?? 2014 American Society for Bone and Mineral Research.</AbstractText>
                <CopyrightInformation>?? 2014 American Society for Bone and Mineral Research.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Kawakami</LastName>
                    <ForeName>Yohei</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Group of Vascular Regeneration, Institute of Biomedical Research and Innovation, Kobe, Japan; Department of Orthopedic Surgery, Kobe University Graduate School of Medicine, Kobe, Japan.</Affiliation>
                </Author>
                <Author>
                    <LastName>Ii</LastName>
                    <ForeName>Masaaki</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author>
                    <LastName>Matsumoto</LastName>
                    <ForeName>Tomoyuki</ForeName>
                    <Initials>T</Initials>
                </Author>
                <Author>
                    <LastName>Kuroda</LastName>
                    <ForeName>Ryosuke</ForeName>
                    <Initials>R</Initials>
                </Author>
                <Author>
                    <LastName>Kuroda</LastName>
                    <ForeName>Tomoya</ForeName>
                    <Initials>T</Initials>
                </Author>
                <Author>
                    <LastName>Kwon</LastName>
                    <ForeName>Sang-Mo</ForeName>
                    <Initials>SM</Initials>
                </Author>
                <Author>
                    <LastName>Kawamoto</LastName>
                    <ForeName>Atsuhiko</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author>
                    <LastName>Akimaru</LastName>
                    <ForeName>Hiroshi</ForeName>
                    <Initials>H</Initials>
                </Author>
                <Author>
                    <LastName>Mifune</LastName>
                    <ForeName>Yutaka</ForeName>
                    <Initials>Y</Initials>
                </Author>
                <Author>
                    <LastName>Shoji</LastName>
                    <ForeName>Taro</ForeName>
                    <Initials>T</Initials>
                </Author>
                <Author>
                    <LastName>Fukui</LastName>
                    <ForeName>Tomoaki</ForeName>
                    <Initials>T</Initials>
                </Author>
                <Author>
                    <LastName>Kurosaka</LastName>
                    <ForeName>Masahiro</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author>
                    <LastName>Asahara</LastName>
                    <ForeName>Takayuki</ForeName>
                    <Initials>T</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>31</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>J Bone Miner Res</MedlineTA>
            <NlmUniqueID>8610640</NlmUniqueID>
            <ISSNLinking>0884-0431</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">CXCR-4 (CX chemokine receptor-4)</Keyword>
            <Keyword MajorTopicYN="N">EPC (Endothelial Progenitor Cell)</Keyword>
            <Keyword MajorTopicYN="N">Fracture healing</Keyword>
            <Keyword MajorTopicYN="N">Knock-out mice</Keyword>
            <Keyword MajorTopicYN="N">SDF-1 (Stromal-derived factor-1)</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>2</Month>
                <Day>11</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>30</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>25</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jbmr.2318</ArticleId>
            <ArticleId IdType="pubmed">25130304</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25130295</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1879-0305</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>1</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Cytokine &amp; growth factor reviews</Title>
                <ISOAbbreviation>Cytokine Growth Factor Rev.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>IL-12-and IL-23 in health and disease.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">S1359-6101(14)00079-3</ELocationID>
            <ELocationID EIdType="doi">10.1016/j.cytogfr.2014.07.017</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Interleukin (IL)-12 and IL-23 play important roles in the development of experimental autoimmune disease models and numerous afflictions affecting humans. Preclinical data over the last 20 years combined with successful clinical trials has identified a clear relationship between IL-12, IL-23 and the generation of pathogenic T helper cells capable of orchestrating tissue inflammation. Observations made in the clinic have shown that IL-12p40, a common subunit shared by IL-12 and IL-23, is critical to pathologies associated with psoriasis, inflammatory bowel disease (IBD) and tumor growth. These advancements have set in motion the development of a number of potential therapeutics aimed at manipulating IL-12/23 signaling pathways in both mice and humans. This review will discuss a brief history of the understanding and expansion of the IL-12 cytokine family, some difficulties associated with preclinical data interpretation and finally the medicinal interventions that have been developed to combat IL-12/23-driven autoimmune disorders.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014. Published by Elsevier Ltd.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Croxford</LastName>
                    <ForeName>Andrew L</ForeName>
                    <Initials>AL</Initials>
                    <Affiliation>Institute of Experimental Immunology, University of Z??rich, Z??rich, Switzerland. Electronic address: andrewlewis.croxford@uzh.ch.</Affiliation>
                </Author>
                <Author>
                    <LastName>Kulig</LastName>
                    <ForeName>Paulina</ForeName>
                    <Initials>P</Initials>
                    <Affiliation>Institute of Experimental Immunology, University of Z??rich, Z??rich, Switzerland.</Affiliation>
                </Author>
                <Author>
                    <LastName>Becher</LastName>
                    <ForeName>Burkhard</ForeName>
                    <Initials>B</Initials>
                    <Affiliation>Institute of Experimental Immunology, University of Z??rich, Z??rich, Switzerland.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>1</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Cytokine Growth Factor Rev</MedlineTA>
            <NlmUniqueID>9612306</NlmUniqueID>
            <ISSNLinking>1359-6101</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Autoimmunity</Keyword>
            <Keyword MajorTopicYN="N">Cytokines</Keyword>
            <Keyword MajorTopicYN="N">IL-12 family</Keyword>
            <Keyword MajorTopicYN="N">Inflammation</Keyword>
            <Keyword MajorTopicYN="N">Treatment</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">S1359-6101(14)00079-3</ArticleId>
            <ArticleId IdType="doi">10.1016/j.cytogfr.2014.07.017</ArticleId>
            <ArticleId IdType="pubmed">25130295</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25130282</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1532-2785</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>2</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Neuropeptides</Title>
                <ISOAbbreviation>Neuropeptides</ISOAbbreviation>
            </Journal>
            <ArticleTitle>The effects of serotonin1A receptor on female mice body weight and food intake are associated with the differential expression of hypothalamic neuropeptides and the GABAA receptor.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">S0143-4179(14)00067-5</ELocationID>
            <ELocationID EIdType="doi">10.1016/j.npep.2014.07.003</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Both common eating disorders anorexia nervosa and bulimia nervosa are characteristically diseases of women. To characterize the role of the 5-HT1A receptor (5-HT1A-R) in these eating disorders in females, we investigated the effect of saline or 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) treatment on feeding behavior and body weight in adult WT female mice and in adult 5-HT1A-R knockout (KO) female mice. Our results showed that KO female mice have lower food intake and body weight than WT female mice. Administration of 8-OH-DPAT decreased food intake but not body weight in WT female mice. Furthermore, qRT-PCR was employed to analyze the expression levels of neuropeptides, ??-aminobutyric acid A receptor subunit ?? (GABAA ?? subunits) and glutamic acid decarboxylase in the hypothalamic area. The results showed the difference in food intake between WT and KO mice was accompanied by differential expression of POMC, CART and GABAA ??2, and the difference in body weight between WT and KO mice was associated with significantly different expression levels of CART and GABAA ??2. As such, our data provide new insight into the role of 5-HT1A-R in both feeding behavior and the associated expression of neuropeptides and the GABAA receptor.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014. Published by Elsevier Ltd.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Butt</LastName>
                    <ForeName>Isma</ForeName>
                    <Initials>I</Initials>
                    <Affiliation>Department of Biology, College of Staten Island, City University of New York, Staten Island, NY 10314, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Hong</LastName>
                    <ForeName>Andrew</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Department of Biology, College of Staten Island, City University of New York, Staten Island, NY 10314, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Di</LastName>
                    <ForeName>Jing</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>Department of Biology, College of Staten Island, City University of New York, Staten Island, NY 10314, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Aracena</LastName>
                    <ForeName>Sonia</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Department of Chemistry, College of Staten Island, City University of New York, Staten Island, NY 10314, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Banerjee</LastName>
                    <ForeName>Probal</ForeName>
                    <Initials>P</Initials>
                    <Affiliation>Institute for Macromolecular Assemblies, City University of New York, Staten Island, NY 10314, USA; Department of Chemistry, College of Staten Island, City University of New York, Staten Island, NY 10314, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Shen</LastName>
                    <ForeName>Chang-Hui</ForeName>
                    <Initials>CH</Initials>
                    <Affiliation>Department of Biology, College of Staten Island, City University of New York, Staten Island, NY 10314, USA; Institute for Macromolecular Assemblies, City University of New York, Staten Island, NY 10314, USA. Electronic address: ChangHui.Shen@csi.cuny.edu.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>2</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Neuropeptides</MedlineTA>
            <NlmUniqueID>8103156</NlmUniqueID>
            <ISSNLinking>0143-4179</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Body weight</Keyword>
            <Keyword MajorTopicYN="N">Food intake</Keyword>
            <Keyword MajorTopicYN="N">GABA(A) ?? subunits</Keyword>
            <Keyword MajorTopicYN="N">Gene expression</Keyword>
            <Keyword MajorTopicYN="N">Neuropeptides</Keyword>
            <Keyword MajorTopicYN="N">Serotonin</Keyword>
            <Keyword MajorTopicYN="N">qRT-PCR</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>1</Month>
                <Day>26</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>1</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>23</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">S0143-4179(14)00067-5</ArticleId>
            <ArticleId IdType="doi">10.1016/j.npep.2014.07.003</ArticleId>
            <ArticleId IdType="pubmed">25130282</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25130259</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2041-1723</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>5</Volume>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Nature communications</Title>
                <ISOAbbreviation>Nat Commun</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Myc inhibition is effective against glioma and reveals a role for Myc in proficient mitosis.</ArticleTitle>
            <Pagination>
                <MedlinePgn>4632</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1038/ncomms5632</ELocationID>
            <Abstract>
                <AbstractText>Gliomas are the most common primary tumours affecting the adult central nervous system and respond poorly to standard therapy. Myc is causally implicated in most human tumours and the majority of glioblastomas have elevated Myc levels. Using the Myc dominant negative Omomyc, we previously showed that Myc inhibition is a promising strategy for cancer therapy. Here, we preclinically validate Myc inhibition as a therapeutic strategy in mouse and human glioma, using a mouse model of spontaneous multifocal invasive astrocytoma and its derived neuroprogenitors, human glioblastoma cell lines, and patient-derived tumours both in vitro and in orthotopic xenografts. Across all these experimental models we find that Myc inhibition reduces proliferation, increases apoptosis and remarkably, elicits the formation of multinucleated cells that then arrest or die by mitotic catastrophe, revealing a new role for Myc in the proficient division of glioma cells.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Annibali</LastName>
                    <ForeName>Daniela</ForeName>
                    <Initials>D</Initials>
                    <Affiliation>1] Department of Pathology, Helen Diller Family Comprehensive Cancer Center, University of California at San Francisco, San Francisco, California 94143, USA [2] Istituto di Biologia, Medicina Molecolare e NanoBiotecnologie, C.N.R., Dipartimento di Biologia e Biotecnologie, Universit?? La Sapienza, 00185 Rome, Italy [3].</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Whitfield</LastName>
                    <ForeName>Jonathan R</ForeName>
                    <Initials>JR</Initials>
                    <Affiliation>1] Vall d'Hebron Institute of Oncology (VHIO), Edifici Mediterr??nia, Hospital Vall d'Hebron, 08035 Barcelona, Spain [2] Universitat Aut??noma de Barcelona, Bellaterra (Cerdanyola del Vall??s), 08193 Barcelona, Spain [3].</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Favuzzi</LastName>
                    <ForeName>Emilia</ForeName>
                    <Initials>E</Initials>
                    <Affiliation>Istituto di Biologia, Medicina Molecolare e NanoBiotecnologie, C.N.R., Dipartimento di Biologia e Biotecnologie, Universit?? La Sapienza, 00185 Rome, Italy.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jauset</LastName>
                    <ForeName>Toni</ForeName>
                    <Initials>T</Initials>
                    <Affiliation>1] Vall d'Hebron Institute of Oncology (VHIO), Edifici Mediterr??nia, Hospital Vall d'Hebron, 08035 Barcelona, Spain [2] Universitat Aut??noma de Barcelona, Bellaterra (Cerdanyola del Vall??s), 08193 Barcelona, Spain.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Serrano</LastName>
                    <ForeName>Erika</ForeName>
                    <Initials>E</Initials>
                    <Affiliation>1] Vall d'Hebron Institute of Oncology (VHIO), Edifici Mediterr??nia, Hospital Vall d'Hebron, 08035 Barcelona, Spain [2] Universitat Aut??noma de Barcelona, Bellaterra (Cerdanyola del Vall??s), 08193 Barcelona, Spain.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cuartas</LastName>
                    <ForeName>Isabel</ForeName>
                    <Initials>I</Initials>
                    <Affiliation>1] Vall d'Hebron Institute of Oncology (VHIO), Edifici Mediterr??nia, Hospital Vall d'Hebron, 08035 Barcelona, Spain [2] Universitat Aut??noma de Barcelona, Bellaterra (Cerdanyola del Vall??s), 08193 Barcelona, Spain.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Redondo-Campos</LastName>
                    <ForeName>Sara</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>1] Vall d'Hebron Institute of Oncology (VHIO), Edifici Mediterr??nia, Hospital Vall d'Hebron, 08035 Barcelona, Spain [2] Universitat Aut??noma de Barcelona, Bellaterra (Cerdanyola del Vall??s), 08193 Barcelona, Spain.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Folch</LastName>
                    <ForeName>Gerard</ForeName>
                    <Initials>G</Initials>
                    <Affiliation>1] Vall d'Hebron Institute of Oncology (VHIO), Edifici Mediterr??nia, Hospital Vall d'Hebron, 08035 Barcelona, Spain [2] Universitat Aut??noma de Barcelona, Bellaterra (Cerdanyola del Vall??s), 08193 Barcelona, Spain.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gonz??lez-Junc??</LastName>
                    <ForeName>Alba</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>1] Vall d'Hebron Institute of Oncology (VHIO), Edifici Mediterr??nia, Hospital Vall d'Hebron, 08035 Barcelona, Spain [2] Universitat Aut??noma de Barcelona, Bellaterra (Cerdanyola del Vall??s), 08193 Barcelona, Spain.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sodir</LastName>
                    <ForeName>Nicole M</ForeName>
                    <Initials>NM</Initials>
                    <Affiliation>1] Department of Pathology, Helen Diller Family Comprehensive Cancer Center, University of California at San Francisco, San Francisco, California 94143, USA [2] Department of Biochemistry, Sanger Building, University of Cambridge, Cambridge CB2 1QW, UK.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mass??-Vall??s</LastName>
                    <ForeName>Daniel</ForeName>
                    <Initials>D</Initials>
                    <Affiliation>1] Vall d'Hebron Institute of Oncology (VHIO), Edifici Mediterr??nia, Hospital Vall d'Hebron, 08035 Barcelona, Spain [2] Universitat Aut??noma de Barcelona, Bellaterra (Cerdanyola del Vall??s), 08193 Barcelona, Spain.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Beaulieu</LastName>
                    <ForeName>Marie-Eve</ForeName>
                    <Initials>ME</Initials>
                    <Affiliation>1] Vall d'Hebron Institute of Oncology (VHIO), Edifici Mediterr??nia, Hospital Vall d'Hebron, 08035 Barcelona, Spain [2] Universitat Aut??noma de Barcelona, Bellaterra (Cerdanyola del Vall??s), 08193 Barcelona, Spain.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Swigart</LastName>
                    <ForeName>Lamorna B</ForeName>
                    <Initials>LB</Initials>
                    <Affiliation>Department of Pathology, Helen Diller Family Comprehensive Cancer Center, University of California at San Francisco, San Francisco, California 94143, USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mc Gee</LastName>
                    <ForeName>Margaret M</ForeName>
                    <Initials>MM</Initials>
                    <Affiliation>UCD School of Biomolecular &amp;Biomedical Science, UCD Conway Institute, University College Dublin, Belfield, Dublin 4, Ireland.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Somma</LastName>
                    <ForeName>Maria Patrizia</ForeName>
                    <Initials>MP</Initials>
                    <Affiliation>Istituto di Biologia, Medicina Molecolare e NanoBiotecnologie, C.N.R., Dipartimento di Biologia e Biotecnologie, Universit?? La Sapienza, 00185 Rome, Italy.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nasi</LastName>
                    <ForeName>Sergio</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Istituto di Biologia, Medicina Molecolare e NanoBiotecnologie, C.N.R., Dipartimento di Biologia e Biotecnologie, Universit?? La Sapienza, 00185 Rome, Italy.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Seoane</LastName>
                    <ForeName>Joan</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>1] Vall d'Hebron Institute of Oncology (VHIO), Edifici Mediterr??nia, Hospital Vall d'Hebron, 08035 Barcelona, Spain [2] Universitat Aut??noma de Barcelona, Bellaterra (Cerdanyola del Vall??s), 08193 Barcelona, Spain [3] Instituci?? Catalana de Recerca i Estudis Avan??ats (ICREA), 08010 Barcelona, Spain.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Evan</LastName>
                    <ForeName>Gerard I</ForeName>
                    <Initials>GI</Initials>
                    <Affiliation>Department of Biochemistry, Sanger Building, University of Cambridge, Cambridge CB2 1QW, UK.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Soucek</LastName>
                    <ForeName>Laura</ForeName>
                    <Initials>L</Initials>
                    <Affiliation>1] Vall d'Hebron Institute of Oncology (VHIO), Edifici Mediterr??nia, Hospital Vall d'Hebron, 08035 Barcelona, Spain [2] Universitat Aut??noma de Barcelona, Bellaterra (Cerdanyola del Vall??s), 08193 Barcelona, Spain.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Nat Commun</MedlineTA>
            <NlmUniqueID>101528555</NlmUniqueID>
            <ISSNLinking>2041-1723</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>2</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>09</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">ncomms5632</ArticleId>
            <ArticleId IdType="doi">10.1038/ncomms5632</ArticleId>
            <ArticleId IdType="pubmed">25130259</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25130202</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>20</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1096-0333</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>15</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Toxicology and applied pharmacology</Title>
                <ISOAbbreviation>Toxicol. Appl. Pharmacol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Protective effects of myricitrin against osteoporosis via reducing reactive oxygen species and bone-resorbing cytokines.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">S0041-008X(14)00296-8</ELocationID>
            <ELocationID EIdType="doi">10.1016/j.taap.2014.08.004</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Oxidative stress is a crucial pathogenic factor in the development of osteoporosis. Myricitrin, isolated from Myrica cerifera, is a potent antioxidant. We hypothesized that myricitrin possessed protective effects against osteoporosis by partially reducing reactive oxygen species (ROS) and bone-resorbing cytokines in osteoblastic MC3T3-E1 cells and human bone marrow stromal cells (hBMSCs). We investigated myricitrin on osteogenic differentiation under oxidative stress. Hydrogen peroxide (H2O2) was used to establish an oxidative cell injury model. Our results revealed that myricitrin significantly improved some osteogenic markers in these cells. Myricitrin decreased lipid production and reduced peroxisome proliferator-activated receptor gamma-2 (PPAR??2) expression in hBMSCs. Moreover, myricitrin reduced the expression of receptor activator of nuclear factor kappa-B ligand (RANKL) and IL-6 and partially suppressed ROS production. In vivo, we established a murine ovariectomized (OVX) osteoporosis model. Our results demonstrated that myricitrin supplementation reduced serum malondialdehyde (MDA) activity and increased reduced glutathione (GSH) activity. Importantly, it ameliorated the micro-architecture of trabecular bones in the 4th lumbar vertebrae (L4) and distal femur. Taken together, these results indicated that the protective effects of myricitrin against osteoporosis are linked to a reduction in ROS and bone-resorbing cytokines, suggesting that myricitrin may be useful in bone metabolism diseases, particularly osteoporosis.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014. Published by Elsevier Inc.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Huang</LastName>
                    <ForeName>Qiang</ForeName>
                    <Initials>Q</Initials>
                    <Affiliation>Institute of Orthopedic Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, People's Republic of China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Gao</LastName>
                    <ForeName>Bo</ForeName>
                    <Initials>B</Initials>
                    <Affiliation>Institute of Orthopedic Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, People's Republic of China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Wang</LastName>
                    <ForeName>Long</ForeName>
                    <Initials>L</Initials>
                    <Affiliation>Institute of Orthopedic Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, People's Republic of China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Hu</LastName>
                    <ForeName>Ya-Qian</ForeName>
                    <Initials>YQ</Initials>
                    <Affiliation>Institute of Orthopedic Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, People's Republic of China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Lu</LastName>
                    <ForeName>Wei-Guang</ForeName>
                    <Initials>WG</Initials>
                    <Affiliation>Institute of Orthopedic Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, People's Republic of China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Yang</LastName>
                    <ForeName>Liu</ForeName>
                    <Initials>L</Initials>
                    <Affiliation>Institute of Orthopedic Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, People's Republic of China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Luo</LastName>
                    <ForeName>Zhuo-Jing</ForeName>
                    <Initials>ZJ</Initials>
                    <Affiliation>Institute of Orthopedic Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, People's Republic of China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Liu</LastName>
                    <ForeName>Jian</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>Institute of Orthopedic Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, People's Republic of China. Electronic address: liujianhq@sina.com.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>15</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Toxicol Appl Pharmacol</MedlineTA>
            <NlmUniqueID>0416575</NlmUniqueID>
            <ISSNLinking>0041-008X</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Bone-resorbing cytokine</Keyword>
            <Keyword MajorTopicYN="N">Human bone marrow stromal cell</Keyword>
            <Keyword MajorTopicYN="N">MC3T3-E1 cell</Keyword>
            <Keyword MajorTopicYN="N">Myricitrin</Keyword>
            <Keyword MajorTopicYN="N">Osteoporosis</Keyword>
            <Keyword MajorTopicYN="N">Ovariectomized mouse</Keyword>
            <Keyword MajorTopicYN="N">Reactive oxygen species</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>26</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>4</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">25130202</ArticleId>
            <ArticleId IdType="pii">S0041-008X(14)00296-8</ArticleId>
            <ArticleId IdType="doi">10.1016/j.taap.2014.08.004</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25130187</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2045-2322</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>4</Volume>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Scientific reports</Title>
                <ISOAbbreviation>Sci Rep</ISOAbbreviation>
            </Journal>
            <ArticleTitle>A protective role of murine langerin(+) cells in immune responses to cutaneous vaccination with microneedle patches.</ArticleTitle>
            <Pagination>
                <MedlinePgn>6094</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1038/srep06094</ELocationID>
            <Abstract>
                <AbstractText>Cutaneous vaccination with microneedle patches offers several advantages over more frequently used approaches for vaccine delivery, including improved protective immunity. However, the involvement of specific APC subsets and their contribution to the induction of immunity following cutaneous vaccine delivery is not well understood. A better understanding of the functions of individual APC subsets in the skin will allow us to target specific skin cell populations in order to further enhance vaccine efficacy. Here we use a Langerin-EGFP-DTR knock-in mouse model to determine the contribution of langerin(+) subsets of skin APCs in the induction of adaptive immune responses following cutaneous microneedle delivery of influenza vaccine. Depletion of langerin(+) cells prior to vaccination resulted in substantial impairment of both Th1 and Th2 responses, and decreased post-challenge survival rates, in mice vaccinated cutaneously but not in those vaccinated via the intramuscular route or in non-depleted control mice. Our results indicate that langerin(+) cells contribute significantly to the induction of protective immune responses following cutaneous vaccination with a subunit influenza vaccine.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Pulit-Penaloza</LastName>
                    <ForeName>Joanna A</ForeName>
                    <Initials>JA</Initials>
                    <Affiliation>Department of Microbiology and Immunology and Emory Vaccine Center, Emory University School of Medicine, Atlanta, Georgia, 30322.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Esser</LastName>
                    <ForeName>E Stein</ForeName>
                    <Initials>ES</Initials>
                    <Affiliation>Department of Microbiology and Immunology and Emory Vaccine Center, Emory University School of Medicine, Atlanta, Georgia, 30322.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Vassilieva</LastName>
                    <ForeName>Elena V</ForeName>
                    <Initials>EV</Initials>
                    <Affiliation>Department of Microbiology and Immunology and Emory Vaccine Center, Emory University School of Medicine, Atlanta, Georgia, 30322.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lee</LastName>
                    <ForeName>Jeong Woo</ForeName>
                    <Initials>JW</Initials>
                    <Affiliation>School of Chemical and Biomolecular Engineering, Georgia Institute of Technology, Atlanta, Georgia, 30332.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Taherbhai</LastName>
                    <ForeName>Misha T</ForeName>
                    <Initials>MT</Initials>
                    <Affiliation>Department of Microbiology and Immunology and Emory Vaccine Center, Emory University School of Medicine, Atlanta, Georgia, 30322.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pollack</LastName>
                    <ForeName>Brian P</ForeName>
                    <Initials>BP</Initials>
                    <Affiliation>1] Department of Veterans Affairs, Atlanta VA Medical Center, Decatur, Georgia 30033 [2] Department of Dermatology, Emory University, School of Medicine, Atlanta, Georgia 30322.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Prausnitz</LastName>
                    <ForeName>Mark R</ForeName>
                    <Initials>MR</Initials>
                    <Affiliation>School of Chemical and Biomolecular Engineering, Georgia Institute of Technology, Atlanta, Georgia, 30332.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Compans</LastName>
                    <ForeName>Richard W</ForeName>
                    <Initials>RW</Initials>
                    <Affiliation>Department of Microbiology and Immunology and Emory Vaccine Center, Emory University School of Medicine, Atlanta, Georgia, 30322.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Skountzou</LastName>
                    <ForeName>Ioanna</ForeName>
                    <Initials>I</Initials>
                    <Affiliation>Department of Microbiology and Immunology and Emory Vaccine Center, Emory University School of Medicine, Atlanta, Georgia, 30322.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Sci Rep</MedlineTA>
            <NlmUniqueID>101563288</NlmUniqueID>
            <ISSNLinking>2045-2322</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <CommentsCorrectionsList>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Virol. 2000 Jun;74(11):4999-5005</RefSource>
                <PMID Version="1">10799573</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Rev Immunol. 2014 May;14(5):289-301</RefSource>
                <PMID Version="1">24722477</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Exp Med. 1977 May 1;145(5):1316-27</RefSource>
                <PMID Version="1">300783</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Exp Med. 1987 Jan 1;165(1):64-9</RefSource>
                <PMID Version="1">3794607</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Science. 1987 May 22;236(4804):944-7</RefSource>
                <PMID Version="1">3107127</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>FASEB J. 1992 Nov;6(14):3245-52</RefSource>
                <PMID Version="1">1385241</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Clin Exp Immunol. 1993 Nov;94(2):291-6</RefSource>
                <PMID Version="1">8222320</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Annu Rev Immunol. 1997;15:297-322</RefSource>
                <PMID Version="1">9143690</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Immunol Rev. 1997 Oct;159:95-103</RefSource>
                <PMID Version="1">9416505</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Immunol Methods. 1998 Mar 15;212(2):187-92</RefSource>
                <PMID Version="1">9672206</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Infect Dis. 1999 Sep;180(3):579-85</RefSource>
                <PMID Version="1">10438342</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Immunity. 2005 May;22(5):643-54</RefSource>
                <PMID Version="1">15894281</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Cell Biol. 2005 May 23;169(4):569-76</RefSource>
                <PMID Version="1">15897263</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Invest Dermatol. 2005 Jul;125(1):116-25</RefSource>
                <PMID Version="1">15982311</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Proc Natl Acad Sci U S A. 2006 May 16;103(20):7783-8</RefSource>
                <PMID Version="1">16672373</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Control Release. 2007 Feb 12;117(2):227-37</RefSource>
                <PMID Version="1">17169459</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Pharm Res. 2007 Jul;24(7):1369-80</RefSource>
                <PMID Version="1">17385011</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Immunol. 2007 Jul 15;179(2):886-93</RefSource>
                <PMID Version="1">17617579</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Exp Med. 2007 Dec 24;204(13):3119-31</RefSource>
                <PMID Version="1">18086861</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Exp Med. 2007 Dec 24;204(13):3147-56</RefSource>
                <PMID Version="1">18086865</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Immunol. 2008 Mar 15;180(6):3647-50</RefSource>
                <PMID Version="1">18322168</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Immunol. 2008 Apr 1;180(7):4722-7</RefSource>
                <PMID Version="1">18354196</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Immunity. 2008 Sep 19;29(3):319-24</RefSource>
                <PMID Version="1">18799140</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Rev Immunol. 2008 Dec;8(12):935-47</RefSource>
                <PMID Version="1">19029989</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Proc Natl Acad Sci U S A. 2009 Feb 3;106(5):1524-9</RefSource>
                <PMID Version="1">19168629</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3312-7</RefSource>
                <PMID Version="1">19218433</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Eur J Immunol. 2009 Apr;39(4):931-8</RefSource>
                <PMID Version="1">19197943</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Invest Dermatol. 2009 May;129(5):1156-64</RefSource>
                <PMID Version="1">19052565</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Proc Natl Acad Sci U S A. 2009 May 12;106(19):7968-73</RefSource>
                <PMID Version="1">19416832</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Exp Med. 2010 Jan 18;207(1):189-206</RefSource>
                <PMID Version="1">20038600</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Immunol Rev. 2010 Mar;234(1):120-41</RefSource>
                <PMID Version="1">20193016</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Immunol Cell Biol. 2010 May-Jun;88(4):366-75</RefSource>
                <PMID Version="1">20231850</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Exp Med. 2010 May 10;207(5):953-61</RefSource>
                <PMID Version="1">20421390</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Gene Ther. 2010 Jun;17(6):811-4</RefSource>
                <PMID Version="1">20200562</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Med. 2010 Aug;16(8):915-20</RefSource>
                <PMID Version="1">20639891</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Immunol. 2010 Sep 15;185(6):3463-71</RefSource>
                <PMID Version="1">20713888</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Control Release. 2010 Nov 1;147(3):326-32</RefSource>
                <PMID Version="1">20692307</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Immunol. 2011 Jan 1;186(1):103-12</RefSource>
                <PMID Version="1">21135170</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Biomed Opt. 2011 Jan-Feb;16(1):011008</RefSource>
                <PMID Version="1">21280895</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Infect Dis. 2011 Aug 15;204(4):582-91</RefSource>
                <PMID Version="1">21685355</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Curr Top Microbiol Immunol. 2012;351:113-38</RefSource>
                <PMID Version="1">21253784</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nature. 2012 Feb 2;482(7383):89-93</RefSource>
                <PMID Version="1">22217938</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Invest Dermatol. 2012 Mar;132(3 Pt 1):615-25</RefSource>
                <PMID Version="1">22170490</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Invest Dermatol. 2012 Mar;132(3 Pt 2):829-34</RefSource>
                <PMID Version="1">22237702</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>MBio. 2012;3(2):e00012-12</RefSource>
                <PMID Version="1">22396479</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Control Release. 2012 Apr 10;159(1):34-42</RefSource>
                <PMID Version="1">22245683</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Sci Rep. 2012;2:357</RefSource>
                <PMID Version="1">22500210</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Control Release. 2012 Apr 30;159(2):215-21</RefSource>
                <PMID Version="1">22306334</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Control Release. 2012 Jun 28;160(3):495-501</RefSource>
                <PMID Version="1">22516091</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>PLoS One. 2012;7(7):e41501</RefSource>
                <PMID Version="1">22848514</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Adv Drug Deliv Rev. 2012 Nov;64(14):1547-68</RefSource>
                <PMID Version="1">22575858</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Infect Dis. 2013 Mar 15;207(6):974-81</RefSource>
                <PMID Version="1">23307936</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Proc Natl Acad Sci U S A. 2013 Feb 19;110(8):3041-6</RefSource>
                <PMID Version="1">23386724</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Adv Exp Med Biol. 2013;785:121-32</RefSource>
                <PMID Version="1">23456844</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Vaccine. 2013 Jul 25;31(34):3435-41</RefSource>
                <PMID Version="1">23398932</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Int Immunol. 2003 Aug;15(8):937-44</RefSource>
                <PMID Version="1">12882831</PMID>
            </CommentsCorrections>
        </CommentsCorrectionsList>
        <OtherID Source="NLM">PMC4135340</OtherID>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>4</Month>
                <Day>08</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>04</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">srep06094</ArticleId>
            <ArticleId IdType="doi">10.1038/srep06094</ArticleId>
            <ArticleId IdType="pubmed">25130187</ArticleId>
            <ArticleId IdType="pmc">PMC4135340</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25130171</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>24</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1872-7980</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>15</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Cancer letters</Title>
                <ISOAbbreviation>Cancer Lett.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Hypoxia inducible factor (HIF)-1?? directly activates leptin receptor (Ob-R) in pancreatic cancer cells.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">S0304-3835(14)00429-7</ELocationID>
            <ELocationID EIdType="doi">10.1016/j.canlet.2014.08.001</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">The aim of this study is to investigate the regulatory mechanism of leptin receptors (Ob-R) in pancreatic cancer. We found that the over-expression of hypoxia inducible factor (HIF-1)?? and hypoxia up-regulated the expression of Ob-R in pancreatic cancer cells. When HIF-1?? gene was silenced in vitro, the expression of Ob-R was significantly decreased. Xenograft mouse models showed that the inhibition of HIF-1?? resulted in the concomitant decrease of Ob-R in vivo. In addition, HIF-1?? expression was correlated with Ob-R in pancreatic cancer tissues by immunohistochemical staining. Clinical data showed that over-expression of HIF-1 was associated with pathologica tumor node metastasis stage, lymph node metastasis and overall survival. HIF-1?? directly bound to the hypoxia-responsive element (HRE) located in Ob-R gene promoter (-828/-832) and activated the transcription. Finally, we demonstrated that the silence of HIF-1?? gene reversed the inhibitory effect of leptin/Ob-R in pancreatic cancer cells. Taken together, our results indicate that HIF-1?? directly regulated Ob-R expression in pancreatic cancer, which might be a valuable therapeutic target for pancreatic cancer.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 Elsevier Ireland Ltd. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Ren</LastName>
                    <ForeName>He</ForeName>
                    <Initials>H</Initials>
                    <Affiliation>National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Department of Pancreatic Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Jia</LastName>
                    <ForeName>Lingling</ForeName>
                    <Initials>L</Initials>
                    <Affiliation>School of Public Health, Tianjin Medical University, Tianjin, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Zhao</LastName>
                    <ForeName>Tiansuo</ForeName>
                    <Initials>T</Initials>
                    <Affiliation>National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Department of Pancreatic Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Zhang</LastName>
                    <ForeName>Huan</ForeName>
                    <Initials>H</Initials>
                    <Affiliation>National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Department of Pancreatic Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Chen</LastName>
                    <ForeName>Jing</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Department of Pancreatic Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Yang</LastName>
                    <ForeName>Shaoguang</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Department of Pancreatic Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Liu</LastName>
                    <ForeName>Jingcheng</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Department of Pancreatic Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Yu</LastName>
                    <ForeName>Ming</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>School of Public Health, Tianjin Medical University, Tianjin, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Hao</LastName>
                    <ForeName>Jihui</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Department of Pancreatic Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China. Electronic address: haojihui@tjmuch.com.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>15</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Cancer Lett</MedlineTA>
            <NlmUniqueID>7600053</NlmUniqueID>
            <ISSNLinking>0304-3835</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Hypoxia inducible factor-1?? (HIF-1??)</Keyword>
            <Keyword MajorTopicYN="N">Leptin</Keyword>
            <Keyword MajorTopicYN="N">Leptin receptor (Ob-R)</Keyword>
            <Keyword MajorTopicYN="N">Pancreatic cancer</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>3</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>23</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>4</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">25130171</ArticleId>
            <ArticleId IdType="pii">S0304-3835(14)00429-7</ArticleId>
            <ArticleId IdType="doi">10.1016/j.canlet.2014.08.001</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25130141</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1432-0878</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>19</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Cell and tissue research</Title>
                <ISOAbbreviation>Cell Tissue Res.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>??-adrenergic receptor antagonists inhibit vasculogenesis of embryonic stem cells by downregulation of nitric oxide generation and interference with VEGF signalling.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">The ??-adrenoceptor antagonist Propranolol has been successfully used to treat infantile hemangioma. However, its mechanism of action is so far unknown. The hypothesis of this research was that ??-adrenoceptor antagonists may interfere with endothelial cell differentiation of stem cells. Specifically, the effects of the non-specific ??-adrenergic receptor (??-adrenoceptor) antagonist Propranolol, the ??1-adrenoceptor-specific antagonist Atenolol and the ??2-adrenoceptor-specific antagonist ICI118,551 on vasculogenesis of mouse embryonic stem (ES) cells were investigated. All three ??-blockers dose-dependently downregulated formation of capillary structures in ES cell-derived embryoid bodies and decreased the expression of the vascular cell markers CD31 and VE-cadherin. Furthermore, ??-blockers downregulated the expression of fibroblast growth factor-2 (FGF-2), hypoxia inducible factor-1?? (HIF-1??), vascular endothelial growth factor 165 (VEGF165), VEGF receptor 2 (VEGF-R2) and phospho VEGF-R2, as well as neuropilin 1 (NRP1) and plexin-B1 which are essential modulators of embryonic angiogenesis with additional roles in vessel remodelling and arteriogenesis. Under conditions of ??-adrenoceptor inhibition, the endogenous generation of nitric oxide (NO) as well as the phosphorylation of endothelial nitric oxide synthase (eNOS) was decreased in embryoid bodies, whereas an increase in NO generation was observed with the NO donor S-nitroso-N-acetyl-D,L-penicillamine (SNAP). Consequently, vasculogenesis of ES cells was restored upon treatment of differentiating ES cells with ??-adrenoceptor antagonists in the presence of NO donor. In summary, our data suggest that ??-blockers impair vasculogenesis of ES cells by interfering with NO generation which could be the explanation for their anti-angiogenic effects in infantile hemangioma.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Sharifpanah</LastName>
                    <ForeName>Fatemeh</ForeName>
                    <Initials>F</Initials>
                    <Affiliation>Department of Physiology, Justus Liebig University Giessen, Aulweg 129, 35392, Gie??en, Germany.</Affiliation>
                </Author>
                <Author>
                    <LastName>Saliu</LastName>
                    <ForeName>Fatjon</ForeName>
                    <Initials>F</Initials>
                </Author>
                <Author>
                    <LastName>Bekhite</LastName>
                    <ForeName>Mohamed M</ForeName>
                    <Initials>MM</Initials>
                </Author>
                <Author>
                    <LastName>Wartenberg</LastName>
                    <ForeName>Maria</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author>
                    <LastName>Sauer</LastName>
                    <ForeName>Heinrich</ForeName>
                    <Initials>H</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Cell Tissue Res</MedlineTA>
            <NlmUniqueID>0417625</NlmUniqueID>
            <ISSNLinking>0302-766X</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>3</Month>
                <Day>26</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>17</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="aheadofprint">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00441-014-1976-8</ArticleId>
            <ArticleId IdType="pubmed">25130141</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25130140</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1432-0878</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>19</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Cell and tissue research</Title>
                <ISOAbbreviation>Cell Tissue Res.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Double homeobox gene, Duxbl, promotes myoblast proliferation and abolishes myoblast differentiation by blocking MyoD transactivation.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Homeobox genes encode transcription factors that regulate embryonic development programs including organogenesis, axis formation and limb development. Previously, we identified and cloned a mouse double homeobox gene, Duxbl, whose homeodomain exhibits the highest identity (67??%) to human DUX4, a candidate gene of facioscapulohumeral muscular dystrophy (FSHD). Duxbl proteins have been shown to be expressed in elongated myocytes and myotubes of trunk and limb muscles during embryogenesis. In this study, we found that Duxbl maintained low expression levels in various adult muscles. Duxbl proteins were induced to express in activated satellite cells and colocalized with MyoG, a myogenic differentiating marker. Furthermore, Duxbl proteins were not detected in quiescent satellite cells but detected in regenerated myocytes and colocalized with MyoD and MyoG following cardiotoxin-induced muscle injury. Ectopic Duxbl overexpressions in C2C12 myoblast cells promoted cell proliferation through mainly enhancing cyclin D1 and hyper-phosphorylated retinoblastoma protein but reducing p21 expression. However, Duxbl overexpression in C2C12 cells inhibited myogenic differentiation by decreasing MyoD downstream gene expressions, including M-cadherin, MyoG, p21 and cyclin D3 but not MyoD itself. Duxbl overexpressions also promoted cell proliferation but blocked MyoD-induced myogenic conversion in multipotent mesenchymal C3H10T1/2 cells. In addition, results of a luciferase reporter assay suggest that Duxbl negatively regulated MyoG promoter activity through the proximal two E boxes. In conclusion, these results indicate that Duxbl may play a crucial role in myogenesis and postnatal muscle regeneration by activating and proliferating satellite and myoblast cells.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Wu</LastName>
                    <ForeName>Shey-Lin</ForeName>
                    <Initials>SL</Initials>
                    <Affiliation>Department of Neurology, Chang-Hua Christian Hospital, Changhua, Taiwan, Republic of China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Li</LastName>
                    <ForeName>Guo-Zili</ForeName>
                    <Initials>GZ</Initials>
                </Author>
                <Author>
                    <LastName>Chou</LastName>
                    <ForeName>Chin-Yi</ForeName>
                    <Initials>CY</Initials>
                </Author>
                <Author>
                    <LastName>Tsai</LastName>
                    <ForeName>Ming-Shiun</ForeName>
                    <Initials>MS</Initials>
                </Author>
                <Author>
                    <LastName>Chen</LastName>
                    <ForeName>Yi-Pei</ForeName>
                    <Initials>YP</Initials>
                </Author>
                <Author>
                    <LastName>Li</LastName>
                    <ForeName>Chung-Jung</ForeName>
                    <Initials>CJ</Initials>
                </Author>
                <Author>
                    <LastName>Liou</LastName>
                    <ForeName>Gan-Guang</ForeName>
                    <Initials>GG</Initials>
                </Author>
                <Author>
                    <LastName>Chang</LastName>
                    <ForeName>Wen-Wei</ForeName>
                    <Initials>WW</Initials>
                </Author>
                <Author>
                    <LastName>Chen</LastName>
                    <ForeName>Shen-Liang</ForeName>
                    <Initials>SL</Initials>
                </Author>
                <Author>
                    <LastName>Wang</LastName>
                    <ForeName>Sue-Hong</ForeName>
                    <Initials>SH</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Cell Tissue Res</MedlineTA>
            <NlmUniqueID>0417625</NlmUniqueID>
            <ISSNLinking>0302-766X</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>2</Month>
                <Day>11</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>21</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="aheadofprint">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00441-014-1974-x</ArticleId>
            <ArticleId IdType="pubmed">25130140</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25130072</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1365-3024</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>8</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Parasite immunology</Title>
                <ISOAbbreviation>Parasite Immunol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Immune response of ????T cells in Schistosome japonicum infected C57BL/6 mouse liver.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.1111/pim.12135</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Systematic evaluation of the role of ???? T cells during the Schistosoma japonicum infection has not been reported, despite the fact that ???? T cells contribute to many infectious diseases in innate immunity. Therefore, the aim of this study was to observe the properties of ???? T cells in the liver of C57BL/6 mice infected by S. japonicum. In this report, using immuno-fluorescent histological analysis, ???? T cells were found around hepatic granulomatous. Moreover, the flow cytometry results revealed that the percentage of hepatic ???? T cells increased significantly after S. japonicum infection.More interestingly, a subset of CD3(-) ????TCR(+) cells were found and markedly increased after infection. Furthermore, expression of activation markers (CD25 and CD69) and cytokine profiles were detected in these hepatic CD3(+) ????TCR(+) and CD3(-) ????TCR(+) cells. The significantly higher level of CD69, IL-4 and IL-17 were observed in CD3(+) ????TCR(+) cells after infection, suggesting that CD3(+) ????TCR(+) cells instead of CD3(-) ????TCR(+) cells might play apredominant role during the infection. Finally, our results indicated that the expression of NKG2D on CD3(+) ????TCR(+) cells was higher than that on CD3(-) ????TCR(+) cells.Collectively, ???? T cells could play an important role in the liver of C57BL/6 mouse during japonicum infection. This article is protected by copyright. All rights reserved.</AbstractText>
                <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Xie</LastName>
                    <ForeName>Hongyan</ForeName>
                    <Initials>H</Initials>
                    <Affiliation>Functional Experiment Centre, Guangzhou Medical University, 510182, Guangzhou, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Chen</LastName>
                    <ForeName>Dianhui</ForeName>
                    <Initials>D</Initials>
                </Author>
                <Author>
                    <LastName>Li</LastName>
                    <ForeName>Lu</ForeName>
                    <Initials>L</Initials>
                </Author>
                <Author>
                    <LastName>Yu</LastName>
                    <ForeName>Xiuxue</ForeName>
                    <Initials>X</Initials>
                </Author>
                <Author>
                    <LastName>Wu</LastName>
                    <ForeName>Changyou</ForeName>
                    <Initials>C</Initials>
                </Author>
                <Author>
                    <LastName>Gu</LastName>
                    <ForeName>Haigang</ForeName>
                    <Initials>H</Initials>
                </Author>
                <Author>
                    <LastName>Tang</LastName>
                    <ForeName>Xiaoping</ForeName>
                    <Initials>X</Initials>
                </Author>
                <Author>
                    <LastName>Peng</LastName>
                    <ForeName>Anping</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author>
                    <LastName>Huang</LastName>
                    <ForeName>Jun</ForeName>
                    <Initials>J</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>8</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Parasite Immunol</MedlineTA>
            <NlmUniqueID>7910948</NlmUniqueID>
            <ISSNLinking>0141-9838</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">NKG2D</Keyword>
            <Keyword MajorTopicYN="N">Schistosoma japonicum</Keyword>
            <Keyword MajorTopicYN="N">cytokines</Keyword>
            <Keyword MajorTopicYN="N">????T cell</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1111/pim.12135</ArticleId>
            <ArticleId IdType="pubmed">25130072</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Process">
        <PMID Version="1">25130042</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Print">0071-786X</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>69</Volume>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Progress in drug research. Fortschritte der Arzneimittelforschung. Progr??s des recherches pharmaceutiques</Title>
                <ISOAbbreviation>Prog Drug Res</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Genetic manipulation and genetic variation of the kallikrein-kinin system: impact on cardiovascular and renal diseases.</ArticleTitle>
            <Pagination>
                <MedlinePgn>145-96</MedlinePgn>
            </Pagination>
            <Abstract>
                <AbstractText>Genetic manipulation of the kallikrein-kinin system (KKS) in mice, with either gain or loss of function, and study of human genetic variability in KKS components which has been well documented at the phenotypic and genomic level, have allowed recognizing the physiological role of KKS in health and in disease. This role has been especially documented in the cardiovascular system and the kidney. Kinins are produced at slow rate in most organs in resting condition and/or inactivated quickly. Yet the KKS is involved in arterial function and in renal tubular function. In several pathological situations, kinin production increases, kinin receptor synthesis is upregulated, and kinins play an important role, whether beneficial or detrimental, in disease outcome. In the setting of ischemic, diabetic or hemodynamic aggression, kinin release by tissue kallikrein protects against organ damage, through B2 and/or B1 bradykinin receptor activation, depending on organ and disease. This has been well documented for the ischemic or diabetic heart, kidney and skeletal muscle, where KKS activity reduces oxidative stress, limits necrosis or fibrosis and promotes angiogenesis. On the other hand, in some pathological situations where plasma prekallikrein is inappropriately activated, excess kinin release in local or systemic circulation is detrimental, through oedema or hypotension. Putative therapeutic application of these clinical and experimental findings through current pharmacological development is discussed in the chapter.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Girolami</LastName>
                    <ForeName>Jean-Pierre</ForeName>
                    <Initials>JP</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Blaes</LastName>
                    <ForeName>Nelly</ForeName>
                    <Initials>N</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bouby</LastName>
                    <ForeName>Nadine</ForeName>
                    <Initials>N</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Alhenc-Gelas</LastName>
                    <ForeName>Fran??ois</ForeName>
                    <Initials>F</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>Switzerland</Country>
            <MedlineTA>Prog Drug Res</MedlineTA>
            <NlmUniqueID>1304021</NlmUniqueID>
            <ISSNLinking>0071-786X</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">25130042</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Process">
        <PMID Version="1">25130038</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Print">0071-786X</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>69</Volume>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Progress in drug research. Fortschritte der Arzneimittelforschung. Progr??s des recherches pharmaceutiques</Title>
                <ISOAbbreviation>Prog Drug Res</ISOAbbreviation>
            </Journal>
            <ArticleTitle>The kallikrein-kinin pathways in hypertension and diabetes.</ArticleTitle>
            <Pagination>
                <MedlinePgn>15-36</MedlinePgn>
            </Pagination>
            <Abstract>
                <AbstractText>Cardiovascular diseases are the most common causes of mortality worldwide. Hypertension and diabetes are the two major risk factors in the development of cardiac hypertrophy, ischemic heart disease, and cardiac failure. In Kuwait, high rate of prevalence of hypertension and diabetes has been documented. Previous studies have indicated altered activities of the BK-generating components in hypertension and diabetes. Bradykinin is pharmacologically active polypeptide that can promote both cardiovascular and renal function, for example, vasodilation, natriuresis, diuresis, and release of nitric oxide (NO). In addition, B2 kinin receptors are present in the cardiac endothelial cells which may enhance the biosynthesis and release of NO. It has been demonstrated that reduced urinary (renal) kallikrein levels may be associated with the development of high blood pressure in humans and spontaneously hypertensive and diabetic rats. The BK may produce its pharmacological effects via NO and cyclic GMP release. Furthermore, it is established that the BK has cardioprotective actions in myocardial ischemia and can prevent left ventricular hypertrophy. Also, transgenic mice carrying tissue kallikrein gene and overexpressing tissue kallikrein had reduced blood pressure. NO synthase and renal tissue kallikrein are both involved in blood pressure regulation. The ability of kallikrein gene delivery and the use of kinin B2 receptor agonists to produce a wide spectrum of beneficial effects make it a powerful candidate in treating hypertension, cardiovascular, and renal diseases. Strategies that activate kinin receptors might be applicable to the treatment of cardiovascular disease. Increased plasma prekallikrein levels in diabetic patients may serve as an indicator of developing hypertension and renal damage. Also high plasma and urine concentrations of tissue kallikrein may cause higher glucose levels in the blood.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Sharma</LastName>
                    <ForeName>Jagdish N</ForeName>
                    <Initials>JN</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Narayanan</LastName>
                    <ForeName>Parvathy</ForeName>
                    <Initials>P</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>Switzerland</Country>
            <MedlineTA>Prog Drug Res</MedlineTA>
            <NlmUniqueID>1304021</NlmUniqueID>
            <ISSNLinking>0071-786X</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">25130038</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Process">
        <PMID Version="1">25129979</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Print">1001-1781</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>28</Volume>
                    <Issue>10</Issue>
                    <PubDate>
                        <Year>2014</Year>
                        <Month>May</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery</Title>
                <ISOAbbreviation>Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi</ISOAbbreviation>
            </Journal>
            <ArticleTitle>[Clinical efficacy of mouse nerve growth factor in the treatment of sudden deafness].</ArticleTitle>
            <Pagination>
                <MedlinePgn>735-7</MedlinePgn>
            </Pagination>
            <Abstract>
                <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To study the clinical efficacy of mouse nerve growth factor (NGF) in the treatment of sudden deafness.</AbstractText>
                <AbstractText Label="METHOD" NlmCategory="METHODS">A retrospective analysis was performed on 115 cases of hospitalized patients who were suffered from sudden deafness. Patients were divided into two groups according to treatment medicine. Control group: patients were treated with intravenous vasodilators, energy mixture, steroid pulse therapy, and methylcobalamin neurotrophic therapy. NGF group: intramuscular NGF treatment was added on the basis of conventional therapy mentioned above. Both treatments lasted 14 days, the total efficiency were compared. Patients were further divided into sub-groups according to age, duration and the level of pre-treatment PTA, and the treatment efficiency was further compared. By SPSS 11.0 statistical analysis, a P &lt; 0.05 was considered as statistical significant difference.</AbstractText>
                <AbstractText Label="RESULT" NlmCategory="RESULTS">(1) The total efficiency of NGF group was significantly higher than control group. (2) Regard of age, the efficiency of NGF treatment group was significantly higher than control group. (3) For the patients whose duration were less than 7 d, or the PTA &lt; or = 60 dBHL, the efficiency of NGF group were significantly higher. For the patients whose duration were more than 7 d, or the PTA&gt;60 dBHL, the efficiency of NGF therapy was not superior to the traditional treatment.</AbstractText>
                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">NGF can significantly improve the symptom of patients with short duration or low PTA. For this kind of patients, NGF adjuvant therapy should be recommended. For the patients with longer duration and higher level of PTA, NGF therapy is not advocated. NGF treatment should not be in consideration of the age.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Xu</LastName>
                    <ForeName>Ting</ForeName>
                    <Initials>T</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Xiao</LastName>
                    <ForeName>Dajiang</ForeName>
                    <Initials>D</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wu</LastName>
                    <ForeName>Sihai</ForeName>
                    <Initials>S</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yuan</LastName>
                    <ForeName>Yuan</ForeName>
                    <Initials>Y</Initials>
                </Author>
            </AuthorList>
            <Language>chi</Language>
            <PublicationTypeList>
                <PublicationType>English Abstract</PublicationType>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>China</Country>
            <MedlineTA>Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi</MedlineTA>
            <NlmUniqueID>101303164</NlmUniqueID>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">25129979</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25129858</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>17</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1096-0929</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>16</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Toxicological sciences : an official journal of the Society of Toxicology</Title>
                <ISOAbbreviation>Toxicol. Sci.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Normalization of Nano-Sized TiO2 Induced Clastogenicity, Genotoxicity and Mutagenicity by Chlorophyllin Administration in Mice Brain, Liver and Bone Marrow Cells.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">kfu157</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">As titanium dioxide (TiO2) nanoparticles are intensively used in sunscreens, toothpaste, sweats and medications etc. making humans exposed to it daily by not little amounts and also increased its risks including genotoxicity. Thus, the present study was designed as one way to reduce nano-titanium induced clastogenicity, genotoxicity and mutagenicity in mice by co-administration of the free radical scavenger chlorophyllin (CHL). In addition, markers of oxidative stress were detected to shed more light on mechanism(s) underlying nano-sized TiO2 genotoxicity. Male mice were exposed to multiple injection into the abdominal cavity for five consecutive days with either CHL (40 mg/kg bw/day), or each of three dose levels of nano-sized TiO2 (500, 1000 or 2000 mg/kg b.w/day) alone or both simultaneously and sacrificed by cervical dislocation 24h after the last treatment. After CHL co-administration, the observed dose-dependent genotoxicity of TiO2 nanoparticles indicated by the significant elevations in frequencies of both micronuclei and DNA damage induction were significantly decreased and returned to the negative control level. The observed induced mutations in p53 exons 5, 7 &amp; 8 and 5 &amp; 8 in liver and brain, respectively, were declined in most cases. Moreover, CHL significantly decreased hepatic malondialdehyde level and significantly increased glutathione level and superoxide dismutase, catalase and glutathione peroxidase activities which were significantly disrupted in animal groups treated with nano-TiO2 alone. In conclusion, the evidenced in vivo genotoxicity of nano-TiO2 in the present study was normalized after CHL co-administration which supports the previously suggested oxidative stress as the possible mechanism for titanium toxicity.</AbstractText>
                <CopyrightInformation>?? The Author 2014. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For permissions, please email: journals.permissions@oup.com.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>El-Ghor</LastName>
                    <ForeName>Akmal Abdelraheim</ForeName>
                    <Initials>AA</Initials>
                </Author>
                <Author>
                    <LastName>Noshy</LastName>
                    <ForeName>Magda</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author>
                    <LastName>Galal</LastName>
                    <ForeName>Ahmad</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author>
                    <LastName>Mohamed</LastName>
                    <ForeName>Hanan Ramadan</ForeName>
                    <Initials>HR</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>16</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Toxicol Sci</MedlineTA>
            <NlmUniqueID>9805461</NlmUniqueID>
            <ISSNLinking>1096-0929</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Chlorophyllin</Keyword>
            <Keyword MajorTopicYN="N">TiO2 nanoparticles</Keyword>
            <Keyword MajorTopicYN="N">genotoxicity</Keyword>
            <Keyword MajorTopicYN="N">mice</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">kfu157</ArticleId>
            <ArticleId IdType="doi">10.1093/toxsci/kfu157</ArticleId>
            <ArticleId IdType="pubmed">25129858</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25129807</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>17</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1532-2785</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>1</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Neuropeptides</Title>
                <ISOAbbreviation>Neuropeptides</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Desipramine and citalopram attenuate pretest swim-induced increases in prodynorphin immunoreactivity in the dorsal bed nucleus of the stria terminalis and the lateral division of the central nucleus of the amygdala in the forced swimming test.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">S0143-4179(14)00065-1</ELocationID>
            <ELocationID EIdType="doi">10.1016/j.npep.2014.07.001</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Dynorphin in the nucleus accumbens shell plays an important role in antidepressant-like effect in the forced swimming test (FST), but it is unclear whether desipramine and citalopram treatments alter prodynorphin levels in other brain areas. To explore this possibility, we injected mice with desipramine and citalopram 0.5, 19, and 23h after a 15-min pretest swim and observed changes in prodynorphin expression before the test swim, which was conducted 24h after the pretest swim. The pretest swim increased prodynorphin immunoreactivity in the dorsal bed nucleus of the stria terminalis (dBNST) and lateral division of the central nucleus of the amygdala (CeL). This increase in prodynorphin immunoreactivity in the dBNST and CeL was blocked by desipramine and citalopram treatments. Similar changes in prodynorphin mRNA levels were observed in the dBNST and CeL, but these changes did not reach significance. To understand the underlying mechanism, we assessed changes in phosphorylated CREB at Ser(133) (pCREB) immunoreactivity in the dBNST and central nucleus of the amygdala (CeA). Treatment with citalopram but not desipramine after the pretest swim significantly increased pCREB immunoreactivity only in the dBNST. These results suggest that regulation of prodynorphin in the dBNST and CeL before the test swim may be involved in the antidepressant-like effect of desipramine and citalopram in the FST and suggest that changes in pCREB immunoreactivity in these areas may not play an important role in the regulation of prodynorphin in the dBNST and CeA.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 Elsevier Ltd. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Chung</LastName>
                    <ForeName>Sung</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Department of Pharmacology, Korea University College of Medicine, Anam-Dong, Sungbuk-Gu, Seoul, Republic of Korea.</Affiliation>
                </Author>
                <Author>
                    <LastName>Kim</LastName>
                    <ForeName>Hee Jeong</ForeName>
                    <Initials>HJ</Initials>
                    <Affiliation>Department of Pharmacology, Korea University College of Medicine, Anam-Dong, Sungbuk-Gu, Seoul, Republic of Korea.</Affiliation>
                </Author>
                <Author>
                    <LastName>Kim</LastName>
                    <ForeName>Hyun Ju</ForeName>
                    <Initials>HJ</Initials>
                    <Affiliation>Department of Pharmacology, Korea University College of Medicine, Anam-Dong, Sungbuk-Gu, Seoul, Republic of Korea.</Affiliation>
                </Author>
                <Author>
                    <LastName>Choi</LastName>
                    <ForeName>Sun Hye</ForeName>
                    <Initials>SH</Initials>
                    <Affiliation>Department of Pharmacology, Korea University College of Medicine, Anam-Dong, Sungbuk-Gu, Seoul, Republic of Korea.</Affiliation>
                </Author>
                <Author>
                    <LastName>Cho</LastName>
                    <ForeName>Jin Hee</ForeName>
                    <Initials>JH</Initials>
                    <Affiliation>Department of Pharmacology, Korea University College of Medicine, Anam-Dong, Sungbuk-Gu, Seoul, Republic of Korea.</Affiliation>
                </Author>
                <Author>
                    <LastName>Cho</LastName>
                    <ForeName>Yun Ha</ForeName>
                    <Initials>YH</Initials>
                    <Affiliation>Department of Pharmacology, Korea University College of Medicine, Anam-Dong, Sungbuk-Gu, Seoul, Republic of Korea.</Affiliation>
                </Author>
                <Author>
                    <LastName>Kim</LastName>
                    <ForeName>Dong-Hoon</ForeName>
                    <Initials>DH</Initials>
                    <Affiliation>Department of Pharmacology, Korea University College of Medicine, Anam-Dong, Sungbuk-Gu, Seoul, Republic of Korea.</Affiliation>
                </Author>
                <Author>
                    <LastName>Shin</LastName>
                    <ForeName>Kyung Ho</ForeName>
                    <Initials>KH</Initials>
                    <Affiliation>Department of Pharmacology, Korea University College of Medicine, Anam-Dong, Sungbuk-Gu, Seoul, Republic of Korea. Electronic address: kyungho@korea.ac.kr.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>1</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Neuropeptides</MedlineTA>
            <NlmUniqueID>8103156</NlmUniqueID>
            <ISSNLinking>0143-4179</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Amygdala</Keyword>
            <Keyword MajorTopicYN="N">Antidepressive agents</Keyword>
            <Keyword MajorTopicYN="N">Bed nucleus of stria terminalis</Keyword>
            <Keyword MajorTopicYN="N">FST</Keyword>
            <Keyword MajorTopicYN="N">Prodynorphin</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2013</Year>
                <Month>8</Month>
                <Day>9</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>3</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">S0143-4179(14)00065-1</ArticleId>
            <ArticleId IdType="doi">10.1016/j.npep.2014.07.001</ArticleId>
            <ArticleId IdType="pubmed">25129807</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25129792</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1879-1344</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>112</Volume>
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Nov</Month>
                        <Day>4</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Carbohydrate polymers</Title>
                <ISOAbbreviation>Carbohydr Polym</ISOAbbreviation>
            </Journal>
            <ArticleTitle>pH sensitive N-succinyl chitosan grafted polyacrylamide hydrogel for oral insulin delivery.</ArticleTitle>
            <Pagination>
                <MedlinePgn>627-37</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.carbpol.2014.06.045</ELocationID>
            <ELocationID EIdType="pii" ValidYN="Y">S0144-8617(14)00621-3</ELocationID>
            <Abstract>
                <AbstractText>pH sensitive PAA/S-chitosan hydrogel was prepared using ammonium persulfate (APS) as an initiator and methylenebisacrylamide (MBA) as a crosslinker for oral insulin delivery. The synthesized copolymer was characterized by Fourier transform infrared spectroscopy (FT-IR) and X-ray diffraction (XRD) study; morphology was observed under scanning electron microscope (SEM). The PAA/S-chitosan with ???38% of insulin loading efficiency (LE) and ???76% of insulin encapsulation efficiency (EE), showed excellent pH sensitivity, retaining ???26% of encapsulated insulin in acidic stomach pH 1.2 and releasing of ???98% of insulin in the intestine (pH 7.4), providing a prolonged attachment with the intestinal tissue. The oral administration of insulin loaded PAA/S-chitosan hydrogel was successful in lowering the blood glucose level of diabetic mice. The bioavailability of insulin was ???4.43%. Furthermore, no lethality or toxicity was documented after its peroral administration. Thus, PAA/S-chitosan hydrogel could serve as a promising oral insulin carrier in future.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 Elsevier Ltd. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Mukhopadhyay</LastName>
                    <ForeName>Piyasi</ForeName>
                    <Initials>P</Initials>
                    <Affiliation>Department of Polymer Science and Technology, University of Calcutta, 92, A.P.C. Road, Kolkata 700009, India.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sarkar</LastName>
                    <ForeName>Kishor</ForeName>
                    <Initials>K</Initials>
                    <Affiliation>Department of Polymer Science and Technology, University of Calcutta, 92, A.P.C. Road, Kolkata 700009, India.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bhattacharya</LastName>
                    <ForeName>Sourav</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Department of Physiology, University of Calcutta, 92, A.P.C. Road, Kolkata 700009, India.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bhattacharyya</LastName>
                    <ForeName>Aditi</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Department of Polymer Science and Technology, University of Calcutta, 92, A.P.C. Road, Kolkata 700009, India.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mishra</LastName>
                    <ForeName>Roshnara</ForeName>
                    <Initials>R</Initials>
                    <Affiliation>Department of Physiology, University of Calcutta, 92, A.P.C. Road, Kolkata 700009, India.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kundu</LastName>
                    <ForeName>P P</ForeName>
                    <Initials>PP</Initials>
                    <Affiliation>Department of Polymer Science and Technology, University of Calcutta, 92, A.P.C. Road, Kolkata 700009, India. Electronic address: ppk923@yahoo.com.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>06</Month>
                <Day>28</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Carbohydr Polym</MedlineTA>
            <NlmUniqueID>8307156</NlmUniqueID>
            <ISSNLinking>0144-8617</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Hydrogel</Keyword>
            <Keyword MajorTopicYN="N">Oral insulin delivery</Keyword>
            <Keyword MajorTopicYN="N">S-chitosan</Keyword>
            <Keyword MajorTopicYN="N">pH sensitivity</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>4</Month>
                <Day>8</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>2</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>11</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="aheadofprint">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>28</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">S0144-8617(14)00621-3</ArticleId>
            <ArticleId IdType="doi">10.1016/j.carbpol.2014.06.045</ArticleId>
            <ArticleId IdType="pubmed">25129792</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25129743</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1879-1344</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>112</Volume>
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Nov</Month>
                        <Day>4</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Carbohydrate polymers</Title>
                <ISOAbbreviation>Carbohydr Polym</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Bio-inspired Aloe vera sponges for biomedical applications.</ArticleTitle>
            <Pagination>
                <MedlinePgn>264-70</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.carbpol.2014.05.042</ELocationID>
            <ELocationID EIdType="pii" ValidYN="Y">S0144-8617(14)00512-8</ELocationID>
            <Abstract>
                <AbstractText>Chemical composition and biological properties of Aloe vera (AV), a tropical plant, explain its potential use for cosmetic, nutritional and biomedical applications. AV gel present in AV leaves is rich in several compounds, nutrients and polysaccharides. This work proposes using AV gel complex structure and chemical composition, associated with freeze-drying, to produce sponges. To increase the structures stability in aqueous media, a thin coating of gellan gum (GG), was applied onto AV gel. AV-based sponges showed a heterogeneous porous formation, interconnected pores and good porosity (72-77%). The coating with a GG layer onto AV influenced the stability, swelling behavior and mechanical properties of the resulting sponges. Moreover, sponges provided the sustained release of BSA-FTIC, used as a model protein, over 3 weeks. Also, in vitro cell culture studies evidenced that sponges are not cytotoxic for a mouse fibroblast-like cell line. Therefore, developed AV-based sponges have potential use in biomedical applications.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 Elsevier Ltd. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Silva</LastName>
                    <ForeName>S S</ForeName>
                    <Initials>SS</Initials>
                    <Affiliation>3B's Research Group - Biomaterials, Biodegradables and Biomimetics, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, AvePark, 4806-909 Taipas, Guimar??es, Portugal; ICVS/3B's - PT Government Associate Laboratory, Braga/Guimar??es, Portugal. Electronic address: simonesilva@dep.uminho.pt.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Oliveira</LastName>
                    <ForeName>M B</ForeName>
                    <Initials>MB</Initials>
                    <Affiliation>3B's Research Group - Biomaterials, Biodegradables and Biomimetics, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, AvePark, 4806-909 Taipas, Guimar??es, Portugal; ICVS/3B's - PT Government Associate Laboratory, Braga/Guimar??es, Portugal.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mano</LastName>
                    <ForeName>J F</ForeName>
                    <Initials>JF</Initials>
                    <Affiliation>3B's Research Group - Biomaterials, Biodegradables and Biomimetics, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, AvePark, 4806-909 Taipas, Guimar??es, Portugal; ICVS/3B's - PT Government Associate Laboratory, Braga/Guimar??es, Portugal.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Reis</LastName>
                    <ForeName>R L</ForeName>
                    <Initials>RL</Initials>
                    <Affiliation>3B's Research Group - Biomaterials, Biodegradables and Biomimetics, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, AvePark, 4806-909 Taipas, Guimar??es, Portugal; ICVS/3B's - PT Government Associate Laboratory, Braga/Guimar??es, Portugal.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>05</Month>
                <Day>27</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Carbohydr Polym</MedlineTA>
            <NlmUniqueID>8307156</NlmUniqueID>
            <ISSNLinking>0144-8617</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Aloe vera gel</Keyword>
            <Keyword MajorTopicYN="N">Gellan gum</Keyword>
            <Keyword MajorTopicYN="N">Regenerative medicine</Keyword>
            <Keyword MajorTopicYN="N">Sponges</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2013</Year>
                <Month>11</Month>
                <Day>27</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>6</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>14</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="aheadofprint">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>27</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">S0144-8617(14)00512-8</ArticleId>
            <ArticleId IdType="doi">10.1016/j.carbpol.2014.05.042</ArticleId>
            <ArticleId IdType="pubmed">25129743</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25129737</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1879-1344</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>112</Volume>
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Nov</Month>
                        <Day>4</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Carbohydrate polymers</Title>
                <ISOAbbreviation>Carbohydr Polym</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Starch granules as a vehicle for the oral administration of immobilized antigens.</ArticleTitle>
            <Pagination>
                <MedlinePgn>210-5</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.carbpol.2014.05.089</ELocationID>
            <ELocationID EIdType="pii" ValidYN="Y">S0144-8617(14)00567-0</ELocationID>
            <Abstract>
                <AbstractText>Microparticles of diverse compositions are often used as carriers for interesting antigens. In this work, we propose the use of natural microparticulated starch as a vehicle for antigens. The proposed system is composed of raw starch microparticles and a starch-binding domain that when fused to another protein, allows for a stable protein immobilization onto the granule surface. To demonstrate the use of starch as an antigen carrier, a fusion combining fragment C of the tetanus toxin with the starch-binding domain was adsorbed to starch and administered orally to mice in two different doses and, importantly, without the use of any adjuvant. The results showed that the system allows the induction of specific antibodies; moreover mice given this immobilized protein presented a delay in the onset of tetanus symptoms compared to mice administered the non-immobilized protein. The study outlines the viability of this immobilization system as an antigen and protein carrier.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 Elsevier Ltd. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Guill??n</LastName>
                    <ForeName>Daniel</ForeName>
                    <Initials>D</Initials>
                    <Affiliation>Instituto de Investigaciones Biom??dicas, Universidad Nacional Aut??noma de M??xico, A.P.70228, Ciudad Universitaria, 04510 M??xico, D.F., Mexico; Programa de Doctorado en Ciencias Bioqu??micas, Universidad Nacional Aut??noma de M??xico, A.P.70228, Ciudad Universitaria, 04510 M??xico, D.F., Mexico. Electronic address: dguillen@biomedicas.unam.mx.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Moreno-Mendieta</LastName>
                    <ForeName>Silvia</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Instituto de Investigaciones Biom??dicas, Universidad Nacional Aut??noma de M??xico, A.P.70228, Ciudad Universitaria, 04510 M??xico, D.F., Mexico; Programa de Posgrado en Ciencias Biom??dicas, Universidad Nacional Aut??noma de M??xico, A.P.70228, Ciudad Universitaria, 04510 M??xico, D.F., Mexico. Electronic address: silviamoreno.m@gmail.com.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>P??rez</LastName>
                    <ForeName>Ricardo</ForeName>
                    <Initials>R</Initials>
                    <Affiliation>Instituto de Investigaciones Biom??dicas, Universidad Nacional Aut??noma de M??xico, A.P.70228, Ciudad Universitaria, 04510 M??xico, D.F., Mexico. Electronic address: ricasup@yahoo.com.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Espitia</LastName>
                    <ForeName>Clara</ForeName>
                    <Initials>C</Initials>
                    <Affiliation>Instituto de Investigaciones Biom??dicas, Universidad Nacional Aut??noma de M??xico, A.P.70228, Ciudad Universitaria, 04510 M??xico, D.F., Mexico. Electronic address: espitia@biomedicas.unam.mx.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>S??nchez</LastName>
                    <ForeName>Sergio</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Instituto de Investigaciones Biom??dicas, Universidad Nacional Aut??noma de M??xico, A.P.70228, Ciudad Universitaria, 04510 M??xico, D.F., Mexico. Electronic address: sersan@biomedicas.unam.mx.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rodr??guez-Sanoja</LastName>
                    <ForeName>Romina</ForeName>
                    <Initials>R</Initials>
                    <Affiliation>Instituto de Investigaciones Biom??dicas, Universidad Nacional Aut??noma de M??xico, A.P.70228, Ciudad Universitaria, 04510 M??xico, D.F., Mexico. Electronic address: romina@biomedicas.unam.mx.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>06</Month>
                <Day>06</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Carbohydr Polym</MedlineTA>
            <NlmUniqueID>8307156</NlmUniqueID>
            <ISSNLinking>0144-8617</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Microparticle</Keyword>
            <Keyword MajorTopicYN="N">Microparticle vaccine</Keyword>
            <Keyword MajorTopicYN="N">Oral immunization</Keyword>
            <Keyword MajorTopicYN="N">Oral vehicle</Keyword>
            <Keyword MajorTopicYN="N">Protein delivery system</Keyword>
            <Keyword MajorTopicYN="N">Starch-binding domain</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>2</Month>
                <Day>17</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>6</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="aheadofprint">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>6</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">S0144-8617(14)00567-0</ArticleId>
            <ArticleId IdType="doi">10.1016/j.carbpol.2014.05.089</ArticleId>
            <ArticleId IdType="pubmed">25129737</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25129719</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1879-1344</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>112</Volume>
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Nov</Month>
                        <Day>4</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Carbohydrate polymers</Title>
                <ISOAbbreviation>Carbohydr Polym</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Physicochemical characteristics of polysaccharide conjugates prepared from fresh tea leaves and their improving impaired glucose tolerance.</ArticleTitle>
            <Pagination>
                <MedlinePgn>77-84</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.carbpol.2014.05.030</ELocationID>
            <ELocationID EIdType="pii" ValidYN="Y">S0144-8617(14)00500-1</ELocationID>
            <Abstract>
                <AbstractText>Hot-water extracts were prepared from fresh tea leaves and fractionated by DEAE-cellulose DE-52 column chromatography to yield one unexplored polysaccharide-conjugate fraction TPC-L (tea polysaccharide conjugates). Chemical components, molecular weight and its distribution, water vapor sorption properties, zeta potentials and optical characteristics of TPC-L were investigated. As compared with injured cell group, the two dosages of TPC-L (150 and 300??g/mL) were discovered to possess remarkably protective effect on human umbilical vein endothelial cells against impairments induced by high glucose in a dose-dependent manner (p&lt;0.05, p&lt;0.001, respectively). Compared with group NC (normal control), the ingestion of 40mg/kg of TPC-L could significantly reduce blood glucose levels of normal mice ingesting starch, and significant difference of AUC (area under the curve of blood glucose) and ??AUC (p&lt;0.05, p&lt;0.01) at the postprandial time point of 0.5 and 1.0h were observed. The three dosages of TPC-L (10, 40 and 160mg/kg) did not significantly lower postprandial blood glucose levels of normal mice ingesting glucose. TPC-L could improve starch tolerance to prevent impaired glucose tolerance (IGT) from developing into diabetes as well as protective effects on HUVE cells against impairments induced by high glucose It was suggested that TPC-L improved IGT through its capability of inhibition on digestive enzymes.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 Elsevier Ltd. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>Xiaoqiang</ForeName>
                    <Initials>X</Initials>
                    <Affiliation>Hubei Collaborative Innovation Center for Industrial Fermentation, Glyn O. Phillips Hydrocolloid Research Centre at HUT, Hubei University of Technology, Wuhan 430068, China; College of Food Science and Biotechnology, Zhejiang Gongshang University, Hangzhou 310035, China. Electronic address: biomed528@163.com.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Fang</LastName>
                    <ForeName>Yapeng</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Hubei Collaborative Innovation Center for Industrial Fermentation, Glyn O. Phillips Hydrocolloid Research Centre at HUT, Hubei University of Technology, Wuhan 430068, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nishinari</LastName>
                    <ForeName>Katsuyoshi</ForeName>
                    <Initials>K</Initials>
                    <Affiliation>Hubei Collaborative Innovation Center for Industrial Fermentation, Glyn O. Phillips Hydrocolloid Research Centre at HUT, Hubei University of Technology, Wuhan 430068, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>We</LastName>
                    <ForeName>Heng</ForeName>
                    <Initials>H</Initials>
                    <Affiliation>Xinhua Hospital of Hubei Province, Wuhan 430015, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sun</LastName>
                    <ForeName>Chaochao</ForeName>
                    <Initials>C</Initials>
                    <Affiliation>Hangzhou Hospital of Traditional Chinese Medicine, Hangzhou 310007, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Jianrong</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>Bohai University, Jinzhou 121013, China. Electronic address: lijr6491@163.com.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jiang</LastName>
                    <ForeName>Yongwen</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Tea Research Institute, China Academy of Agricultural Sciences, Key Laboratory of Tea Biology and Resources Utilization, Ministry of Agriculture, China, Key Laboratory of Tea Processing Engineering of Zhejiang Province, Hangzhou 310008, China. Electronic address: jywtea@163.com.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>05</Month>
                <Day>29</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Carbohydr Polym</MedlineTA>
            <NlmUniqueID>8307156</NlmUniqueID>
            <ISSNLinking>0144-8617</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Endothelial cells</Keyword>
            <Keyword MajorTopicYN="N">Impaired glucose tolerance</Keyword>
            <Keyword MajorTopicYN="N">Tea polysaccharides conjugates</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>2</Month>
                <Day>7</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>4</Month>
                <Day>29</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>4</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="aheadofprint">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>29</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">S0144-8617(14)00500-1</ArticleId>
            <ArticleId IdType="doi">10.1016/j.carbpol.2014.05.030</ArticleId>
            <ArticleId IdType="pubmed">25129719</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25129711</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1879-1344</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>112</Volume>
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Nov</Month>
                        <Day>4</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Carbohydrate polymers</Title>
                <ISOAbbreviation>Carbohydr Polym</ISOAbbreviation>
            </Journal>
            <ArticleTitle>The excreted polysaccharide of Pleurotus eryngii inhibits the foam-cell formation via down-regulation of CD36.</ArticleTitle>
            <Pagination>
                <MedlinePgn>16-23</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.carbpol.2014.05.068</ELocationID>
            <ELocationID EIdType="pii" ValidYN="Y">S0144-8617(14)00545-1</ELocationID>
            <Abstract>
                <AbstractText>Previous study has verified the polysaccharide from the fruiting body of Pleurotus eryngii (PEPE) is capable of decreasing the lipid content in both of cell-line and mouse model. However, little is known about underlying mechanisms and whether this bioactive polysaccharide exists in submerged culture. Here, we verified the excreted polysaccharides EP and EP-1 from submersion culture of P. eryngii have the remarkable inhibitory effects on lipid accumulation in macrophage-derived foam cells. Structure analysis indicates EP-1 consists of d-types of glucose, galactose and mannose with the main ??(1???3)-glucan glycosidic linkage branched at O-6 by ??-d-glucose while EP digested by ??-1,3-glucanase fails to decrease the lipid accumulation, suggesting that the special structure is essential for its function. Expression analysis suggests that EP is able to cause the down-regulation of the scavenger receptor-CD36 on both transcription and protein levels. Most importantly, EP can be obtained by fermentation in a mass-production.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 Elsevier Ltd. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>Jingjing</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>Jiangsu Key Laboratory for Microbes and Functional Genomics, Jiangsu Engineering and Technology Research Center for Microbiology, College of Life Sciences, Nanjing Normal University, No. 1 Wen Yuan Rd, Qi Xia Qu, Nanjing, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yong</LastName>
                    <ForeName>Yangyang</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Jiangsu Key Laboratory for Microbes and Functional Genomics, Jiangsu Engineering and Technology Research Center for Microbiology, College of Life Sciences, Nanjing Normal University, No. 1 Wen Yuan Rd, Qi Xia Qu, Nanjing, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Xia</LastName>
                    <ForeName>Xian</ForeName>
                    <Initials>X</Initials>
                    <Affiliation>Jiangsu Key Laboratory for Microbes and Functional Genomics, Jiangsu Engineering and Technology Research Center for Microbiology, College of Life Sciences, Nanjing Normal University, No. 1 Wen Yuan Rd, Qi Xia Qu, Nanjing, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Zeliang</ForeName>
                    <Initials>Z</Initials>
                    <Affiliation>Jiangsu Key Laboratory for Microbes and Functional Genomics, Jiangsu Engineering and Technology Research Center for Microbiology, College of Life Sciences, Nanjing Normal University, No. 1 Wen Yuan Rd, Qi Xia Qu, Nanjing, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Liang</LastName>
                    <ForeName>Youxing</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Jiangsu Key Laboratory for Microbes and Functional Genomics, Jiangsu Engineering and Technology Research Center for Microbiology, College of Life Sciences, Nanjing Normal University, No. 1 Wen Yuan Rd, Qi Xia Qu, Nanjing, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhang</LastName>
                    <ForeName>Shizhu</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Jiangsu Key Laboratory for Microbes and Functional Genomics, Jiangsu Engineering and Technology Research Center for Microbiology, College of Life Sciences, Nanjing Normal University, No. 1 Wen Yuan Rd, Qi Xia Qu, Nanjing, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lu</LastName>
                    <ForeName>Ling</ForeName>
                    <Initials>L</Initials>
                    <Affiliation>Jiangsu Key Laboratory for Microbes and Functional Genomics, Jiangsu Engineering and Technology Research Center for Microbiology, College of Life Sciences, Nanjing Normal University, No. 1 Wen Yuan Rd, Qi Xia Qu, Nanjing, China. Electronic address: linglu@njnu.edu.cn.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>06</Month>
                <Day>02</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Carbohydr Polym</MedlineTA>
            <NlmUniqueID>8307156</NlmUniqueID>
            <ISSNLinking>0144-8617</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Excreted polysaccharide</Keyword>
            <Keyword MajorTopicYN="N">Lipid accumulation</Keyword>
            <Keyword MajorTopicYN="N">Pleurotus eryngii</Keyword>
            <Keyword MajorTopicYN="N">Scavenger receptor</Keyword>
            <Keyword MajorTopicYN="N">Submerged culture</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>3</Month>
                <Day>30</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>20</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>21</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="aheadofprint">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>2</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">S0144-8617(14)00545-1</ArticleId>
            <ArticleId IdType="doi">10.1016/j.carbpol.2014.05.068</ArticleId>
            <ArticleId IdType="pubmed">25129711</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25129695</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>17</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1535-9484</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>16</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Molecular &amp; cellular proteomics : MCP</Title>
                <ISOAbbreviation>Mol. Cell Proteomics</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Bayesian Proteoform Modeling Improves Protein Quantification of Global Proteomic Measurements.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">mcp.O113.030932</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">As the capability of mass spectrometry-based proteomics has matured, tens of thousands of peptides can be measured simultaneously, which has the benefit of offering a systems view of protein expression. However, a major challenge is that with an increase in throughput, protein quantification estimation from the native measured peptides has become a computational task. A limitation to existing computationally-driven protein quantification methods is that most ignore protein variation, such as alternate splicing of the RNA transcript and post-translational modifications or other possible proteoforms, which will affect a significant fraction of the proteome. The consequence of this assumption is that statistical inference at the protein level, and consequently downstream analyses, such as network and pathway modeling, have only limited power for biomarker discovery. Here, we describe a Bayesian model (BP-Quant) that uses statistically derived peptides signatures to identify peptides that are outside the dominant pattern, or the existence of multiple over-expressed patterns to improve relative protein abundance estimates. It is a research-driven approach that utilizes the objectives of the experiment, defined in the context of a standard statistical hypothesis, to identify a set of peptides exhibiting similar statistical behavior relating to a protein. This approach infers that changes in relative protein abundance can be used as a surrogate for changes in function, without necessarily taking into account the effect of differential post-translational modifications, processing, or splicing in altering protein function. We verify the approach using a dilution study from mouse plasma samples and demonstrate that BP-Quant achieves similar accuracy as the current state-of-the-art methods at proteoform identification with significantly better specificity. BP-Quant is available as a MatLab ?? and R packages at https://github.com/PNNL-Comp-Mass-Spec/BP-Quant.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014, The American Society for Biochemistry and Molecular Biology.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Webb-Robertson</LastName>
                    <ForeName>Bobbie-Jo M</ForeName>
                    <Initials>BJ</Initials>
                    <Affiliation>Pacific Northwest National Laboratory, United States; bj@pnnl.gov.</Affiliation>
                </Author>
                <Author>
                    <LastName>Matzke</LastName>
                    <ForeName>Melissa M</ForeName>
                    <Initials>MM</Initials>
                    <Affiliation>Pacific Northwest National Laboratory, United States;</Affiliation>
                </Author>
                <Author>
                    <LastName>Datta</LastName>
                    <ForeName>Susmita</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>University of Louisville, United States.</Affiliation>
                </Author>
                <Author>
                    <LastName>Payne</LastName>
                    <ForeName>Samuel H</ForeName>
                    <Initials>SH</Initials>
                    <Affiliation>Pacific Northwest National Laboratory, United States;</Affiliation>
                </Author>
                <Author>
                    <LastName>Kang</LastName>
                    <ForeName>Jiyun</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>Pacific Northwest National Laboratory, United States;</Affiliation>
                </Author>
                <Author>
                    <LastName>Bramer</LastName>
                    <ForeName>Lisa M</ForeName>
                    <Initials>LM</Initials>
                    <Affiliation>Pacific Northwest National Laboratory, United States;</Affiliation>
                </Author>
                <Author>
                    <LastName>Nicora</LastName>
                    <ForeName>Carrie D</ForeName>
                    <Initials>CD</Initials>
                    <Affiliation>Pacific Northwest National Laboratory, United States;</Affiliation>
                </Author>
                <Author>
                    <LastName>Shukla</LastName>
                    <ForeName>Anil K</ForeName>
                    <Initials>AK</Initials>
                    <Affiliation>Pacific Northwest National Laboratory, United States;</Affiliation>
                </Author>
                <Author>
                    <LastName>Metz</LastName>
                    <ForeName>Thomas O</ForeName>
                    <Initials>TO</Initials>
                    <Affiliation>Pacific Northwest National Laboratory, United States;</Affiliation>
                </Author>
                <Author>
                    <LastName>Rodland</LastName>
                    <ForeName>Karin D</ForeName>
                    <Initials>KD</Initials>
                    <Affiliation>Pacific Northwest National Laboratory, United States;</Affiliation>
                </Author>
                <Author>
                    <LastName>Smith</LastName>
                    <ForeName>Richard D</ForeName>
                    <Initials>RD</Initials>
                    <Affiliation>Pacific Northwest National Laboratory, United States;</Affiliation>
                </Author>
                <Author>
                    <LastName>Tardiff</LastName>
                    <ForeName>Mark F</ForeName>
                    <Initials>MF</Initials>
                    <Affiliation>Pacific Northwest National Laboratory, United States;</Affiliation>
                </Author>
                <Author>
                    <LastName>McDermott</LastName>
                    <ForeName>Jason E</ForeName>
                    <Initials>JE</Initials>
                    <Affiliation>Pacific Northwest National Laboratory, United States;</Affiliation>
                </Author>
                <Author>
                    <LastName>Pounds</LastName>
                    <ForeName>Joel G</ForeName>
                    <Initials>JG</Initials>
                    <Affiliation>Pacific Northwest National Laboratory, United States;</Affiliation>
                </Author>
                <Author>
                    <LastName>Waters</LastName>
                    <ForeName>Katrina M</ForeName>
                    <Initials>KM</Initials>
                    <Affiliation>Pacific Northwest National Laboratory, United States;</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>16</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Mol Cell Proteomics</MedlineTA>
            <NlmUniqueID>101125647</NlmUniqueID>
            <ISSNLinking>1535-9476</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Bioinformatics</Keyword>
            <Keyword MajorTopicYN="N">Biomarkers</Keyword>
            <Keyword MajorTopicYN="N">Computational Biology</Keyword>
            <Keyword MajorTopicYN="N">Quantification</Keyword>
            <Keyword MajorTopicYN="N">Statistics</Keyword>
            <Keyword MajorTopicYN="N">Tandem Mass Spectrometry</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">O113.030932</ArticleId>
            <ArticleId IdType="doi">10.1074/mcp.O113.030932</ArticleId>
            <ArticleId IdType="pubmed">25129695</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25129680</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>17</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1097-6825</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>13</Day>
                    </PubDate>
                </JournalIssue>
                <Title>The Journal of allergy and clinical immunology</Title>
                <ISOAbbreviation>J. Allergy Clin. Immunol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Eosinophil-dependent skin innervation and itching following??contact toxicant exposure in mice.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">S0091-6749(14)00954-3</ELocationID>
            <ELocationID EIdType="doi">10.1016/j.jaci.2014.07.003</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Contact toxicant reactions are accompanied by localized skin inflammation and concomitant increases in site-specific itch responses. The role(s) of eosinophils in these reactions is poorly understood. However, previous studies have suggested that localized eosinophil-nerve interactions at sites of inflammation significantly alter tissue innervation.</AbstractText>
                <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To define a potential mechanistic link between eosinophils and neurosensory responses in the skin leading to itching.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">BALB/cJ mice were exposed to different contact toxicants, identifying trimellitic anhydride (TMA) for further study on the basis of inducing a robust eosinophilia accompanied by degranulation. Subsequent studies using TMA were performed with wild type versus eosinophil-deficient PHIL mice, assessing edematous responses and remodeling events such as sensory nerve innervation of the skin and induced pathophysiological responses (ie, itching).</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Exposure to TMA, but not dinitrofluorobenzene, resulted in a robust eosinophil skin infiltrate accompanied by significant levels of degranulation. Follow-up studies using TMA with wild type versus eosinophil-deficient PHIL mice showed that the induced edematous responses and histopathology were, in part, causatively linked with the presence of eosinophils. Significantly, these data also demonstrated that eosinophil-mediated events correlated with a significant increase in substance P content of the cutaneous nerves and an accompanying increase in itching, both of which were abolished in the absence of eosinophils.</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Eosinophil-mediated events following TMA contact toxicant reactions increase skin sensory nerve substance P and, in turn, increase itching responses. Thus, eosinophil-nerve interactions provide a potential mechanistic link between eosinophil-mediated events and neurosensory responses following exposure to some contact toxicants.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 American Academy of Allergy, Asthma &amp; Immunology. Published by Mosby, Inc. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Lee</LastName>
                    <ForeName>James J</ForeName>
                    <Initials>JJ</Initials>
                    <Affiliation>Division of Pulmonary Medicine, Department of Biochemistry and Molecular Biology, Mayo Clinic in Arizona, Scottsdale, Ariz. Electronic address: jjlee@mayo.edu.</Affiliation>
                </Author>
                <Author>
                    <LastName>Protheroe</LastName>
                    <ForeName>Cheryl A</ForeName>
                    <Initials>CA</Initials>
                    <Affiliation>Division of Hematology and Oncology, Department of Biochemistry and Molecular Biology, Mayo Clinic in Arizona, Scottsdale, Ariz.</Affiliation>
                </Author>
                <Author>
                    <LastName>Luo</LastName>
                    <ForeName>Huijun</ForeName>
                    <Initials>H</Initials>
                    <Affiliation>Division of Pulmonary Medicine, Department of Biochemistry and Molecular Biology, Mayo Clinic in Arizona, Scottsdale, Ariz.</Affiliation>
                </Author>
                <Author>
                    <LastName>Ochkur</LastName>
                    <ForeName>Sergei I</ForeName>
                    <Initials>SI</Initials>
                    <Affiliation>Division of Pulmonary Medicine, Department of Biochemistry and Molecular Biology, Mayo Clinic in Arizona, Scottsdale, Ariz.</Affiliation>
                </Author>
                <Author>
                    <LastName>Scott</LastName>
                    <ForeName>Gregory D</ForeName>
                    <Initials>GD</Initials>
                    <Affiliation>Division of Pulmonary and Critical Care Medicine, Oregon Health and Science University, Portland, Ore.</Affiliation>
                </Author>
                <Author>
                    <LastName>Zellner</LastName>
                    <ForeName>Katie R</ForeName>
                    <Initials>KR</Initials>
                    <Affiliation>Division of Pulmonary Medicine, Department of Biochemistry and Molecular Biology, Mayo Clinic in Arizona, Scottsdale, Ariz.</Affiliation>
                </Author>
                <Author>
                    <LastName>Raish</LastName>
                    <ForeName>Randall J</ForeName>
                    <Initials>RJ</Initials>
                    <Affiliation>Media Support Services, Mayo Clinic in Arizona, Scottsdale, Ariz.</Affiliation>
                </Author>
                <Author>
                    <LastName>Dahl</LastName>
                    <ForeName>Mark V</ForeName>
                    <Initials>MV</Initials>
                    <Affiliation>Department of Dermatology, Mayo Clinic in Arizona, Scottsdale, Ariz.</Affiliation>
                </Author>
                <Author>
                    <LastName>Vega</LastName>
                    <ForeName>Miriam L</ForeName>
                    <Initials>ML</Initials>
                    <Affiliation>Department of Dermatology, Mayo Clinic in Arizona, Scottsdale, Ariz.</Affiliation>
                </Author>
                <Author>
                    <LastName>Conley</LastName>
                    <ForeName>Olivia</ForeName>
                    <Initials>O</Initials>
                    <Affiliation>Division of Hematology and Oncology, Department of Biochemistry and Molecular Biology, Mayo Clinic in Arizona, Scottsdale, Ariz.</Affiliation>
                </Author>
                <Author>
                    <LastName>Condjella</LastName>
                    <ForeName>Rachel M</ForeName>
                    <Initials>RM</Initials>
                    <Affiliation>Division of Hematology and Oncology, Department of Biochemistry and Molecular Biology, Mayo Clinic in Arizona, Scottsdale, Ariz.</Affiliation>
                </Author>
                <Author>
                    <LastName>Kloeber</LastName>
                    <ForeName>Jake A</ForeName>
                    <Initials>JA</Initials>
                    <Affiliation>Brophy College Preparatory, Department of Science, Phoenix, Ariz.</Affiliation>
                </Author>
                <Author>
                    <LastName>Neely</LastName>
                    <ForeName>Joseph L</ForeName>
                    <Initials>JL</Initials>
                    <Affiliation>Brophy College Preparatory, Department of Science, Phoenix, Ariz.</Affiliation>
                </Author>
                <Author>
                    <LastName>Patel</LastName>
                    <ForeName>Yash S</ForeName>
                    <Initials>YS</Initials>
                    <Affiliation>Brophy College Preparatory, Department of Science, Phoenix, Ariz.</Affiliation>
                </Author>
                <Author>
                    <LastName>Maizer</LastName>
                    <ForeName>Patty</ForeName>
                    <Initials>P</Initials>
                    <Affiliation>Brophy College Preparatory, Department of Science, Phoenix, Ariz.</Affiliation>
                </Author>
                <Author>
                    <LastName>Mazzolini</LastName>
                    <ForeName>Andrew</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Brophy College Preparatory, Department of Science, Phoenix, Ariz.</Affiliation>
                </Author>
                <Author>
                    <LastName>Fryer</LastName>
                    <ForeName>Allison D</ForeName>
                    <Initials>AD</Initials>
                    <Affiliation>Department of Physiology and Pharmacology, Oregon Health and Science University, Portland, Ore.</Affiliation>
                </Author>
                <Author>
                    <LastName>Jacoby</LastName>
                    <ForeName>Noah W</ForeName>
                    <Initials>NW</Initials>
                    <Affiliation>Division of Pulmonary and Critical Care Medicine, Oregon Health and Science University, Portland, Ore.</Affiliation>
                </Author>
                <Author>
                    <LastName>Jacoby</LastName>
                    <ForeName>David B</ForeName>
                    <Initials>DB</Initials>
                    <Affiliation>Division of Pulmonary and Critical Care Medicine, Oregon Health and Science University, Portland, Ore.</Affiliation>
                </Author>
                <Author>
                    <LastName>Lee</LastName>
                    <ForeName>Nancy A</ForeName>
                    <Initials>NA</Initials>
                    <Affiliation>Division of Hematology and Oncology, Department of Biochemistry and Molecular Biology, Mayo Clinic in Arizona, Scottsdale, Ariz.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>13</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>J Allergy Clin Immunol</MedlineTA>
            <NlmUniqueID>1275002</NlmUniqueID>
            <ISSNLinking>0091-6749</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Contact hypersensitivity</Keyword>
            <Keyword MajorTopicYN="N">degranulation</Keyword>
            <Keyword MajorTopicYN="N">eosinophil-deficient</Keyword>
            <Keyword MajorTopicYN="N">sensory nerve</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>2</Month>
                <Day>3</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>16</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>3</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">S0091-6749(14)00954-3</ArticleId>
            <ArticleId IdType="doi">10.1016/j.jaci.2014.07.003</ArticleId>
            <ArticleId IdType="pubmed">25129680</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25129573</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1574-4647</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>36</Volume>
                    <Issue>5</Issue>
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Oct</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Age (Dordrecht, Netherlands)</Title>
                <ISOAbbreviation>Age (Dordr)</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Long-term wheel running changes on sensorimotor activity and skeletal muscle in male and female mice of accelerated senescence.</ArticleTitle>
            <Pagination>
                <MedlinePgn>9697</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1007/s11357-014-9697-1</ELocationID>
            <Abstract>
                <AbstractText>The senescence-accelerated mouse prone 8 (SAMP8) is considered a useful non-transgenic model for studying aspects of aging. Using SAM resistant 1 (SAMR1) as controls, the long-term effects of wheel running on skeletal muscle adaptations and behavioral traits were evaluated in senescent (P8) and resistant (R1) male and female mice. Long-term wheel running (WR) led to increases in locomotor activity, benefits in sensorimotor function, and changes in body weight in a gender-dependent manner. WR increased body weight and baseline levels of locomotor activity in female mice and improved balance and strength in male mice, compared to sedentary-control mice. WR resulted in key metabolic adaptations in skeletal muscle, associated with an increased activity of the sirtuin 1-AMP-activated protein kinase (AMPK)-PGC-1 alpha axis and changes in vascular endothelial growth factor A (Vegfa), glucose transporter type 4 (Glut4), and Cluster of Differentiation 36 (Cd36) gene expression. Overall, our data indicate that activity, balance, and strength decrease with age and that long-term WR may significantly improve the motor function in a mouse model of senescence in a gender-dependent manner.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Sanchez-Roige</LastName>
                    <ForeName>Sandra</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>School of Psychology, University of Sussex, Falmer, Brighton, BN1 9QG, UK.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lalanza</LastName>
                    <ForeName>Jaume F</ForeName>
                    <Initials>JF</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Alvarez-L??pez</LastName>
                    <ForeName>Mar??a Jes??s</ForeName>
                    <Initials>MJ</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cos??n-Tom??s</LastName>
                    <ForeName>Marta</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gri??an-Ferr??</LastName>
                    <ForeName>Christian</ForeName>
                    <Initials>C</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pall??s</LastName>
                    <ForeName>Merce</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kaliman</LastName>
                    <ForeName>Perla</ForeName>
                    <Initials>P</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Escorihuela</LastName>
                    <ForeName>Rosa M</ForeName>
                    <Initials>RM</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>17</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Netherlands</Country>
            <MedlineTA>Age (Dordr)</MedlineTA>
            <NlmUniqueID>101250497</NlmUniqueID>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>1</Month>
                <Day>29</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>27</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="aheadofprint">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>17</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11357-014-9697-1</ArticleId>
            <ArticleId IdType="pubmed">25129573</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25129504</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>17</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1095-9157</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>13</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of autoimmunity</Title>
                <ISOAbbreviation>J. Autoimmun.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Thymic CCL2 influences induction of T-cell tolerance.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">S0896-8411(14)00117-6</ELocationID>
            <ELocationID EIdType="doi">10.1016/j.jaut.2014.07.004</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Thymic epithelial cells (TEC) and dendritic cells (DC) play a role in T cell development by controlling the selection of the T cell receptor repertoire. DC have been described to take up antigens in the periphery and migrate into the thymus where they mediate tolerance via deletion of autoreactive T cells, or by induction of natural regulatory T cells. Migration of DC to thymus is driven by chemokine receptors. CCL2, a major ligand for the chemokine receptor CCR2, is an inflammation-associated chemokine that induces the recruitment of immune cells in tissues. CCL2 and CCR2 are implicated in promoting experimental autoimmune encephalomyelitis (EAE), a mouse model for multiple sclerosis. We here show that CCL2 is constitutively expressed by endothelial cells and TEC in the thymus. Transgenic mice overexpressing CCL2 in the thymus showed an increased number of thymic plasmacytoid DC and pronounced impairment of T cell development. Consequently, CCL2 transgenic mice were resistant to EAE. These findings demonstrate that expression of CCL2 in thymus regulates DC homeostasis and controls development of autoreactive T cells, thus preventing development of autoimmune diseases.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 Elsevier Ltd. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>C??dile</LastName>
                    <ForeName>O</ForeName>
                    <Initials>O</Initials>
                    <Affiliation>Institute of Molecular Medicine, Department of Neurobiology Research, University of Southern Denmark, J.B. Winsl??wsvej 25, DK-5000 Odense C, Denmark.</Affiliation>
                </Author>
                <Author>
                    <LastName>L??bner</LastName>
                    <ForeName>M</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Institute of Molecular Medicine, Department of Neurobiology Research, University of Southern Denmark, J.B. Winsl??wsvej 25, DK-5000 Odense C, Denmark.</Affiliation>
                </Author>
                <Author>
                    <LastName>Toft-Hansen</LastName>
                    <ForeName>H</ForeName>
                    <Initials>H</Initials>
                    <Affiliation>Institute of Molecular Medicine, Department of Neurobiology Research, University of Southern Denmark, J.B. Winsl??wsvej 25, DK-5000 Odense C, Denmark.</Affiliation>
                </Author>
                <Author>
                    <LastName>Frank</LastName>
                    <ForeName>I</ForeName>
                    <Initials>I</Initials>
                    <Affiliation>Institute of Molecular Medicine, Department of Neurobiology Research, University of Southern Denmark, J.B. Winsl??wsvej 25, DK-5000 Odense C, Denmark.</Affiliation>
                </Author>
                <Author>
                    <LastName>Wlodarczyk</LastName>
                    <ForeName>A</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Institute of Molecular Medicine, Department of Neurobiology Research, University of Southern Denmark, J.B. Winsl??wsvej 25, DK-5000 Odense C, Denmark.</Affiliation>
                </Author>
                <Author>
                    <LastName>Irla</LastName>
                    <ForeName>M</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Centre d'Immunologie de Marseille-Luminy - CIML, Institut National de la Sant?? et de la Recherche M??dicale, U1104, Centre National de la Recherche Scientifique, UMR7280 and Aix Marseille Universit??, UM2, F-13009 Marseille, France.</Affiliation>
                </Author>
                <Author>
                    <LastName>Owens</LastName>
                    <ForeName>T</ForeName>
                    <Initials>T</Initials>
                    <Affiliation>Institute of Molecular Medicine, Department of Neurobiology Research, University of Southern Denmark, J.B. Winsl??wsvej 25, DK-5000 Odense C, Denmark. Electronic address: towens@health.sdu.dk.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>13</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>J Autoimmun</MedlineTA>
            <NlmUniqueID>8812164</NlmUniqueID>
            <ISSNLinking>0896-8411</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">CCL2</Keyword>
            <Keyword MajorTopicYN="N">EAE</Keyword>
            <Keyword MajorTopicYN="N">Plasmacytoid dendritic cells</Keyword>
            <Keyword MajorTopicYN="N">Tolerance</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>28</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>22</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">S0896-8411(14)00117-6</ArticleId>
            <ArticleId IdType="doi">10.1016/j.jaut.2014.07.004</ArticleId>
            <ArticleId IdType="pubmed">25129504</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25129481</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>24</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1546-170X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>17</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Nature medicine</Title>
                <ISOAbbreviation>Nat. Med.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.1038/nm.3645</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Alopecia areata (AA) is a common autoimmune disease resulting from damage of the hair follicle by T cells. The immune pathways required for autoreactive T cell activation in AA are not defined limiting clinical development of rational targeted therapies. Genome-wide association studies (GWAS) implicated ligands for the NKG2D receptor (product of the KLRK1 gene) in disease pathogenesis. Here, we show that cytotoxic CD8(+)NKG2D(+) T cells are both necessary and sufficient for the induction of AA in mouse models of disease. Global transcriptional profiling of mouse and human AA skin revealed gene expression signatures indicative of cytotoxic T cell infiltration, an interferon-?? (IFN-??) response and upregulation of several ??-chain (??c) cytokines known to promote the activation and survival of IFN-??-producing CD8(+)NKG2D(+) effector T cells. Therapeutically, antibody-mediated blockade of IFN-??, interleukin-2 (IL-2) or interleukin-15 receptor ?? (IL-15R??) prevented disease development, reducing the accumulation of CD8(+)NKG2D(+) T cells in the skin and the dermal IFN response in a mouse model of AA. Systemically administered pharmacological inhibitors of Janus kinase (JAK) family protein tyrosine kinases, downstream effectors of the IFN-?? and ??c cytokine receptors, eliminated the IFN signature and prevented the development of AA, while topical administration promoted hair regrowth and reversed established disease. Notably, three patients treated with oral ruxolitinib, an inhibitor of JAK1 and JAK2, achieved near-complete hair regrowth within 5 months of treatment, suggesting the potential clinical utility of JAK inhibition in human AA.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Xing</LastName>
                    <ForeName>Luzhou</ForeName>
                    <Initials>L</Initials>
                    <Affiliation>1] Department of Pathology, Columbia University, New York, New York, USA. [2].</Affiliation>
                </Author>
                <Author>
                    <LastName>Dai</LastName>
                    <ForeName>Zhenpeng</ForeName>
                    <Initials>Z</Initials>
                    <Affiliation>1] Department of Dermatology, Columbia University, New York, New York, USA. [2].</Affiliation>
                </Author>
                <Author>
                    <LastName>Jabbari</LastName>
                    <ForeName>Ali</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>1] Department of Dermatology, Columbia University, New York, New York, USA. [2].</Affiliation>
                </Author>
                <Author>
                    <LastName>Cerise</LastName>
                    <ForeName>Jane E</ForeName>
                    <Initials>JE</Initials>
                    <Affiliation>1] Department of Dermatology, Columbia University, New York, New York, USA. [2] Department of Psychiatry, Columbia University, New York, New York, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Higgins</LastName>
                    <ForeName>Claire A</ForeName>
                    <Initials>CA</Initials>
                    <Affiliation>Department of Dermatology, Columbia University, New York, New York, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Gong</LastName>
                    <ForeName>Weijuan</ForeName>
                    <Initials>W</Initials>
                    <Affiliation>Department of Dermatology, Columbia University, New York, New York, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>de Jong</LastName>
                    <ForeName>Annemieke</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Department of Dermatology, Columbia University, New York, New York, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Harel</LastName>
                    <ForeName>Sivan</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Department of Dermatology, Columbia University, New York, New York, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>DeStefano</LastName>
                    <ForeName>Gina M</ForeName>
                    <Initials>GM</Initials>
                    <Affiliation>1] Department of Dermatology, Columbia University, New York, New York, USA. [2] Department of Epidemiology, Columbia University, New York, New York, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Rothman</LastName>
                    <ForeName>Lisa</ForeName>
                    <Initials>L</Initials>
                    <Affiliation>Department of Dermatology, Columbia University, New York, New York, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Singh</LastName>
                    <ForeName>Pallavi</ForeName>
                    <Initials>P</Initials>
                    <Affiliation>Department of Dermatology, Columbia University, New York, New York, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Petukhova</LastName>
                    <ForeName>Lynn</ForeName>
                    <Initials>L</Initials>
                    <Affiliation>Department of Dermatology, Columbia University, New York, New York, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Mackay-Wiggan</LastName>
                    <ForeName>Julian</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>Department of Dermatology, Columbia University, New York, New York, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Christiano</LastName>
                    <ForeName>Angela M</ForeName>
                    <Initials>AM</Initials>
                    <Affiliation>1] Department of Dermatology, Columbia University, New York, New York, USA. [2] Department of Genetics and Development, Columbia University, New York, New York, USA. [3].</Affiliation>
                </Author>
                <Author>
                    <LastName>Clynes</LastName>
                    <ForeName>Raphael</ForeName>
                    <Initials>R</Initials>
                    <Affiliation>1] Department of Pathology, Columbia University, New York, New York, USA. [2] Department of Dermatology, Columbia University, New York, New York, USA. [3] Department of Medicine, Columbia University, New York, New York, USA. [4].</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>17</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Nat Med</MedlineTA>
            <NlmUniqueID>9502015</NlmUniqueID>
            <ISSNLinking>1078-8956</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2013</Year>
                <Month>12</Month>
                <Day>22</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>30</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">nm.3645</ArticleId>
            <ArticleId IdType="doi">10.1038/nm.3645</ArticleId>
            <ArticleId IdType="pubmed">25129481</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25129479</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>24</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1546-170X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>17</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Nature medicine</Title>
                <ISOAbbreviation>Nat. Med.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>CAPON-nNOS coupling can serve as a target for developing new anxiolytics.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.1038/nm.3644</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Anxiety disorders are highly prevalent psychiatric diseases. There is need for a deeper understanding of anxiety control mechanisms in the mammalian brain and for development of new anxiolytic agents. Here we report that the coupling between neuronal nitric oxide synthase (nNOS) and its carboxy-terminal PDZ ligand (CAPON) can serve as a target for developing new anxiolytic agents. Augmenting nNOS-CAPON interaction in the hippocampus of mice by overexpressing full-length CAPON gave rise to anxiogenic-like behaviors, whereas dissociating CAPON from nNOS by overexpressing CAPON-125C or CAPON-20C (the C-terminal 125 or 20 amino acids of CAPON) or delivering Tat-CAPON-12C (a peptide comprising Tat and the 12 C-terminal amino acids of CAPON) in the hippocampus of mice produced anxiolytic-like effects. Mice subjected to chronic mild stress (CMS) displayed a substantial increase in nNOS-CAPON coupling in the hippocampus and a consequent anxiogenic-like phenotype. Disrupting nNOS-CAPON coupling reversed the CMS-induced anxiogenic-like behaviors. Moreover, small-molecule blockers of nNOS-CAPON binding rapidly produced anxiolytic-like effects. Dexamethasone-induced ras protein 1 (Dexras1)-extracellular signal-regulated kinase (ERK) signaling was involved in the behavioral effects of nNOS-CAPON association. Thus, nNOS-CAPON association contributes to the modulation of anxiety-related behaviors via regulating Dexras1-ERK signaling and can serve as a target for developing potential anxiolytics.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Zhu</LastName>
                    <ForeName>Li-Juan</ForeName>
                    <Initials>LJ</Initials>
                    <Affiliation>1] Laboratory of Cerebrovascular Disease, Key Laboratory of Cardiovascular Disease and Molecular Intervention, Nanjing Medical University, Nanjing, China. [2] Department of Pharmacology, Nanjing Medical University, Nanjing, China. [3].</Affiliation>
                </Author>
                <Author>
                    <LastName>Li</LastName>
                    <ForeName>Ting-You</ForeName>
                    <Initials>TY</Initials>
                    <Affiliation>1] Department of Medicinal Chemistry, Nanjing Medical University, Nanjing, China. [2].</Affiliation>
                </Author>
                <Author>
                    <LastName>Luo</LastName>
                    <ForeName>Chun-Xia</ForeName>
                    <Initials>CX</Initials>
                    <Affiliation>1] Laboratory of Cerebrovascular Disease, Key Laboratory of Cardiovascular Disease and Molecular Intervention, Nanjing Medical University, Nanjing, China. [2] Department of Pharmacology, Nanjing Medical University, Nanjing, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Jiang</LastName>
                    <ForeName>Nan</ForeName>
                    <Initials>N</Initials>
                    <Affiliation>Department of Medicinal Chemistry, Nanjing Medical University, Nanjing, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Chang</LastName>
                    <ForeName>Lei</ForeName>
                    <Initials>L</Initials>
                    <Affiliation>1] Laboratory of Cerebrovascular Disease, Key Laboratory of Cardiovascular Disease and Molecular Intervention, Nanjing Medical University, Nanjing, China. [2] Department of Medicinal Chemistry, Nanjing Medical University, Nanjing, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Lin</LastName>
                    <ForeName>Yu-Hui</ForeName>
                    <Initials>YH</Initials>
                    <Affiliation>1] Laboratory of Cerebrovascular Disease, Key Laboratory of Cardiovascular Disease and Molecular Intervention, Nanjing Medical University, Nanjing, China. [2] Department of Pharmacology, Nanjing Medical University, Nanjing, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Zhou</LastName>
                    <ForeName>Hai-Hui</ForeName>
                    <Initials>HH</Initials>
                    <Affiliation>1] Laboratory of Cerebrovascular Disease, Key Laboratory of Cardiovascular Disease and Molecular Intervention, Nanjing Medical University, Nanjing, China. [2] Department of Pharmacology, Nanjing Medical University, Nanjing, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Chen</LastName>
                    <ForeName>Chen</ForeName>
                    <Initials>C</Initials>
                    <Affiliation>1] Laboratory of Cerebrovascular Disease, Key Laboratory of Cardiovascular Disease and Molecular Intervention, Nanjing Medical University, Nanjing, China. [2] Department of Pharmacology, Nanjing Medical University, Nanjing, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Zhang</LastName>
                    <ForeName>Yu</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Department of Pharmacology, Nanjing Medical University, Nanjing, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Lu</LastName>
                    <ForeName>Wei</ForeName>
                    <Initials>W</Initials>
                    <Affiliation>1] Department of Neurobiology, Nanjing Medical University, Nanjing, China. [2].</Affiliation>
                </Author>
                <Author>
                    <LastName>Gao</LastName>
                    <ForeName>Li-Yan</ForeName>
                    <Initials>LY</Initials>
                    <Affiliation>1] Laboratory of Cerebrovascular Disease, Key Laboratory of Cardiovascular Disease and Molecular Intervention, Nanjing Medical University, Nanjing, China. [2] Department of Pharmacology, Nanjing Medical University, Nanjing, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Ma</LastName>
                    <ForeName>Yu</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Department of Medicinal Chemistry, Nanjing Medical University, Nanjing, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Zhou</LastName>
                    <ForeName>Qi-Gang</ForeName>
                    <Initials>QG</Initials>
                    <Affiliation>Department of Pharmacology, Nanjing Medical University, Nanjing, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Hu</LastName>
                    <ForeName>Qin</ForeName>
                    <Initials>Q</Initials>
                    <Affiliation>Department of Chemistry, Nanjing Medical University, Nanjing, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Hu</LastName>
                    <ForeName>Xiao-Ling</ForeName>
                    <Initials>XL</Initials>
                    <Affiliation>Center of Drug Metabolism &amp;Pharmacokinetics, Jiangsu Simcere Pharmaceutical, Nanjing, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Zhang</LastName>
                    <ForeName>Jing</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>Department of Pharmacology, Nanjing Medical University, Nanjing, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Wu</LastName>
                    <ForeName>Hai-Yin</ForeName>
                    <Initials>HY</Initials>
                    <Affiliation>1] Laboratory of Cerebrovascular Disease, Key Laboratory of Cardiovascular Disease and Molecular Intervention, Nanjing Medical University, Nanjing, China. [2] Department of Pharmacology, Nanjing Medical University, Nanjing, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Zhu</LastName>
                    <ForeName>Dong-Ya</ForeName>
                    <Initials>DY</Initials>
                    <Affiliation>1] Laboratory of Cerebrovascular Disease, Key Laboratory of Cardiovascular Disease and Molecular Intervention, Nanjing Medical University, Nanjing, China. [2] Department of Pharmacology, Nanjing Medical University, Nanjing, China.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>17</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Nat Med</MedlineTA>
            <NlmUniqueID>9502015</NlmUniqueID>
            <ISSNLinking>1078-8956</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>2</Month>
                <Day>05</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>27</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">nm.3644</ArticleId>
            <ArticleId IdType="doi">10.1038/nm.3644</ArticleId>
            <ArticleId IdType="pubmed">25129479</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25129477</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>17</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1878-3279</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>5</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Immunobiology</Title>
                <ISOAbbreviation>Immunobiology</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Role of Fas/FasL signaling in regulation of anti-viral response during HSV-2 vaginal infection in mice.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">S0171-2985(14)00134-X</ELocationID>
            <ELocationID EIdType="doi">10.1016/j.imbio.2014.07.021</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Fas receptor-Fas ligand (FasL) signaling is involved in apoptosis of virus-infected cells but increasing evidence accumulates on Fas receptor as a mediator of apoptosis-independent processes such as induction of activating and pro-inflammatory signals. In this study, we examined the role of Fas/FasL pathway in regulation of anti-viral response to genital HSV-2 infection using a murine model of HSV-2 infection applied to C57BL6/J, B6. MRL-Faslpr/J and B6Smn.C3-Faslgld/J mice. HSV-2 infection of Fas- and FasL-deficient mice led to decreased migration of IFN-?? expressing NK cells and CD4+ T cells, but not of ???? T cells, into the vaginal tissue. The vaginal tissues of HSV-2 infected Fas- and FasL-deficient mice showed increased production of IL-10, followed by low expression of the early CD69 activation marker on CD4+ and CD8+ T cells and increased numbers of regulatory T cells (Tregs). Experiments in co-cultures of CD4+ T cells and bone marrow derived dendritic cells showed that lack of bilateral Fas-FasL signaling led to expansion of Tregs and increased production of IL-10 and TGF-??1. Our results demonstrate that Fas/FasL can regulate development of tolerogenic dendritic cells and expansion of Tregs early during HSV-2 infection, which further influences effective anti-viral response.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 Elsevier GmbH. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Krzyzowska</LastName>
                    <ForeName>Malgorzata</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Military Institute of Hygiene and Epidemiology, Warsaw, Poland; Department of Preclinical Sciences, Faculty of Veterinary Medicine, Warsaw University of Life Sciences, Warsaw, Poland. Electronic address: krzyzowskam@yahoo.com.</Affiliation>
                </Author>
                <Author>
                    <LastName>Or??owski</LastName>
                    <ForeName>Piotr</ForeName>
                    <Initials>P</Initials>
                    <Affiliation>Military Institute of Hygiene and Epidemiology, Warsaw, Poland.</Affiliation>
                </Author>
                <Author>
                    <LastName>B??ska</LastName>
                    <ForeName>Piotr</ForeName>
                    <Initials>P</Initials>
                    <Affiliation>Department of Preclinical Sciences, Faculty of Veterinary Medicine, Warsaw University of Life Sciences, Warsaw, Poland.</Affiliation>
                </Author>
                <Author>
                    <LastName>Bodera</LastName>
                    <ForeName>Pawel</ForeName>
                    <Initials>P</Initials>
                    <Affiliation>Military Institute of Hygiene and Epidemiology, Warsaw, Poland.</Affiliation>
                </Author>
                <Author>
                    <LastName>Zdanowski</LastName>
                    <ForeName>Robert</ForeName>
                    <Initials>R</Initials>
                    <Affiliation>Military Institute of Hygiene and Epidemiology, Warsaw, Poland.</Affiliation>
                </Author>
                <Author>
                    <LastName>Stankiewicz</LastName>
                    <ForeName>Wanda</ForeName>
                    <Initials>W</Initials>
                    <Affiliation>Military Institute of Hygiene and Epidemiology, Warsaw, Poland.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>5</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Immunobiology</MedlineTA>
            <NlmUniqueID>8002742</NlmUniqueID>
            <ISSNLinking>0171-2985</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Dendritic cells</Keyword>
            <Keyword MajorTopicYN="N">Fas/FasL</Keyword>
            <Keyword MajorTopicYN="N">HSV-2</Keyword>
            <Keyword MajorTopicYN="N">IL-10</Keyword>
            <Keyword MajorTopicYN="N">Tregs</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>2</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>29</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>29</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">S0171-2985(14)00134-X</ArticleId>
            <ArticleId IdType="doi">10.1016/j.imbio.2014.07.021</ArticleId>
            <ArticleId IdType="pubmed">25129477</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25129462</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Print">1995-7645</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>7</Volume>
                    <Issue>10</Issue>
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Oct</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Asian Pacific journal of tropical medicine</Title>
                <ISOAbbreviation>Asian Pac J Trop Med</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Effect of simvastatin on expression of IL17, HMGB1 and TLR4 in LN kidney tissues of rats.</ArticleTitle>
            <Pagination>
                <MedlinePgn>792-5</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/S1995-7645(14)60138-3</ELocationID>
            <ELocationID EIdType="pii" ValidYN="Y">S1995-7645(14)60138-3</ELocationID>
            <Abstract>
                <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To observe the intervention influence and effect of simvastatin on the expression of interleukin 17 (LI17), high mobility group protein 1 (HMGB1) and TLR4 path in Lupus nephritis (LN) rats.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">A total of 28 BSXSB male mice with LN (16 weeks) were randomly divided into observation group and the comparison group, observation group was given 6 mg???kg(-1)???d(-1) simvastatin in 0.1% PBS lavage for 4 weeks, the comparison group was not given any treatment. Blood urea nitrogen (BUN) level and urine trace albumin (Scr) level of two groups were determined. The expression of IL17, HMGB1 and TLR4 protein was detected using immune histochemical method, and the kidney histological damage was observed.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">BNU, LI17, HMGB1, TLR4 protein and HMGB1 mRNA in observation group was significantly lower than that in control group (P&lt;0.05); There was no statistical difference of Scr level between two groups (P&gt;0.05). Histological observation showed glomerular lesions integral of observation group was obviously lower than that of control group.</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Simvastatin can reduce the expression of IL17, HMGB1 and TLR4 protein in LN mice, thereby can inhibit the autoimmune response as a potential treatment function of LN.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 Hainan Medical College. Published by Elsevier B.V. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Qin</LastName>
                    <ForeName>Ying</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Urology Department, Shanghai Pudong Hospital of traditional Chinese medicine, Shanghai 201299, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sun</LastName>
                    <ForeName>Ya-Ting</ForeName>
                    <Initials>YT</Initials>
                    <Affiliation>Urology Department, Shuguang Hospital affiliated to Shanghai Traditional Chinese Medicine University, Shanghai 201203, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Xia</LastName>
                    <ForeName>Lin-Xia</ForeName>
                    <Initials>LX</Initials>
                    <Affiliation>Urology Department, Shanghai Pudong Hospital of traditional Chinese medicine, Shanghai 201299, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhang</LastName>
                    <ForeName>Ying-Jie</ForeName>
                    <Initials>YJ</Initials>
                    <Affiliation>Urology Department, Shuguang Hospital affiliated to Shanghai Traditional Chinese Medicine University, Shanghai 201203, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yang</LastName>
                    <ForeName>Xue-Jun</ForeName>
                    <Initials>XJ</Initials>
                    <Affiliation>Urology Department, Shuguang Hospital affiliated to Shanghai Traditional Chinese Medicine University, Shanghai 201203, China. Electronic address: qinytg1973@163.com.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>Singapore</Country>
            <MedlineTA>Asian Pac J Trop Med</MedlineTA>
            <NlmUniqueID>101533720</NlmUniqueID>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Expression</Keyword>
            <Keyword MajorTopicYN="N">HMGB1</Keyword>
            <Keyword MajorTopicYN="N">IL17</Keyword>
            <Keyword MajorTopicYN="N">Lupus nephritis</Keyword>
            <Keyword MajorTopicYN="N">Simvastatin</Keyword>
            <Keyword MajorTopicYN="N">TLR4</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>4</Month>
                <Day>10</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">S1995-7645(14)60138-3</ArticleId>
            <ArticleId IdType="doi">10.1016/S1995-7645(14)60138-3</ArticleId>
            <ArticleId IdType="pubmed">25129462</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25129458</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Print">1995-7645</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>7</Volume>
                    <Issue>10</Issue>
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Oct</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Asian Pacific journal of tropical medicine</Title>
                <ISOAbbreviation>Asian Pac J Trop Med</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Influence of As2O3 combined with ginsenosides Rg3 on inhibition of lung cancer NCI-H1299 cells and on subsistence of nude mice bearing hepatoma.</ArticleTitle>
            <Pagination>
                <MedlinePgn>772-5</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/S1995-7645(14)60134-6</ELocationID>
            <ELocationID EIdType="pii" ValidYN="Y">S1995-7645(14)60134-6</ELocationID>
            <Abstract>
                <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To study the effect of arsenic trioxide (As2O3) combined with ginsenosides Rg3 on inhibiting the NCI-H1299 lung cancer cells and subsistence in nude mice bearing hepatoma.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">MTT method was used to measure the inhibition effect of As2O3 combined Rg3 on NCI-H1299 cells, and the proliferation inhibiting effect was observed via establishing the transplanted tumor model in vitro. A total of 40 tumor-bearing nude mice were randomly divided into normal saline group, As2O3, Rg3 and As2O3+Rg3 group. Transplantation tumor model of lung cancer in nude mice was constructed, followed by injection of certain concentrations of normal saline, As2O3, ginseng saponin Rg3 and As2O3+Rg3 every day. The survival duration and the tumors size of the mice were recorded and the Kaplan-Meier curve was made; microscopic observation of apoptosis of tumor cells in vivo was done using TUNEL staining.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">After 72 h of injection, inhibition rate of tumor cell in normal saline group, As2O3 group, Rg3 group and As2O3+Rg3 group was (5.66??0.31)%, (65.58??4.75)%, (44.69??3.32)% and (82.67??5.43)%, respectively. Inhibition rate of tumor cell in As2O3 group, Rg3 group and As2O3+Rg3 group was significantly higher than that of normal saline group (P&lt;0.01); inhibition rate of tumor cells of As2O3+Rg3 group was significantly higher than that of the two groups given As2O3 or Rg3 alone (P&lt;0.01). The tumor volume of As2O3 group, Rg3 group and As2O3+Rg3 group shrank to (65.38??3.25)%, (77.68??3.43)% and (42.65??3.55)% of the original, tumor volume of saline group was 1.21 times of the original size (P&lt;0.01); Median survival of saline group, Rg3 group, As2O3 group were significantly shorter than that of As2O3+Rg3 group (P&lt;0.01); co-ordinated intervention ability of As2O3+Rg3 on NCI-H1299 cell was significantly higher than that of As2O3 or Rg3, separately.</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">As2O3 combined with Rg3 can significantly inhibit proliferation of NCI-H1299 cells in lung cancer, prolong survival of tumor-bearing nude mice, and promote tumor cell apoptosis, and have significant effect on lung cancer treatment.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 Hainan Medical College. Published by Elsevier B.V. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Che</LastName>
                    <ForeName>Jian-Bo</ForeName>
                    <Initials>JB</Initials>
                    <Affiliation>Huaihe River Hospital, Henan University, Kaifeng 475000, Henan, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Liu</LastName>
                    <ForeName>Zhong-Hua</ForeName>
                    <Initials>ZH</Initials>
                    <Affiliation>Huaihe River Hospital, Henan University, Kaifeng 475000, Henan, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ma</LastName>
                    <ForeName>Hong-Bing</ForeName>
                    <Initials>HB</Initials>
                    <Affiliation>Huaihe River Hospital, Henan University, Kaifeng 475000, Henan, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Yong</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Huaihe River Hospital, Henan University, Kaifeng 475000, Henan, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhao</LastName>
                    <ForeName>Hui</ForeName>
                    <Initials>H</Initials>
                    <Affiliation>Huaihe River Hospital, Henan University, Kaifeng 475000, Henan, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Xiao-Hui</ForeName>
                    <Initials>XH</Initials>
                    <Affiliation>Huaihe River Hospital, Henan University, Kaifeng 475000, Henan, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Liu</LastName>
                    <ForeName>Wei-Chao</ForeName>
                    <Initials>WC</Initials>
                    <Affiliation>Huaihe River Hospital, Henan University, Kaifeng 475000, Henan, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Shi</LastName>
                    <ForeName>Gong-Ning</ForeName>
                    <Initials>GN</Initials>
                    <Affiliation>Huaihe River Hospital, Henan University, Kaifeng 475000, Henan, China. Electronic address: chejbt@163.com.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>Singapore</Country>
            <MedlineTA>Asian Pac J Trop Med</MedlineTA>
            <NlmUniqueID>101533720</NlmUniqueID>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">As(2)O(3)</Keyword>
            <Keyword MajorTopicYN="N">Combination therapy</Keyword>
            <Keyword MajorTopicYN="N">Lung cancer</Keyword>
            <Keyword MajorTopicYN="N">Rg3</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>10</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>9</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">S1995-7645(14)60134-6</ArticleId>
            <ArticleId IdType="doi">10.1016/S1995-7645(14)60134-6</ArticleId>
            <ArticleId IdType="pubmed">25129458</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25129451</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>17</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1573-9546</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>17</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Purinergic signalling</Title>
                <ISOAbbreviation>Purinergic Signal.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Effect of ecto-5'-nucleotidase (eN) in astrocytes on adenosine and inosine formation.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">ATP is a gliotransmitter released from astrocytes. Extracellularly, ATP is metabolized by a series of enzymes, including ecto-5'-nucleotidase (eN; also known as CD73) which is encoded by the gene 5NTE and functions to form adenosine (ADO) from adenosine monophosphate (AMP). Under ischemic conditions, ADO levels in brain increase up to 100-fold. We used astrocytes cultured from 5NTE (+/+) or 5NTE (-/-) mice to evaluate the role of eN expressed by astrocytes in the production of ADO and inosine (INO) in response to glucose deprivation (GD) or oxygen-glucose deprivation (OGD). We also used co-cultures of these astrocytes with wild-type neurons to evaluate the role of eN expressed by astrocytes in the production of ADO and INO in response to GD, OGD, or N-methyl-D-aspartate (NMDA) treatment. As expected, astrocytes from 5NTE (+/+) mice produced adenosine from AMP; the eN inhibitor ??,??-methylene ADP (AOPCP) decreased ADO formation. In contrast, little ADO was formed by astrocytes from 5NTE (-/-) mice and AOPCP had no significant effect. GD and OGD treatment of 5NTE (+/+) astrocytes and 5NTE (+/+) astrocyte-neuron co-cultures produced extracellular ADO levels that were inhibited by AOPCP. In contrast, these conditions did not evoke ADO production in cultures containing 5NTE (-/-) astrocytes. NMDA treatment produced similar increases in ADO in both 5NTE (+/+) and 5NTE (-/-) astrocyte-neuron co-cultures; dipyridamole (DPR) but not AOPCP inhibited ADO production. These results indicate that eN is prominent in the formation of ADO from astrocytes but in astrocyte-neuron co-cultures, other enzymes or pathways contribute to rising ADO levels in ischemia-like conditions.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Chu</LastName>
                    <ForeName>Stephanie</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Department of Pharmacology and Therapeutics, University of Manitoba, A203-753 McDermot Avenue, Winnipeg, MB, R3E 0T6, Canada.</Affiliation>
                </Author>
                <Author>
                    <LastName>Xiong</LastName>
                    <ForeName>Wei</ForeName>
                    <Initials>W</Initials>
                </Author>
                <Author>
                    <LastName>Parkinson</LastName>
                    <ForeName>Fiona E</ForeName>
                    <Initials>FE</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>17</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Purinergic Signal</MedlineTA>
            <NlmUniqueID>101250499</NlmUniqueID>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>7</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>28</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="aheadofprint">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>17</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11302-014-9421-8</ArticleId>
            <ArticleId IdType="pubmed">25129451</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25129445</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>17</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1471-2407</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>14</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>16</Day>
                    </PubDate>
                </JournalIssue>
                <Title>BMC cancer</Title>
                <ISOAbbreviation>BMC Cancer</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Fluoxetine modulates breast cancer metastasis to the brain in a murine model.</ArticleTitle>
            <Pagination>
                <MedlinePgn>598</MedlinePgn>
            </Pagination>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Despite advances in the treatment of primary breast tumors, the outcome of metastatic breast cancer remains dismal. Brain metastases present a particularly difficult therapeutic target due to the &quot;sanctuary&quot; status of the brain, with resulting inability of most chemotherapeutic agents to effectively eliminate cancer cells in the brain parenchyma. A large number of breast cancer patients receive various neuroactive drugs to combat complications of systemic anti-tumor therapies and to treat concomitant diseases. One of the most prescribed groups of neuroactive medications is anti-depressants, in particular selective serotonin reuptake inhibitors (SSRIs). Since SSRIs have profound effects on the brain, it is possible that their use in breast cancer patients could affect the development of brain metastases. This would provide important insight into the mechanisms underlying brain metastasis. Surprisingly, this possibility has been poorly explored.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">We studied the effect of fluoxetine, an SSRI, on the development of brain metastatic breast cancer using MDA-MB-231BR cells in a mouse model.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">The data demonstrate that fluoxetine treatment increases the number of brain metastases, an effect accompanied by elevated permeability of the blood-brain barrier, pro-inflammatory changes in the brain, and glial activation. This suggests a possible role of brain-resident immune cells and glia in promoting increased development of brain metastases.</AbstractText>
                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Our results offer experimental evidence that neuroactive substances may influence the pathogenesis of brain metastatic disease. This provides a starting point for further investigations into possible mechanisms of interaction between various neuroactive drugs, tumor cells, and the brain microenvironment, which may lead to the discovery of compounds that inhibit metastasis to the brain.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Shapovalov</LastName>
                    <ForeName>Yuriy</ForeName>
                    <Initials>Y</Initials>
                </Author>
                <Author>
                    <LastName>Zettel</LastName>
                    <ForeName>Martha</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author>
                    <LastName>Spielman</LastName>
                    <ForeName>Sara C</ForeName>
                    <Initials>SC</Initials>
                </Author>
                <Author>
                    <LastName>Amico-Ruvio</LastName>
                    <ForeName>Stacy A</ForeName>
                    <Initials>SA</Initials>
                </Author>
                <Author>
                    <LastName>Kelly</LastName>
                    <ForeName>Emily A</ForeName>
                    <Initials>EA</Initials>
                </Author>
                <Author>
                    <LastName>Sipe</LastName>
                    <ForeName>Grayson O</ForeName>
                    <Initials>GO</Initials>
                </Author>
                <Author>
                    <LastName>Dickerson</LastName>
                    <ForeName>Ian M</ForeName>
                    <Initials>IM</Initials>
                </Author>
                <Author>
                    <LastName>Majewska</LastName>
                    <ForeName>Ania K</ForeName>
                    <Initials>AK</Initials>
                </Author>
                <Author>
                    <LastName>Brown</LastName>
                    <ForeName>Edward B</ForeName>
                    <Initials>EB</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>16</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>BMC Cancer</MedlineTA>
            <NlmUniqueID>100967800</NlmUniqueID>
            <ISSNLinking>1471-2407</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>2</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>16</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="aheadofprint">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>16</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">1471-2407-14-598</ArticleId>
            <ArticleId IdType="doi">10.1186/1471-2407-14-598</ArticleId>
            <ArticleId IdType="pubmed">25129445</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25129436</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>17</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1096-0341</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>468-470C</Volume>
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>14</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Virology</Title>
                <ISOAbbreviation>Virology</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Plasmid DNA initiates replication of yellow fever vaccine in vitro and elicits virus-specific immune response in mice.</ArticleTitle>
            <Pagination>
                <MedlinePgn>28-35</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii">S0042-6822(14)00367-5</ELocationID>
            <ELocationID EIdType="doi">10.1016/j.virol.2014.07.050</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Yellow fever (YF) causes an acute hemorrhagic fever disease in tropical Africa and Latin America. To develop a novel experimental YF vaccine, we applied iDNA infectious clone technology. The iDNA represents plasmid that encodes the full-length RNA genome of 17D vaccine downstream from a cytomegalovirus (CMV) promoter. The vaccine was designed to transcribe the full-length viral RNA and to launch 17D vaccine virus in vitro and in vivo. Transfection with 10ng of iDNA plasmid was sufficient to start replication of vaccine virus in vitro. Safety of the parental 17D and iDNA-derived 17D viruses was confirmed in AG129 mice deficient in receptors for IFN-??/??/??. Finally, direct vaccination of BALB/c mice with a single 20??g dose of iDNA plasmid resulted in seroconversion and elicitation of virus-specific neutralizing antibodies in animals. We conclude that iDNA immunization approach combines characteristics of DNA and attenuated vaccines and represents a promising vaccination strategy for YF.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 Elsevier Inc. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Tretyakova</LastName>
                    <ForeName>Irina</ForeName>
                    <Initials>I</Initials>
                    <Affiliation>Medigen, Inc., 8420 Gas House Pike, Suite S, Frederick, MD 21701, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Nickols</LastName>
                    <ForeName>Brian</ForeName>
                    <Initials>B</Initials>
                    <Affiliation>Medigen, Inc., 8420 Gas House Pike, Suite S, Frederick, MD 21701, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Hidajat</LastName>
                    <ForeName>Rachmat</ForeName>
                    <Initials>R</Initials>
                    <Affiliation>Medigen, Inc., 8420 Gas House Pike, Suite S, Frederick, MD 21701, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Jokinen</LastName>
                    <ForeName>Jenny</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>Department of Pharmacology and Toxicology, School of Medicine, Center for Predictive Medicine and Emerging Infectious Diseases, University of Louisville, Louisville, KY, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Lukashevich</LastName>
                    <ForeName>Igor S</ForeName>
                    <Initials>IS</Initials>
                    <Affiliation>Department of Pharmacology and Toxicology, School of Medicine, Center for Predictive Medicine and Emerging Infectious Diseases, University of Louisville, Louisville, KY, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Pushko</LastName>
                    <ForeName>Peter</ForeName>
                    <Initials>P</Initials>
                    <Affiliation>Medigen, Inc., 8420 Gas House Pike, Suite S, Frederick, MD 21701, USA. Electronic address: ppushko@medigen-usa.com.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>14</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Virology</MedlineTA>
            <NlmUniqueID>0110674</NlmUniqueID>
            <ISSNLinking>0042-6822</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">17D vaccine</Keyword>
            <Keyword MajorTopicYN="N">DNA vaccine</Keyword>
            <Keyword MajorTopicYN="N">Flavivirus</Keyword>
            <Keyword MajorTopicYN="N">Live attenuated vaccine</Keyword>
            <Keyword MajorTopicYN="N">YFV</Keyword>
            <Keyword MajorTopicYN="N">Yellow fever virus</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>12</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>27</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">S0042-6822(14)00367-5</ArticleId>
            <ArticleId IdType="doi">10.1016/j.virol.2014.07.050</ArticleId>
            <ArticleId IdType="pubmed">25129436</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25129402</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>17</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1935-861X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Jul</Month>
                        <Day>19</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Brain stimulation</Title>
                <ISOAbbreviation>Brain Stimul</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Endogenous Cortical Oscillations Constrain Neuromodulation by Weak Electric Fields.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">S1935-861X(14)00262-9</ELocationID>
            <ELocationID EIdType="doi">10.1016/j.brs.2014.07.033</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Transcranial alternating current stimulation (tACS) is a non-invasive brain stimulation modality that may modulate cognition by enhancing endogenous neocortical oscillations by application of sine-wave electric fields. Yet, the role of endogenous network activity in enabling and shaping the effects of tACS has remained unclear.</AbstractText>
                <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">We combined optogenetic stimulation and multichannel slice electrophysiology to elucidate how the effect of a weak sine-wave electric field depends on the ongoing cortical oscillatory activity. We hypothesized that endogenous cortical oscillations constrain neuromodulation by tACS.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">We studied the effect of weak sine-wave electric fields on oscillatory activity in mouse neocortical slices. Optogenetic control of the network activity enabled the generation of in??vivo-like cortical oscillations for studying the temporal relationship between network activity and sine-wave electric field stimulation.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Weak electric fields enhanced endogenous oscillations but failed to induce a frequency shift of the ongoing oscillation for stimulation frequencies that were not matched to the endogenous oscillation. This constraint on the effect of electric field stimulation imposed by endogenous network dynamics was limited to the case of weak electric fields targeting in??vivo-like network dynamics. Together, these results suggest that the key mechanism of tACS may be enhancing, but not overriding, intrinsic network dynamics.</AbstractText>
                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Our results contribute to understanding the inconsistent tACS results from human studies and propose that stimulation precisely adjusted in frequency to the endogenous oscillations is key to rational design of non-invasive brain stimulation paradigms.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 Elsevier Inc. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Schmidt</LastName>
                    <ForeName>Stephen L</ForeName>
                    <Initials>SL</Initials>
                    <Affiliation>Department of Psychiatry, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA; Department of Biomedical Engineering, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Iyengar</LastName>
                    <ForeName>Apoorva K</ForeName>
                    <Initials>AK</Initials>
                    <Affiliation>Department of Biology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Foulser</LastName>
                    <ForeName>A Alban</ForeName>
                    <Initials>AA</Initials>
                    <Affiliation>Department of Psychology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Boyle</LastName>
                    <ForeName>Michael R</ForeName>
                    <Initials>MR</Initials>
                    <Affiliation>Department of Psychiatry, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA; Department of Biomedical Engineering, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Fr??hlich</LastName>
                    <ForeName>Flavio</ForeName>
                    <Initials>F</Initials>
                    <Affiliation>Department of Psychiatry, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA; Neurobiology Curriculum, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA; Department of Cell Biology and Physiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA; Department of Biomedical Engineering, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA; Neuroscience Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. Electronic address: flavio_frohlich@med.unc.edu.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <GrantList>
                <Grant>
                    <GrantID>R01 MH101547</GrantID>
                    <Acronym>MH</Acronym>
                    <Agency>NIMH NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>19</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Brain Stimul</MedlineTA>
            <NlmUniqueID>101465726</NlmUniqueID>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Electric field</Keyword>
            <Keyword MajorTopicYN="N">Multielectrode array</Keyword>
            <Keyword MajorTopicYN="N">Optogenetics</Keyword>
            <Keyword MajorTopicYN="N">Resonance</Keyword>
            <Keyword MajorTopicYN="N">Transcranial alternating current stimulation</Keyword>
            <Keyword MajorTopicYN="N">tACS</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>3</Month>
                <Day>11</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>13</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">S1935-861X(14)00262-9</ArticleId>
            <ArticleId IdType="doi">10.1016/j.brs.2014.07.033</ArticleId>
            <ArticleId IdType="pubmed">25129402</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25129384</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>17</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1873-2542</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Jul</Month>
                        <Day>29</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Veterinary microbiology</Title>
                <ISOAbbreviation>Vet. Microbiol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Detection of a pneumonia virus of mice (PVM) in an African hedgehog (Atelerix arbiventris) with suspected wobbly hedgehog syndrome (WHS).</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">S0378-1135(14)00335-6</ELocationID>
            <ELocationID EIdType="doi">10.1016/j.vetmic.2014.07.012</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">A pneumonia virus of mice (PVM) from an African hedgehog (Atelerix arbiventris) with suspected wobbly hedgehog syndrome (WHS) was detected and genetically characterized. The affected hedgehog had a nonsuppurative encephalitis with vacuolization of the white matter, and the brain samples yielded RNA reads highly homogeneous to PVM strain 15 (96.5% of full genomic sequence homology by analysis of next generation sequencing). PVM antigen was also detected in the brain and the lungs immunohistochemically. A PVM was strongly suggested as a causative agent of encephalitis of a hedgehog with suspected WHS. This is a first report of PVM infection in hedgehogs.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 Elsevier B.V. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Madarame</LastName>
                    <ForeName>Hiroo</ForeName>
                    <Initials>H</Initials>
                    <Affiliation>Laboratory of Small Animal Clinics, Veterinary Teaching Hospital, Azabu University, 1-17-71, Fuchinobe, Chuo, Sagamihara 252-5201, Kanagawa, Japan. Electronic address: madarame@azabu-u.ac.jp.</Affiliation>
                </Author>
                <Author>
                    <LastName>Ogihara</LastName>
                    <ForeName>Kikumi</ForeName>
                    <Initials>K</Initials>
                    <Affiliation>Laboratory of Pathology, Department of Environmental Hygine, Azabu University, 1-17-71, Fuchinobe, Chuo, Sagamihara 252-5201, Kanagawa, Japan.</Affiliation>
                </Author>
                <Author>
                    <LastName>Kimura</LastName>
                    <ForeName>Moe</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Laboratory of Small Animal Clinics, Veterinary Teaching Hospital, Azabu University, 1-17-71, Fuchinobe, Chuo, Sagamihara 252-5201, Kanagawa, Japan.</Affiliation>
                </Author>
                <Author>
                    <LastName>Nagai</LastName>
                    <ForeName>Makoto</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Research and Education Center for Prevention of Global Infectious Diseases of Animals, Tokyo University of Agriculture and Technology, 3-5-8 Saiwai, Fuchu 183-8509, Tokyo, Japan.</Affiliation>
                </Author>
                <Author>
                    <LastName>Omatsu</LastName>
                    <ForeName>Tsutomu</ForeName>
                    <Initials>T</Initials>
                    <Affiliation>Research and Education Center for Prevention of Global Infectious Diseases of Animals, Tokyo University of Agriculture and Technology, 3-5-8 Saiwai, Fuchu 183-8509, Tokyo, Japan.</Affiliation>
                </Author>
                <Author>
                    <LastName>Ochiai</LastName>
                    <ForeName>Hideharu</ForeName>
                    <Initials>H</Initials>
                    <Affiliation>Research Institute of Biosciences, Azabu University, 1-17-71, Fuchinobe, Chuo, Sagamihara 252-5201, Kanagawa, Japan.</Affiliation>
                </Author>
                <Author>
                    <LastName>Mizutani</LastName>
                    <ForeName>Tetsyuya</ForeName>
                    <Initials>T</Initials>
                    <Affiliation>Research and Education Center for Prevention of Global Infectious Diseases of Animals, Tokyo University of Agriculture and Technology, 3-5-8 Saiwai, Fuchu 183-8509, Tokyo, Japan.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>29</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Vet Microbiol</MedlineTA>
            <NlmUniqueID>7705469</NlmUniqueID>
            <ISSNLinking>0378-1135</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">African hedgehog (Atelerix arbiventris)</Keyword>
            <Keyword MajorTopicYN="N">Encephalitis</Keyword>
            <Keyword MajorTopicYN="N">Pneumonia virus of mice (PVM)</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>4</Month>
                <Day>10</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>4</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>13</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">S0378-1135(14)00335-6</ArticleId>
            <ArticleId IdType="doi">10.1016/j.vetmic.2014.07.012</ArticleId>
            <ArticleId IdType="pubmed">25129384</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25129370</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>24</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1529-2916</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>17</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Nature immunology</Title>
                <ISOAbbreviation>Nat. Immunol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>A ThPOK-LRF transcriptional node maintains the integrity and effector potential of post-thymic CD4(+) T cells.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.1038/ni.2960</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">The transcription factor ThPOK promotes CD4(+) T cell differentiation in the thymus. Here, using a mouse strain that allows post-thymic gene deletion, we show that ThPOK maintains CD4(+) T lineage integrity and couples effector differentiation to environmental cues after antigenic stimulation. ThPOK preserved the integrity and amplitude of effector responses and was required for proper differentiation of types 1 and 2 helper T cells in vivo by restraining the expression and function of Runx3, a nuclear factor crucial for cytotoxic T cell differentiation. The transcription factor LRF acts redundantly with ThPOK to prevent the transdifferentiation of mature CD4(+) T cells into CD8(+) T cells. As such, the ThPOK-LRF transcriptional module was essential for CD4(+) T cell integrity and responses.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Vacchio</LastName>
                    <ForeName>Melanie S</ForeName>
                    <Initials>MS</Initials>
                    <Affiliation>Laboratory of Immune Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Wang</LastName>
                    <ForeName>Lie</ForeName>
                    <Initials>L</Initials>
                    <Affiliation>1] Laboratory of Immune Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA. [2].</Affiliation>
                </Author>
                <Author>
                    <LastName>Bouladoux</LastName>
                    <ForeName>Nicolas</ForeName>
                    <Initials>N</Initials>
                    <Affiliation>Mucosal Immunology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Carpenter</LastName>
                    <ForeName>Andrea C</ForeName>
                    <Initials>AC</Initials>
                    <Affiliation>Laboratory of Immune Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Xiong</LastName>
                    <ForeName>Yumei</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Laboratory of Immune Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Williams</LastName>
                    <ForeName>Linus C</ForeName>
                    <Initials>LC</Initials>
                    <Affiliation>Laboratory of Immune Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Wohlfert</LastName>
                    <ForeName>Elizabeth</ForeName>
                    <Initials>E</Initials>
                    <Affiliation>1] Mucosal Immunology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA. [2].</Affiliation>
                </Author>
                <Author>
                    <LastName>Song</LastName>
                    <ForeName>Ki-Duk</ForeName>
                    <Initials>KD</Initials>
                    <Affiliation>1] Section on Cellular and Developmental Biology, Program in Genomics of Differentiation, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA. [2].</Affiliation>
                </Author>
                <Author>
                    <LastName>Belkaid</LastName>
                    <ForeName>Yasmine</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Mucosal Immunology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Love</LastName>
                    <ForeName>Paul E</ForeName>
                    <Initials>PE</Initials>
                    <Affiliation>Section on Cellular and Developmental Biology, Program in Genomics of Differentiation, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Bosselut</LastName>
                    <ForeName>R??my</ForeName>
                    <Initials>R</Initials>
                    <Affiliation>Laboratory of Immune Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>17</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Nat Immunol</MedlineTA>
            <NlmUniqueID>100941354</NlmUniqueID>
            <ISSNLinking>1529-2908</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>3</Month>
                <Day>24</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">ni.2960</ArticleId>
            <ArticleId IdType="doi">10.1038/ni.2960</ArticleId>
            <ArticleId IdType="pubmed">25129370</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>
